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CHAPTER 1
General Introduction
ABSTRACT
The aim of this thesis is to explore orientation of detection elements on biosensor 
surfaces. To this end, diﬀ erent aspects of a biosensor set-up, such as surface che-
mistry, coupling chemistry and biological detection elements are discussed. Further 
on, the basics of surface plasmon resonance, an often used optical biosensor, are 
described.
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1.1 BIOSENSORS
The desire to provide real-time monitoring of target analytes is the driving force 
in the biosensor research sector. One of the best-known examples is the develop-
ment of the glucose biosensor for diabetes patients. The development of this biosen-
sor started with the pioneering work by Clark and Lyons in 1962.1 Glucose oxidase, 
an enzyme catalyzing the oxidation of glucose, coupled to an amperometric oxygen 
electrode was used as detection element for glucose determination. In 1967, Updike 
and Hicks2 entrapped glucose oxidase in a polyacrylamide gel on an electrode to 
generate one of the fi rst ´enzyme electrodes`. This innovation served as fundament 
for the probably most successful product generated for biomedical microanalysis: 
the glucose biosensor. This biosensor is able to determine the approximate concen-
tration of glucose in blood and is used for diabetes management, mainly because 
of its simple handling for users: ´prick-apply-read`. A small volume of blood from 
a fi nger prick is placed on a disposable test strip that the electrochemical analyzer 
reads and uses to calculate the blood glucose level. To provide this function, bio-
sensor devices such as the glucose biosensor consist of two main parts: A biological 
detection element and a transducer. The biological detection element provides spe-
cifi city by binding to an analyte of interest. In the glucose biosensor, the biological 
detection element is an enzyme (glucose oxidase) which reacts with a target analyte 
(glucose) in the blood. This binding event causes changes in optical, mass, thermal 
or electrical properties proportional to the amount of target analyte. These changes 
are converted into a measurable electrical signal by a physicochemical detector com-
ponent, the transducer. In a glucose biosensor, the reaction between glucose oxidase 
and glucose produces an electric current and this current is translated to a number 
by the transducer for an easy read-out by the user.
In addition to the health care sector, biosensing-devices fi nd their application in 
the detection of infectious diseases, food contamination or the detection of biological 
threat agents in the environment. Development in these fi elds aims for low cost, easy 
handling, reliability and miniaturization. Given the diversity of technologies availa-
ble today it is beyond the scope of this overview to cover all the changes happening 
in the biosensor fi eld. In this introduction I will treat the following aspects:
a) advances in nanotechnology leading to more sensitive detection methods, 
b) progress in surface chemistry,
c)  improved coupling chemistry and
d) development of engineered biological detection elements.
Progress in these fi elds will steer the sensitive and specifi c detection of target 
analytes in the future. 
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1.2 NANOTECHNOLOGY 
 
Nanotechnology refers to the techniques and methods for studying, designing, 
and constructing things at the nanometer scale.3 By defi nition nanotechnology uses 
materials or devices that have structural features on the nanometer scale (from 1 
to 100 nanometers).3 One nanometer (nm) is one billionth, or 10−9, of a meter. By 
comparison, chemical bonds between two atoms are in the order of 0.1 to 0.2 nm 
in length, the DNA double-helix has a diameter of about 2 nm and the bacterium 
Escherichia coli, present in the humans digestive system, is 2000 nm in length. 
Nanomaterial is especially interesting because nanoparticles possess diﬀ erent 
properties compared to the bulk material. Whereas gold is known to be relative 
inert, gold nanoparticles can act as a catalyst that can oxidize carbon monoxide.4 A 
gold nanoparticle (90 nm in size) will appear blue-green instead of being shiny as 
the bulk material. This change results from the fact that nanoparticles absorb colors 
on the red and yellow end of the color spectrum instead of refl ecting the light like 
the bulk material does.4 In the same way, ensembles of nanoparticles can possess 
collective characteristics that are diﬀ erent to those of individual nanoparticles.5 To 
explore and use these properties in new devices is the key challenge in nanotechno-
logy. Two main approaches are used in the nanotechnology world: the ´bott om-up` 
and the ´top-down` approach (Fig. 1). 
In the ´bott om-up` approach, molecular components assemble themselves via mo-
lecular recognition, without guidance from an outside source to the fi nal structure. 
Self-organization of nanoparticles can result in a variety of structures such as chains,6 
vesicles7 or crystals.8 The arrangement is directed through non-covalent interactions 
(e.g. hydrogen bonding, metal coordination, hydrophobic forces, van der Waals 
forces, π-π interactions and/or electrostatic interactions)9 as well as electromagnetic 
Figure 1. The ´bott om-up` and ´top-down` nanostructure assembly approaches.
bulk?materialnanostructured?
material
nano?building?
blocks
Bottom?up Top?down
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interactions. In nanobiotechnology, biological molecules such as carbohydrates and 
lipids can be used as building blocks for the construction of highly ordered struc-
tures as it can be observed in nature.10 The challenge is to control the assembly of 
biomolecules into bioactive nanostructures.11 
In the ´top-down` approach, larger objects are used to construct nanodevices 
without atomic-level control. A process called photolithography is often used to 
carve a desired patt ern in the material. Silicon wafers are often used in the const-
ruction of complex devices and microelectronic circuits. One simple example of the 
device fabrication process includes the formation of an SiO2 layer and its selective 
removal using photolithography. The top surface of the wafer is fi rst coated with a 
light sensitive material called photoresist. With a light source shining through the 
mask, only selected parts of the photoresist on the silicon wafer will be exposed to 
the light. When a negative resist is used, only the light exposed areas become po-
lymerized and more diﬃ  cult to dissolve in solvents. The wafer is then dipped in a 
developer that removes only non-polymerized photoresist at places where it was not 
exposed to light. Areas of the silicon wafer that are not covered with photoresist can 
then be used to etch away material. Today, the challenge to produce features that are 
much smaller than the wavelength of visible light, which is in the 400-700 nm range, 
dominate the fi eld.
With the advances in nanotechnology also the fi eld of biosensors experienced a 
revolution, especially in the area of surface characteristics. As sensors mainly opera-
te through the variation of a surface parameter, increasing the interaction area will 
lead to an increased sensitivity.12 Xie et al.13 used multi-walled carbon nanotubes in 
a novel glucose sensor to signifi cantly improve its sensitivity for glucose detection. 
The carbon nanotubes were functionalized with platinum nanoparticles and used 
to immobilize the enzyme. This improved, amongst other parameters, the loading 
of the enzyme and resulted in a higher electroactive surface area. Knowledge about 
interactions between biomolecules and inorganic materials plays a crucial role in the 
fi eld of biosensors and needs to be explored further.  
Today, scientist work towards the development of high-throughput biosensors, 
bringing together the fi eld of nanotechnology with current detection platforms. 
With the advances achieved in the fi eld of microfl uidics, the analysis of small sample 
volumes (10-9–10-18 L) as well as automated sample preparation is possible.14 Further 
developments include simultaneous multitarget (´multiplex`) bio-detection assays, 
to screen for more than only one target analyte at a time. Barcoding technologies 
using nanoparticles are under development to enable large numbers of analytes to 
be measured in a single sample.15 In this application, particles - each with a unique 
striping patt ern (e.g. a specifi c DNA sequence) - are coated with a unique detection 
element, which binds specifi cally to a particular target analyte. A conclusion can be 
drawn by a read-out of the striping patt erns. In a similar way, semiconductor nanoc-
rystals, or quantum dots (QDs) have been investigated for such purposes.16 QDs are 
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highly fl uorescent, nanometer-size (1-20 nm) clusters of a few hundred to thousands 
atoms. A glucose biosensor based on QDs was developed to accurately determine 
the concentration of glucose.17 The color of the quantum dot is determined by the 
size of the particle and can be tuned. Each color batch can be functionalized with 
diﬀ erent detection elements providing a quick and simple read-out. Such systems 
may yield next generation point of care (POC) testing solutions providing results in 
a very short period of time at or near the location of the patient and over a whole 
spectrum of diseases. 
1.3 SURFACE CHEMISTRY 
Since the relative surface area exposed to the environment increases rapidly 
as device structures become smaller and smaller, a high surface to volume ratio is 
achieved with nanomaterial such as nanoparticles or nanotubes (Fig. 2). This fact 
implies that surface properties start to play a considerable role when the volume 
decreases. Surface chemistry can be used to modify the surface characteristics, e.g. 
by the use of organic monolayers. 
Organic monolayers are thin molecular fi lms of precisely one organic molecule 
thickness att ached in a dense packing on the substrate. The att achment can be weak 
or strong, and can rely on either physical adsorption (e.g. electrostatic interactions) 
or chemical adsorptions (formation of chemical bonds).18 The work of monolayers 
on gold,19 glass20 and oxidized aluminium21 served as landmark in the fi eld of orga-
nic monolayers and nowadays organic monolayers can be prepared on numerous 
surfaces. The exceptionally thin organic monolayers (2-5 nm) can provide the in-
organic surface with added functionality via the adaptable tailoring of monolayer 
properties. Therefore, organic monolayers fi nd application in many fi elds such as 
surface hydrophobicity, surface passivation, chemical and biological sensing, and 
molecular electronics.22 These monolayers keep the bulk features of the material 
(electrical, optical, magnetic, mechanical and structural), while their surface proper-
ties (wett ing, passivation, bio-resistance, biochemical aﬃ  nity) can be tuned through 
Figure 2. Depiction of relative surface area of earth compared to a nanoparticle. 
radius = 6371 km radius = 100 nm  
surface area/volume ratio:   5 x 10-7 surface area/volume ratio: 3 x 107
earth nanoparticle
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a nanometer-sized grafting.18
Alkanethiol monolayers on gold belong to the most studied systems due to the 
high aﬃ  nity of the thiol group towards gold.23 Alkanethiols in solution self-assemble 
on the gold substrate to well defi ned self-assembled monolayers (SAMs). Because 
of the semi-covalent nature of the Au-S bond, diﬀ usion of already adsorbed alkane-
chains along the substrate is possible. As a result, monolayers on gold are nearly 
defect free.22a, 23 However, the special property of the Au-S bond is also the limitati-
on of these monolayers since these fi lms have only a limited chemical and thermal 
stability. In addition is gold not compatible with silicon complementary metal–oxi-
de–semiconductor (CMOS) due to its high diﬀ usion rate and the deep electronic 
traps it forms in silicon.24 This damages the carrier (electron and hole) properties of 
silicon-based semiconductor materials. Therefore, the industry is looking for new 
material to replace gold.
Copper was evaluated as electrical interconnection material on a semiconductor 
chip due to its high electrical conductivity and relatively high melting point.25 The 
drawback of copper is on the contrary, that it readily oxidizes in the presence of air 
and corrodes in aqueous solution. However, in principle these weaknesses might 
be overcome with densely packed organic monolayers on copper. SAMs on copper 
were fi rst studied by Laibinis and Whitesides.26 They showed that copper is more 
reactive to alkanethiols than gold and that alkanethiols form dense monolayers with 
quasi-crystalline packing.26 It was also shown that self-assembled monolayers can 
act as barrier fi lm that hamper oxidation of a copper surface.27 Therefore, with re-
gard to the biosensing interface, SAMs on oxide-free copper can be advantageous to 
achieve control at the molecular level and were investigated in this thesis. 
Next to passivation and tuning of surface properties, SAMs can be used for bio-
functionalization. Coupling of biomolecules is achieved through the intermediate 
layer between the surface and the detection element. In addition, biosensing can be 
tuned to be more selective by choosing a suitable coupling chemistry to immobilize 
the detection elements on the surface.
1.4 COUPLING CHEMISTRY
 
The function of a biosensor depends on the biochemical specifi city of the de-
tection element. The successful integration of the biological detection element with 
the transducer is the most critical component for the realization of any biosensor. 
Biomolecules such as enzymes,28 antibodies23 and microorganisms30 have been used 
as biological sensing elements. Here, only proteins will be discussed as a representa-
tive group of biomolecules to stay within the scope of this introduction. 
A protein consists of a folded polymer, a sequence formed from the 20 possible 
amino acids. Since amino acids have hydrophilic and hydrophobic groups, these po-
lymers tend to fold in aqueous solution to form an ordered three-dimensional sha-
15
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pe. This shape is characterized by a low-energy confi guration with the hydrophilic 
groups outside and the hydrophobic groups inside and driven by a number of non-
covalent interactions of the polymer such as hydrogen bonding, ionic interactions, 
van der Waals forces, and hydrophobic packing. Since the three-dimensional shape 
is responsible for the activity of the protein, any immobilization method needs to be 
compatible with the conformation of the detection element. To improve eﬃ  ciency 
and robustness of biosensors, the orientation of the surface immobilized detection 
elements is a critical factor to consider as well as the nature of its bond to the surface. 
Immobilization strategies can be divided in random and oriented approaches 
(Fig. 3). Random immobilization is often achieved using surface exposed amino acid 
residues such as amine, carboxyl or sulfh ydryl groups. In contrast uses oriented 
immobilization unique chemical functionalities (e.g. carbohydrate groups of the 
protein) or specifi c amino acid motives (e.g. His6 tag on the protein) to direct the 
immobilized protein in a specifi c position. Oriented detection elements will show an 
optimized availability for the target analyte and therefore improve biosensor perfor-
mance (Fig. 3). Immobilization can result in covalent or non-covalent protein att ach-
ment, however, in terms of stability and regeneration potential is covalent immobi-
lization advantageous. A more detailed description about available immobilization 
strategies can be found in chapter 3 of this thesis. 
1.5 ENGINEERED BIOLOGICAL DETECTION ELEMENTS 
Biosensor specifi city relies strongly on the specifi city of the immobilized de-
tection element. In the fi eld of proteins, antibodies represent a class of glycopro-
teins which were used as detection element in this thesis. Conventional antibodies 
(Immunoglobulin Gs, IgGs) consist of two light and two heavy chains (Fig. 4). The 
Figure 3. Depiction of random and oriented immobilized detection elements on a surface. 
oriented?immobilization?random?immobilization?
target?analytedetection?element
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chains are divided into constant (C) and variable (V) regions. The variable domain 
is responsible for the specifi c interaction with the antigen. Apart from conventional 
IgGs, heavy-chain IgGs can be found in dromedary, llama, alpaca and camel.31 These 
antibodies lack the light chain and have only one single domain that binds to the an-
tigen (Fig. 4). The heavy-chain antibodies can be minimized to the variable domain, 
known as VHH, which was employed in this thesis as detection element in biosensors. 
These VHHs have the same high binding ability towards the antigen as the whole 
heavy-chain IgG, but are much smaller in size, and can easily be produced in mi-
crobes such as Escherichia coli or yeast. In this thesis, VHHs specifi c for tuberculosis 
or foot-and-mouth disease virus (FMDV) were employed as detection element in 
biosensors. VHH are already very small in size and stable, but can be further ´tuned` 
using protein engineering approaches.
Protein engineering describes the process of designing proteins with advanta-
geous properties using diﬀ erent techniques of molecular biology. In this manner, 
detection elements that have a smaller size, a longer shelf-life or a higher aﬃ  nity 
towards the target analyte can be obtained.   
One method used for protein engineering is site-directed mutagenesis. This tech-
nique can be used to introduce desired changes in the protein structure if detailed 
structural knowledge of protein folding and interaction are available. Replacement, 
deletion and addition of single amino acids or short amino acid sequences can be 
performed to modify proteins. The group of Orner32 used a computational method 
to identify stability interferences in self-assembled proteins. By site-directed muta-
Figure 4. Schematic depiction of antibodies. Left: Immunoglobulin G (IgG) consists of 2 hea-
vy chains (gray/blue) and 2 light chains (green). Antigens bind to the variable regions VL and 
VH. Right: Heavy-chain IgG contains only 2 heavy chains. Antigens bind only to one variable 
domain (VHH). The VHH domain has a mass of only 15 kDa. The ribbon diagram of VHH shows 
the target analyte binding site in green.  
Heavy-chain IgG
-S-S-
-S-S-
C
N
Conventional immunoglobulin G (IgG)
-S-S-
-S-S-
=
VHH
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tion of two asparagine residues with hydrophobic amino acides, Escherichia coli 
bacterioferritin (EcBfr) proteins folded into α-helical monomers and assembled into 
more stable cages. However, to predict the eﬀ ects of various mutations remains a 
challenge.
If information about protein folding and interaction is missing, methods mi-
micking natural evolution can be applied to improve protein properties. Random 
mutagenesis via error-prone polymerase chain reaction can be applied to a protein 
followed by a selection strategy to pick out protein variants with new characteristics. 
Further rounds of mutation and selection will follow to select proteins with desired 
properties. This method was recently successfully applied to select for more tem-
perature stable bacteriolytic enzymes.33 In another approach, a technique known as 
DNA shuﬄ  ing,34 mixes and matches pieces of protein variants with improved pro-
perties in order to produce bett er results. The drawback of the two latt er methods is 
that they require high-throughput, which is not feasible for all applications. 
Eventually, even unnatural amino acids can be incorporated into proteins by pro-
tein engineering thanks to new methods that allow the inclusion of novel amino 
acids in the genetic code.35 Introduction of unique functional handles in proteins can 
therefore be used to achieve site-specifi c protein modifi cation or coupling on a bio-
sensor surface (chapter 6). Combined with recombinant protein expression in hosts 
such as bacteria, yeast or plants, numerous detection elements are available today. 
With the use of protein engineering techniques, protein properties can be adjusted 
to the needs of the biosensors. However, ´tuning` of protein properties is limited by 
the rules of biological interactions and time-consuming.   
1.6 SURFACE PLASMON RESONANCE AS MODEL BIOSENSOR
 
Diﬀ erent read-out types of biosensors evolved during the last decades. The 
´transducer`, which transforms the physical quantity into a measurable electrical 
signal, can recognize a mass change, a thermal change, an altered surface charge or a 
change in optical properties. In the latt er one, the signal measured by the transducer 
is light. The sensor detects changes in the refractive index which correlates to chan-
ges in concentration, mass or number of analyte.    
The BIAcore 3000 instrument used as model biosensor in this thesis integrates 
surface plasmon resonance (SPR) technology with a microfl uidic system to moni-
tor molecular interactions. SPR is an optical phenomenon based on total internal 
refl ection of plane polarized light at the interface between a metal fi lm and a liquid 
phase.36 Total internal refl ection of light can occur when light from the material of 
high refractive index arrives at an interface with a material of lower refractive index, 
e.g. at a metal-liquid interface. Only if the light arrives above a certain critical angle 
of incidence at the interface, no light is refracted across this interface and total inter-
nal refl ection occurs. During this phenomenon, an electromagnetic fi eld component, 
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known as evanescent wave, penetrates a short distance into the liquid phase.36 At a 
certain angle of incidence all light is adsorbed and no longer refl ected, this angle is 
known as angle of minimum refl ected intensity.36 Computer interpolation routines 
can calculate this angle to a high degree of accuracy. The interaction between target 
analyte and immobilized detection element at the surface will cause a change in the 
refractive index which will lead to a change of the angle. The measured signal is a di-
rect measure of the angle of minimum refl ected intensity. The unit of SPR response 
(Resonance Unit, RU) is an arbitrary unit where 1 RU corresponds to an angle shift 
of 0.0001°. 
SPR-sensing methods allow to observe binding on-line, meaning that a dynamic 
image of the binding events at the surface is obtained. Moreover, the analysis is 
label-free, meaning that no secondary detection elements (such as enzymes, secon-
dary antibodies or particles) are needed. The signal of SPR is proportional to the 
molecular mass of the bound analyte: small molecules like peptides are more dif-
fi cult to detect than large particles such as viruses. In the CM5 dextran sensor chips, 
used in this thesis, the gold surface is modifi ed with a carboxymethylated dextran 
layer. This dextran hydrogel layer forms a hydrophilic, fl exible environment for th e 
immobilized biomolecules with a layer-thickness of about 100 nm. 
1.7 OUTLINE OF THIS THESIS
The work presented in this thesis combines surface chemistry and protein func-
tionalization with the aim to generate a platform for oriented immobilization of anti-
bodies in biosensors. Chapter 2 investigates the formation of organic monolayers on 
oxide-free copper. Detailed studies were performed to characterize the monolayers 
and proof its quality. Apart from being the fi rst oxide-free monolayers on copper 
reported thus far, further functionalization was successfully investigated. 
Chapter 3 gives an overview about approaches used to orient antibodies on sur-
faces. It also summarizes methods used to characterize the orientation of immobi-
lized antibodies in a more direct manner.
In chapter 4 a set of detection elements for tuberculosis bacteria is described. The-
se are variable domains of llama heavy-chain antibodies, known as VHH proteins. A 
number of VHHs, selected by phage display, were expressed by Escherichia coli bac-
teria and characterized for binding towards Mycobacterium tuberculosis bacteria. 
Specifi city of VHHs was investigated and the antigen was identifi ed.
In chapter 5 the impact of orientation on the analyte binding capacity was stu-
died by SPR as model biosensor. Established techniques (NH2 coupling, biotyinylati-
on) were used to immobilize VHHs, and a comparison between oriented and random 
immobilized VHHs was made. The eﬀ ect of molecular weight, epitope number and 
aﬃ  nity of the target analyte was investigated.
In chapter 6, a novel coupling chemistry was used to immobilize VHHs, and in 
19
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this case the same chemistry could be used for oriented and random immobilizati-
on. VHHs were engineered and functionalized with a non-natural amino acid to bear 
either one or fi ve azide groups. Azide groups served as unique chemical handles on 
the VHHs and were used to click proteins onto a cyclooctyne-modifi ed surface in an 
oriented and random approach. Spectacular eﬀ ects on biosensor sensitivity were 
observed when VHHs were immobilized in an oriented manner.    
Finally, in chapter 7, the main results of this thesis are summarized and remai-
ning problems as well as ideas for future research are discussed.  
1.8 REFERENCES
1 LC Jr Clark, C Lyons Annals of the New York Academy of Sciences. 1962, 102, 29-45.
2     a) SJ Updike, GP Hicks Nature. 1967, 214, 986-988.
 b) SJ Updike, GP Hicks Science. 1967, 158, 270-272.
3 T Vo-Dinh Methods in Molecular Biology. 2005, 300, 1-13.
4 Nanotechnology For Dummies, 2nd Edition Publisher: Wiley / For Dummies.
 ISBN: 978-0-470-89191-9
5 Z Nie, A Petukhova, E Kumacheva Nature Nanotechnology. 2010, 5, 15-25.
6 a) GA DeVries, M Brunnbauer, Y Hu, AM Jackson, B Long, BT Neltner, O Uzun, 
 BH Wunsch, F Stellacci Science. 2007, 315, 358–361. 
 b) Z Nie, D Fava, E Kumacheva, S Zou, GC Walker, M Rubinstein Nature  Materials.
  2007, 6, 609–614.
7 a) S Park, JH Lim, SW Chung, CA Mirkin Science. 2004, 303, 348–351. 
 b) MS Nikolic, C Olsson, A Salcher, A Kornowski, A Rank, R Schubert, A Frömsdorf,
  H Weller, S Förster Angewandte Chemie - International Edition. 2009, 48, 2752–2754.
8  a) SY Park, AKR Lytt on-Jean, B Lee, S Weigand, GC Schatz , CA Mirkin Nature. 2008, 
 451, 553–556.
 b) CR Iacovella, SC Glotz er Nano Lett ers. 2009, 9, 1206–1211.
9 WF Smith Nature Nanotechnology. 2007, 2, 77-78.
10 Y Min, M Akbulut, K Kristiansen, Y Golan, J Israelachvili Nature Materials. 2008, 
 7, 527-538.
11 A Tinazli, J Piehler, M Beutt ler, R Guckenberger, R Tampé Nature Nanotechnology. 
 2007, 2, 220-225. 
12 VK Khanna Sensor Review. 2008, 28, 39-45.
13 J Xie, S Wang, L Aryasomayajula, VK Varadan Nanotechnology. 2007, 18, 1-9.
14 S Choi, M Gory, LYM Sin, PK Wong, J Chae Microfl uidics and Nanofl uidics. 2011, 10,
  231–247.
15 a) CS Thaxton, R Elghanian, AD Thomas, SI Stoeva, J-S Lee, ND Smith, AJ Schaeﬀ er, 
 H Klocker, W Horninger, G Bartsch, CA Mirkin PNAS. 2009, 106, 18437–18442.
 b) D Zhang, MC Huarng, EC Alocilja Biosensors & Bioelectronics. 2010, 26, 
 1736-1742.
 c) JM Nam, S-J Park, CA Mirkin Journal of the American Chemical Society. 2002, 
 124, 3820-3821.
16 Y Zhang, T-H Wang Theranostics. 2012, 2, 631-654.
17 X Li, Y Zhou, Z Zheng, X Yue, Z Dai, S Liu, Z Tang Langmuir. 2009, 2, 6580-6586. 
18  Environmental Sciences,  ´Environmental Biosensors‘ Publisher: InTech.
20
Chapter 1
 ISBN 978-953-307-486-3, Chapter 8, Silicon and Silicon-Related Surfaces for 
 Biosensor Applications.
19  RG Nuzzo, DL Allara Journal of the American Chemical Society. 1983, 105, 
 4481-4483.
20  R Maoz, J Sagiv Thin Solid Films. 1985, 132, 135.
21  DL Allara, RG Nuzzo Langmuir. 1985, 1, 45-52.
22 a) JC Love, LA Estroﬀ , JK Kriebel, RG Nuzzo, GM Whitesides Chemical 
 Reviews. 2005, 105, 1103-1169.
 b) S Onclin, BJ Ravoo, DN Reinhoudt Angewandte Chemie - International  
 Edition. 2005, 44, 6282-6304.
23  A Ulman Chemical Reviews. 1996, 96, 1533-1554.
24 a) RJ Walters, RVA van Loon, I Brunets, J Schmitz , A Polman Nature Materials.
  2010, 9, 21-25. 
 b) Z Li, P Beck, DAA Ohlberg, DR Stewart, RS Williams Surface Science. 2003,
  529, 410-418.
25 SP Murarkaa, SW Hymesa Critical Reviews in Solid State and Materials 
 Sciences. 1995, 20, 87-124.
26  PE Laibinis, GM Whitesides, DL Allara, YT Tao, A Parikh, RG Nuzzo Journal of
  the American Chemical Society. 1991, 113, 7152-7167.
27  PE Laibinis, GM Whitesides Journal of the American Chemical Society. 1992,
 114, 9022-9028.
28  SV Dzyadevych, AP Soldatkin, AV El‘skaya, C Martelet, N. Jaﬀ rezic-Renault 
 Analytica Chimica Acta. 2006, 24, 248-258.
29 PJ Conroy, S Hearty, P Leonard, RJ O‘Kennedy Seminars in Cell Development 
 and Biology. 2009, 20, 10-26.
30  Y Lei, W Chen, A Mulchandani Analytica Chimica Acta. 2006, 24, 200-210.
31 C Hamers-Casterman, T Atarhouch, S Muyldermans, G Robinson, C Hamers,
  EB Songa, N Bendahman, R Hamers Nature. 1993, 363, 446–448.
32 MS Ardejani, NX Li, BP Orner Biochemistry. 2011, 50, 4029–4037.
33 RD Heselpoth, DC Nelson Journal of Visualized Experiments. 2012, 69, 4216.
34  J Cohen Science. 2001, 293, 237. 
35  JA Johnson, YY Lu, JA Van Deventer, DA Tirrell Current Opinions in Chemical
  Biology. 2010, 14, 774–780.
36  a) J Homola, SS Yee, G Gauglitz  Sensors and Actuators B. 1999, 54, 3-15.
 b) J Homola Analytical and Bioanalytical Chemistry. 2003, 377, 528-539.


CHAPTER 2
ABSTRACT
The preparation and characterization of self-assembled monolayers on cop-
per with n-alkyl and functional thiols was investigated. Well-ordered monolayers 
were obtained, while the copper remained oxide-free. Direct att achment of N-suc-
cinimidyl mercaptoundecanoate (NHS-MUA) onto the copper surface allowed for 
the successful att achment of biomolecules, such as β-d-glucosamine, the tripeptide 
glutathione, and biotin. Notably, the copper surfaces remained oxide-free even after 
two reaction steps. All monolayers were characterized by static water contact angle 
measurements, X-ray photoelectron spectroscopy, and infrared refl ection absorpti-
on spectroscopy. In addition, the biotinylated copper surfaces were employed in the 
immobilization of biomolecules such as streptavidin.
Self-Assembled Functional Organic 
Monolayers on Oxide-Free Copper
This chapter was published as:
Mabel A. Caipa Campos, Anke K. Trilling, Menglong Yang, Marcel Giesbers, Jules Beekwil-
der, Jos M. J. Paulusse and Han Zuilhof Langmuir. 2011, 27, 8126–8133.
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2.1 INTRODUCTION
The spontaneous organization of organic molecules adsorbed onto metallic (Au, 
Cu, Ag, Pt, Hg, and Pd) and semiconducting surfaces (Si, SiO2, GaAs) has been ex-
tensively investigated.1-3 Due to their high packing density, these so-called self-as-
sembled monolayers (SAMs) enable the tailoring of surface properties such as wett a-
bility, friction, and adhesion. Moreover, functional moieties may be included, which 
allow for the development of biosensors and molecular electronics.4, 5 In particular, 
self-assembled monolayers (SAMs) formed by chemisorption of thiols onto transiti-
on metal surfaces (e.g. Au, Ag, Cu, Zn) are among the most widely studied systems.1 
Due to its high chemical inertness, high aﬃ  nity for thiols, and compatibility with 
cells, gold is the most widely employed metal.6 Ever since the preparation of the 
fi rst SAM on gold with organic disulfi des by Nuzzo and Allara,7 much research has 
focused on the modifi cation of gold surfaces with alkanethiols and functional thi-
ols.3 Apart from gold surfaces, other metal surfaces such as nickel,8, 9 zinc,10, 11 iron,12 
silver,13-15 and copper14, 16, 17 may also form close-packed monolayers; however, these 
monolayers are more prone to oxidation. The monolayers so obtained present simi-
lar surface wett ing properties as those reported for SAMs on gold. In addition, the 
incorporation of terminal functional groups (e.g. -OH, COOH, -NH2, -CONHR)13, 
18-21 has been mainly demonstrated for gold alkanethiol SAMs, making these assem-
blies highly suitable for the manipulation of interfacial properties such as wett abi-
lity, adhesion, and corrosion resistance,22-24 the selective adsorption of proteins, the 
immobilization of cells, protein repellence, and microarray applications.3 Moreover, 
provided that the alkyl chains are long enough, densely packed SAMs may be ob-
tained, which serve as an excellent protection barrier against, for example, oxygen, 
water and aqueous ions.25-28
Copper metal is characterized by several outstanding properties, such as high 
thermal and electrical conductivity and high resistance to electromigration.29, 30 In 
combination with its ready availability, it is generally the material of choice in re-
placing aluminum and gold as interconnecting materials in electronic circuits.31 Alt-
hough gold is more biocompatible than copper, gold is not semiconductor-compa-
tible, preventing integration with commonly employed silicon. The diﬀ usion of gold 
into silicon creates deep levels in the silicon band gap, which damages the carrier 
(electron and hole) properties of silicon-based semiconductor materials. On the con-
trary, copper is widely used for back-end metallization in silicon-based semicon-
ductor process technology.31 In contrast to these advantages, copper readily oxidizes 
upon exposure to air and is easily corroded in aqueous solutions, which drastically 
aﬀ ects the functions and lifetime of integrated devices. These disadvantages may, in 
principle, be overcome by the formation of a passivating SAM.3
Laibinis and Whitesides32 have performed seminal work in the fi eld of self-as-
sembled monolayers of alkanethiols on copper. Although these SAMs exhibit si-
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milar wett ability as SAMs on silver33 and gold,34-38 they diﬀ er signifi cantly in chain 
conformation and surface roughness. Their studies revealed that the adsorbed spe-
cies is a thiolate moiety, and in the case of copper surfaces, the hydrocarbon chain 
adopts a quasi-crystalline structure, where the chains are primarily extended in a 
nearly all-trans conformation and oriented close to the surface normal, at an ang-
le of approximately 12°.33 These monolayers on copper could in their experiments 
protect the metal from oxidation to a certain extent.39, 40 The formation of SAMs on 
copper was, however, severely hampered by a lack of reproducibility resulting from 
the substrates’ susceptibility toward oxidation upon exposure to air during sample 
preparation.32, 33
Over the past decade, several studies have described the development of new 
systems to protect the copper surface against oxidation, as well as the eﬀ ects of cop-
per surface oxidation on SAM quality.41-48 Diﬀ erent etching procedures have been 
investigated, such as the use of a series of diﬀ erent etching solutions (aqueous so-
lutions of HNO3 and HCl) followed by several rinsing steps,49 the electrochemical 
reduction of copper electrodes to remove the oxide layer prior to SAM formation,50 
as well as the addition of acetic acid to the thiol solution, which is suggested to act as 
an in situ etching agent during monolayer formation.42 Employing these techniques 
in the fabrication of functional monolayers on large copper surfaces while maintai-
ning their oxide-free nature remains challenging. Mechanistic studies and investi-
gations into the stability of SAMs on copper upon exposure to air as a function of 
chain length also have been reported.51, 52 The rate of oxidation of copper substrates 
was investigated by impedance and capacitance measurements, revealing that oxi-
dation of copper is signifi cantly slowed down at room temperature upon increasing 
alkanethiol chain length. It is suggested that oxidation of copper substrates aﬀ ects 
surface roughness and perturbs the hydrocarbon latt ice of the SAM into a less crys-
talline state.39 In addition, comparative studies have been reported on the use of ali-
phatic thiols, dithiols, and dithiocarboxylic acids to form SAMs on copper. Although 
molecular order of the latt er two systems is similar as observed for aliphatic thiols, 
these SAMs degrade rapidly.53 Recent studies reported on the use of isoelectronic 
selenium as an alternative linking atom for SAM formation. These systems display 
greater adsorptivity than analogous thiols, but lower surface coverages were achie-
ved.54-57 Although it has been suggested that the rich chemistry to form functional 
monolayers on gold may also be extended to copper,16, 33 the number of reports is 
still limited, evidencing the need for a robust and reproducible approach toward 
functional organic monolayers on copper while maintaining the copper substrate 
oxide-free, as is relevant for a variety of electronic biosensing schemes.
We describe here a facile and accessible wet-chemical route toward oxide-free 
copper surfaces, modifi ed with alkanethiols and functional thiols, with carboxylic 
acid, N-hydroxysuccinimide, and alcohol moieties. Both the carboxylic acid and al-
cohol functional groups are characterized by their robustness, since they are not 
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prone to degradation or side reactions. In addition, they present complementary 
reactivity, as the carboxylate group is easily activated toward further conjugation 
with nucleophiles such as amines, while alcohols readily react with a wide range 
of electrophiles. Hence, immobilizing these moieties onto a copper surface sig-
nifi cantly increases its application potential. The activation of acid moieties with 
N-hydroxysuccinimide (NHS), employing conventional carbodiimide reagents 
such as 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide (EDC), has been fre-
quently applied in the synthesis of biofunctional molecules,58-60 as well as for the 
immobilization of amine-containing biomolecules on gold and silicon surfaces.61, 62
Our group recently reported on the covalent one-step att achment of NHS ester func-
tional monolayers onto silicon surfaces using mild photochemical methods, and 
further biofunctionalization of the resulting surfaces.63 The successful facile modi-
fi cation of these silicon surfaces prompted us to employ this approach in the func-
tionalization of copper surfaces with (bio)molecules (Fig. 1). Subsequently we detail 
the conjugation of these functional monolayers with a variety of amine-functional 
biomolecules while maintaining the copper surface oxide-free, and we present pre-
liminary patt erning data.
2.2 RESULTS AND DISCUSSION
2.2.1 Monolayer Formation with Alkanethiols 
    
In order to prepare monolayers on copper with alkyl- and functional thiols, the 
protective benzotriazole layer that is typically present on wafer-quality copper sur-
faces was fi rst removed with an ethanolic solution of glycolic acid (70 wt %). The 
freshly etched substrates were immersed in neat thiols or in thiol-containing ethanol 
or toluene solution under an argon atmosphere for 16 h, as depicted in Figure 1.
Hydrophobic surfaces were obtained when employing n-decanethiol, as confi r-
med by the static water contact angle of 109°. These decanethiol monolayers on cop-
per were further characterized by X-ray photoelectron spectroscopy (XPS) of freshly 
prepared samples. Wide-scan XPS spectra reveal the presence of copper, carbon, and 
sulfur, and importantly, no oxygen or nitrogen was observed. Under our experimen-
tal conditions, the oxygen content is already, with such short alkyl chains, below the 
Figure 1. Biofunctionalization of oxide-free copper surfaces via functional thiols.
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detection limits, as observed from the O1s XPS narrow scan of the 530–536 eV region 
(Fig. 2b). The absence of nitrogen confi rms eﬃ  cient removal of the protective layer of 
benzotriazole from the copper surface. The C1s XPS narrow scan reveals the presence 
of carbon-bound carbon (C–C) at 285 eV (Fig. 2a). The absence of signals in the 165–
168 eV region in the S2p XPS narrow scan suggests that no oxidation of the thiol took 
place (Fig. S3, Appendix 1). Only a single spin–orbital doublet with a maximum at 
162 eV is observed with an intensity ratio of 1:2, confi rming the presence of thiolate 
bonds att ached to the metallic substrate, similar to those reported for gold substra-
tes.65 When other etching solutions were employed, for instance, hydrochloric acid 
in ethanol (3.3 wt %), low percentages (in the order of 1%) of oxygen are observed 
from the wide-scan XPS (Fig. S10, Appendix 1). In addition, the O1s XPS narrow scan 
in that case shows the presence of several oxidized copper species at 529.5, 530.4, 
and 531.0 eV and of water at 532.1 eV.32
The frequency shifts of the C–H stretching modes as obtained by infrared refl ec-
tion absorption spectroscopy (IRRAS) provided more insight into the ordering of 
these monolayers.66 These C10 alkyl monolayers on copper do not yet display a high 
degree of ordering as indicated by the CH2 stretching vibrations (νanti = 2921 cm–1; 
νsymm = 2851 cm–1), in line with observations of C10 thiols on Au. Increasing the length 
of the alkyl chain in the monolayer is known to increase van der Waals interactions 
and hence to enhance the ordering. Under the same experimental conditions but 
employing n-octadecanethiol, self-assembled monolayers on oxide-free copper were 
obtained as observed by XPS (Fig. S11, Appendix 1) and contact angle (110°) infor-
mation. In addition, these copper monolayers are well-ordered as determined by 
IRRAS (νanti = 2918 cm–1; νsymm = 2849 cm–1) (Fig. 3a), which is in good agreement with 
the analogous all-trans monolayers on gold (typically νanti = 2918 cm–1; νsymm = 2850 
cm–1).25, 33, 67, 68 The signals at 2954 and 2870 cm–1 are assigned to the antisymmetric 
and symmetric C–H stretching vibrations of the terminal CH3 group, respectively, 
as depicted in Figure 3a. This is in agreement with previous infrared studies carried 
Figure 2. (a) XPS C1s and (b) O1s spectra of n-decanethiol (α) and mercaptoundecanoate (MUA) 
(β) self-assembled monolayers on copper.
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out on alkanethiols SAMs on copper. For CnH2n+1SH, where n > 12, hydrocarbon 
chains adopt all-trans confi gurations, with only low percentages of gauche confor-
mers. As a result, well-ordered and more stable monolayers are obtained.33, 39, 69
The formation of high-quality monolayers depends on the concentration of the 
thiol as well as the reaction time. When the assembly reaction was conducted in 
neat n-decanethiol, similar Cu/C ratios (from XPS) were observed after 2 and 16 h 
(Fig. S2 and S3, Appendix 1). In both cases, the Cu surface displays no indication of 
oxidation. For solutions in ethanol (500 and 400 mM), only 2 h of reaction is required 
to reach the same Cu/C ratio (Fig. S4 and S5, Appendix 1). High-quality monolayers 
were also obtained when the reaction was carried out at a relatively low thiol con-
centration (50 mM), but the reaction then required 16 h to reach completion (Fig. S8, 
Appendix 1). At a thiol concentration of 10 mM, formation of the monolayer was not 
complete after 16 h, as inferred from the low C content in the XPS spectrum (Fig. 
S9, Appendix 1). This monolayer is also more prone to undergo oxidation, and only 
in this case the surface showed slight oxidation. A very small signal at 530 eV was 
observed in the O1s XPS narrow scan, indicating the presence of traces of CuO and 
Cu2O.32
2.2.2 Functional Monolayers on Oxide-Free Copper 
The assembly of monolayers by use of functional thiols was examined next. To 
this purpose, 11-mercaptoundecanoic acid (MUA) and 10-mercaptodecanol (MD) 
were selected to be employed in monolayer formation (Fig. 1).
Monolayers were prepared by the same experimental procedure as described for 
alkanethiols (200 mM, 16 h). The monolayers were fi rst characterized by static wa-
ter contact angle measurements. Both the acid- and alcohol-terminated monolayers 
Figure 3. IRRA spectra of (a) n-decanethiol and n-octadecanethiol (expanded region) and (b) 
MUA monolayer on copper. The spectra have been oﬀ set vertically for clarity. Dashed vertical 
lines mark the position of the antisymmetric and symmetric ν(CH2) mode.
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yielded hydrophilic surfaces as confi rmed by the respective contact angles of 40° 70 
and 40°. These values are similar to what was measured by Laibinis and Whitesi-
des,16 but could not be reduced further by treatment with trifl uoroacetic acid, as 
has successfully been developed for gold surfaces.70 Monolayer formation on the 
copper substrates used may proceed less ideally than on gold samples, leading to a 
slightly lower packing density and concomitantly increased exposure to CH2 moi-
eties and higher contact angles. Wide-scan XPS spectra of the acid-terminated mo-
nolayer revealed the presence of sulfur and oxygen, while the C1s XPS narrow scan 
revealed the presence of a COOH carbon atom at 289.2 eV (Fig. 2a), as well as two 
contributions at lower binding energies (286.0 and 285.0 eV), which are assigned to 
C–C=O and C–C carbon atoms, respectively (Fig. S12, Appendix 1). The ratio found 
(1.0:1.0:9.1) is in excellent agreement with the expected ratio (1:1:9). The S2p XPS nar-
row scan displayed a relatively broad signal in the area of 162–164 eV, which was 
fi t with a single spin–orbital doublet. The broad signal observed in the O1s XPS nar-
row scan was deconvoluted into two components, which are assigned to the C=O 
(532.2 eV) and C–OH (533.7 eV) oxygen atoms of the carboxylic acid moiety.71, 72 
Importantly, the narrow scan does not indicate the presence of oxidized Cu atoms, 
since no signals in the area of 529–531 eV were observed. The IRRA spectrum (Fig. 
3b) shows the characteristic C=O stretch of the acid moiety at 1715 cm–1 and the 
CH2 stretch vibrations at 2919 cm–1 and 2850 cm–1, confi rming the formation of well-
ordered monolayers on copper, as reported for similar monolayers on gold.73-75 The 
alcohol-terminated monolayers showed comparable features as the acid-terminated 
monolayers (Fig. S13, Appendix 1). The S2p XPS narrow scan also shows the presence 
of a single spin–orbital doublet, and no oxidation of the thiol was observed, since the 
O1s XPS narrow scan only displays the alcohol signal at 532.6 eV. The C1s XPS narrow 
scan revealed the presence of the C–O carbon atom at 286.5 eV, and the contribution 
at 285.0 eV is assigned to C–C carbon atoms. In addition, the ratio found (1.0:9.0) is 
in excellent agreement with the expected ratio (1:9), confi rming the presence of the 
alcohol monolayer on copper.
2.2.3 NHS Ester-Terminated Monolayers 
Aiming for facile conjugation of biomolecules, we investigated the single-step 
preparation of functional monolayers based on activated esters derived from N-
hydroxysuccinimide (NHS). The corresponding monolayers were prepared from 
N-succinimidyl mercaptoundecanoate (NHS-MUA) in toluene (200 mM, 16 h) fol-
lowing the aforementioned experimental procedure. A hydrophilic monolayer was 
obtained as indicated by a static water contact angle of 55°, similar to the 52° obtai-
ned analogously on Si(111).63 IRRAS demonstrated the presence of the NHS functio-
nality by the characteristic C=O stretching vibrations at 1817, 1788, and 1745 cm–1, 
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corresponding to the ester carbonyl stretches (Fig. S15 and Table S1, Appendix 1).63 
Furthermore, the signals for the antisymmetric and symmetric CH2 stretching vibra-
tions observed at 2919 and 2850 cm–1, respectively, again demonstrate the formation 
of a well-ordered monolayer. Wide-scan XPS data reveal the presence of sulfur and 
nitrogen, in agreement with the presence of NHS-MUA (Fig. S14, Appendix 1). The 
N1s XPS narrow scan displays one signal at 402.4 eV, while the S2p XPS narrow scan 
shows the characteristic spin–orbital doublet (163.9 and 162.6 eV), confi rming the 
successful att achment of NHS-MUA to the copper surface. The C1s XPS narrow scan 
further corroborates this att achment by the presence of the C=O carbon atom at 289.4 
eV (Fig. 4a). The signal was deconvoluted into three components. The experimental 
ratio found for these three peaks is 9.4:2.8:2.8, which is in close agreement with the 
theoretical ratio of 9:3:3.63
In addition, the O1s XPS narrow scan shows a signal at 535.2 eV, which is assigned 
to the oxygen of the C–O–N bond of the NHS moiety, and a signal at 532.8 eV that 
is assigned to the oxygen atoms of the carbonyl groups (Fig. 4b). Importantly, the 
experimental ratio found (3.1:0.9) indicates that, within experimental error, only O 
atoms that belong to the NHS-MUA monolayer are found. In addition, no O signals 
were observed with binding energies in the 529–531 eV range, again demonstrating 
the oxide-free nature of this copper surface.
Figure 4. XPS C1s and O1s spectra of a NHS ester-terminated thiol monolayer on oxide-free 
copper (a, b), and of this monolayer after reaction with glutathione (c, d).
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2.2.4 Bioconjugation Reactions 
    
Essential in the development of new sensing devices is the selective capture of 
biomolecules. This can be achieved, for instance, by making use of complex sugars,76, 
77 peptides,78 or oligo-DNA. After the successful att achment of NHS-MUA, the func-
tionalization of these monolayers with various amines was investigated. Conjugati-
on reactions were carried out at room temperature by immersion of the NHS-func-
tional copper substrates in alcoholic solutions containing the respective amine, as 
well as triethylamine, under an argon atmosphere at room temperature (Fig. 5).
The reaction of β-d-glucosamine (1) with the NHS ester-terminated monolayer 
was investigated fi rst. A water contact angle of 76° was measured for the functio-
nalized substrate, indicating the formation of a hydrophilic monolayer, though less 
hydrophilic than the original NHS-MUA monolayer (55°). The C1s XPS narrow scan 
displays a broad signal at 288.5 eV due to contributions from unreacted NHS-MUA 
as well as the newly formed amide bond (Fig. S16, Appendix 1). Shifting of the N 
signal in the N1s XPS narrow scan to lower binding energies (from 402.4 to 400.0 eV) 
confi rms the formation of an amide bond. A surface coverage of 50% was calculated 
on the basis of the C1s narrow scan spectrum. Importantly, the S2p XPS narrow scan 
and the S/Cu ratio did not change, indicating that the Cu–S bond was not aﬀ ected 
by the conjugation reaction. In addition, the O1s XPS narrow scan displays a broad 
signal, but no additional signals were observed in the area of 529–531 eV, demonst-
rating that the conjugation of the amine did not induce oxidation of the Cu surface.
The versatility of the conjugation approach was further explored for the tripepti-
de glutathione (Glu-Cys-Gly) (2) as a model peptide. Considering the steric bulk of 
this tripeptide, a relatively high conversion of 40% was achieved as determined from 
the C1s XPS narrow scan (Fig. 4c). The O1s XPS narrow scan shows a broad signal, due 
to the contributions of several diﬀ erent types of oxygen atoms (Fig. 4d). However, 
again no additional signals were observed in the area of 529–531 eV, confi rming 
the oxide-free nature of the Cu surface (Fig. S17, Appendix 1). After exposure to air 
under ambient conditions for several hours, the surface was analyzed again by XPS 
and revealed no signifi cant changes in the C1s and O1s narrow scans. IRRAS analysis 
Figure 5. Functionalization of copper surfaces with biomolecules.
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confi rmed the presence of the amide moieties at 1742 cm–1 as well as the carboxylic 
acid at 1659 cm–1 (Fig. S18 and Table S2, Appendix 1).79 The antisymmetric C–H stret-
ching vibration is shifted to higher frequencies (2921 cm–1) as compared to the CH2 
stretching vibrations of the NHS ester monolayer (2919 cm–1), suggesting that the 
alkyl chains become slightly disordered, as can be expected given the fact that the 
monolayer is now topped with a mixture of amides and unreacted NHS moieties.
Biotinylation provides for a versatile yet highly specifi c approach toward the 
att achment of complex biomolecules such as antibodies, via the biotin–streptavi-
din interaction.80 Hence, biotin was immobilized onto the copper substrate, by reac-
tion of the NHS ester-terminated monolayer with 5-(biotinamido)pentylamine (3). 
Successful att achment was confi rmed by the narrow scan XPS C1s spectrum, which 
displayed both biotin and residual NHS ester moieties; careful analysis revealed a 
biotin yield of 30% (Fig. 6a). The O1s XPS narrow scan corroborated the oxide-free 
nature of the Cu surface (Fig. S19, Appendix 1). The biotinylated copper surface was 
characterized by IRRAS. Characteristic signals for the biotin C=O stretching vibra-
tions are observed at 1711 and 1653 cm–1, which correspond to the ureido ring and 
the amide bonds, respectively (Fig. S20 and Table S4, Appendix 1). The antisymmet-
ric and symmetric C–H stretching vibrations are shifted to higher frequencies (2924 
and 2853 cm–1, respectively), as a result of the steric bulk of the biotin moieties that 
hamper a 100% substitution of the densely packed NHS groups and thus disrupt 
monolayer ordering.
2.2.5 Binding of Streptavidin 
    
The immobilization of proteins was investigated for the biotinylated copper sur-
face and the tetrameric protein streptavidin. Due to its exceptionally high binding 
aﬃ  nity toward biotin and easy functionalization of biomolecules, this well-known 
streptavidin–biotin system has been applied in a wide variety of diagnostic assays 
and tagging of molecules for imaging.80, 81 The biotinylated copper surface was incu-
bated with Alexa Fluor 635-labeled streptavidin in phosphate-buﬀ ered saline (PBS, 
pH 8.0) for 1 h. Confocal laser scanning microscopy was used to visualize the at-
Figure 6. (a) XPS C1s and (b) IRRA spectra of the biotinylated copper surface; (c) att achment of 
fl uorescently labeled streptavidin.
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tachment of streptavidin onto the biotinylated surface. Exposure of a part of the 
biotinylated surface to streptavidin resulted in successful local att achment of the 
protein as shown in Figure 6c, showing that contact patt erning techniques will be 
easily applicable to this modifi ed surface.
2.3 CONCLUSION
A variety of alkanethiols and functional thiols was successfully employed in the 
preparation of SAMs on copper while maintaining the substrate oxide-free. Detailed 
characterization demonstrated that these monolayers are well-ordered and are rea-
dily employed as a platform in the surface att achment of biomolecules. NHS ester-
terminated monolayers were conjugated with diﬀ erent amine-functional biomole-
cules, and in all cases high surface coverages were achieved, while the oxide-free 
nature of the copper substrate was maintained. The successful att achment of biotin 
to the copper surface and its binding to streptavidin oﬀ ers a promising approach 
toward the immobilization of biomolecules, whereas the use of copper greatly faci-
litates the implementation of this technique in the development of new biosensors. 
Current research eﬀ orts focus on the applicability of this approach in the binding of 
target biomolecules such as peptides, antibodies, and DNA to these self-assembled 
monolayers on copper.
2.4 MATERIALS AND METHODS
2.4.1 General Information 
    
All materials were obtained from Aldrich and used as received, unless noted 
otherwise. 5-(Biotinamido)pentylamine was purchased from Thermo Fisher Sci-
entifi c, and streptavidin (Alexa Fluor 635 conjugate) was from Invitrogen. Dichlo-
romethane, ethanol, and methanol were distilled before use. Toluene (HPLC gra-
de) was stored over 4 Å activated molecular sieves. Nuclear magnetic resonance 
(1H and 13C NMR) spectra were recorded on a Bruker Avance III 400 MHz spec-
trometer at room temperature. Chemical shifts are reported in parts per milli-
on (δ) relative to CHCl3 (7.26 ppm for 1H and 77.2 ppm for 13C) as internal refe-
rence. Static water contact angles were measured with an automated Krü ss DSA 
100 goniometer under ambient conditions. Small droplets of 3.0 μL deionized wa-
ter (18.3 MΩ·cm resistivity) were dispensed with a microsyringe. The error in the 
contact angles is ±1°. X-ray photoelectron spectroscopy (XPS) measurements were 
performed on a Jeol JPS-9200 system using a standard Al Kα source with X-ray
power of 300 W, analyzer pass energy of 10 eV, and energy resolution of <0.65 eV. 
All C1s (C–C) peaks were calibrated to binding energies of 285.0 eV. Infrared refl ec-
tion absorption spectroscopy (IRRAS) measurements were collected with a Bruker 
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spectrometer (model Tensor 27) equipped with liquid-nitrogen-cooled mercury–
cadmium–telluride (MCT) detector using a commercial variable-angle refl ection 
unit (Auto Seagull, Harrrick Scientifi c). A Harrick grid polarizer was placed in front 
of the refl ection unit and was used for measuring spectra with p-polarized (parallel) 
radiation at an incident angle of 85° with respect to the normal of the sample surface. 
Single channel transmitt ance spectra were taken at a resolution of 2 cm–1 with 2048 
scans and were referenced to a clean copper crystal, sample size 2 × 2 cm. The fl uo-
rescence images were recorded on a Zeiss Axiovert 200 M inverted microscope for 
transmitt ed light and epifl uorescence equipped with a 633 nm laser. Selected images 
were captured with a 40× or 10× objective. Contrast optimization and color scale of 
the fl uorescence images were performed employing Zen 2008 software.
2.4.2 Synthesis of N-Succinimidyl Mercaptoundecanoate (NHS-MUA) 
This compound was synthesized from 11-mercaptoundecanoic acid (MUA) and 
N-hydroxysuccinimide (NHS) via the standard N,N′-dicyclohexylcarbodiimide 
(DCC) coupling reported by Warner and co-workers.64 Under argon atmosphere, 
MUA (4.8 g, 0.022 mol) was dissolved in dry dioxane (100 mL). To this solution, 
NHS (2.90 g, 0.025 mol) and DCC (5.22 g, 0.025 mol) were added portionwise. The 
solution was cooled down to 0 °C and stirred for 2 h. The suspension formed was 
further stirred at room temperature (rt) for 16 h. The solid was fi ltered oﬀ  and the 
solution was concentrated by rotary evaporation. The resulting residue was purifi ed 
by column chromatography on silica gel (eluted with ethyl acetate and n-heptane, 
50:50). The desired compound was isolated as a crystalline powder in 80% yield 
(5.50 g, 0.017 mol) and a purity of 99.8% (GC-MS). 1H NMR (400 MHz, CDCl3): δ 
2.84 (br s, 4 H, NCOCH2), 2.63 (t, J = 7.6 Hz, 2 H, CH2–C=O), 2.54 (q, 2 H, CH2-SH), 
1.73–1.77 (m, 2 H, CH2), 1.59–1.61 (m, 2 H, CH2–CH2–SH), 1.30–1.40 (m, 12 H, CH2). 
13C NMR (100 MHz, CDCl3): δ 169.11 (N–C=O), 168.64 (C=O), 34.01 (CH2–CH2–SH), 
30.88 (CH2–SH), 29.93 (CH2), 29.21 (CH2), 29.00 (CH2), 28.98 (CH2), 28.72 (CH2), 28.32 
(CH2), 25.58 (NCOCH2), 24.62 (CH2), 24.54 (CH2).
2.4.3 Preparation of Organic Monolayers on Oxide-Free Copper 
    
Polycrystalline copper, electroplated on a silicon substrate, polished by chemo-
mechanical polishing (CMP) and coated with benzotriazole (BTA) as a corrosion in-
hibitor (470–600 nm layer thickness, NXP Semiconductors, The Netherlands), was 
used as copper source. Samples of copper (1 × 1 cm) were sonicated for 20 min in ace-
tone (semiconductor grade) in an Elma S-40 Elmasonic sonicator. The samples were 
etched in an argon-saturated 10 % solution of EKC 570 (copper-compatible post-etch 
residue remover from DuPont, consisting of 70 wt % of glycolic acid in ethanol) in 
dry ethanol for 5 min under argon. The substrates were washed with dry ethanol (20 
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mL) and dried with a stream of dry argon. Alkanethiols, neat or in solution (at con-
centrations ranging from 10 to 500 mM in dry EtOH) were poured in a small three-
neck fl ask equipped with a capillary (for the argon inlet). The solution was degassed 
for 30 min by bubbling argon through the capillary. The freshly etched Cu substrate 
was transferred, while maintaining the copper substrate under continuous fl ow of 
argon (underneath a tube with argon fl owing out), to the reaction fl ask. After additi-
on of the substrate, the capillary was moved away from the solution to avoid distur-
bing the forming monolayer. The reaction fl ask was kept at room temperature with 
a low argon fl ow for the indicated time. The copper substrate was removed from the 
solution, rinsed with dichloromethane, and sonicated for 10 min (in CH2Cl2) before 
being dried with a stream of dry argon. The same experimental procedure was em-
ployed for the modifi cation of copper surfaces with functional thiols (MD, MUA, 
NHS-MUA). In all cases, 200 mM solutions in dry toluene (2.0 mL) were employed, 
as this was found to give optimum monolayer quality. The modifi ed copper substra-
tes were characterized by static water contact angle measurements, XPS and IRRAS. 
The formation of these monolayers is fully reproducible, but only if all modifi cation 
steps are performed under argon and all samples are stored under vacuum or argon 
to prevent oxidation of the copper surface.
2.4.4 Conjugation Reactions 
    
In a small three-neck fl ask equipped with a capillary (for the argon inlet), a solu-
tion containing triethylamine (0.1 mL) and the dry amine (0.1 M) in MeOH or EtOH 
(1.9 mL) was degassed for 30 min by bubbling argon through the capillary. To this 
solution, a freshly functionalized (NHS-MUA) copper substrate (previously washed 
with dry toluene and dried with a stream of argon) was added. After the solution 
was bubbled with argon for 5 min, the capillary was moved away. The reaction 
fl ask was kept at room temperature for 16 h under argon. The copper substrates 
were rinsed and sonicated with dry ethanol and dried with a stream of argon. The 
modifi ed copper substrates were characterized by static water contact angle measu-
rements and XPS and IRRAS.
2.4.5 Binding of Fluorescently Labeled Streptavidin 
    
A freshly biotinylated surface was rinsed with dry ethanol and dried with a 
stream of argon. Subsequently, the copper substrate was immersed in a solution 
containing 0.5 mg/mL fl uorescently labeled streptavidin (excitation 633 nm, emissi-
on 647 nm) in phosphate-buﬀ ered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4 and 2 mM KH2PO4, pH 8.0) for 1 h at room temperature. The copper sub-
strate was dried with a stream of argon and rinsed with Tween-20 solution (5.0 mL, 
0.05% in PBS, pH 8.0) and 5.0 mL of PBS. The copper substrate was dried with a 
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stream of dry argon before characterization by confocal fl uorescence microscopy.
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CHAPTER 3
ABSTRACT 
Detection elements play a key role for analyte recognition in biosensors. There-
fore, detection elements with high analyte specifi city and binding strength are re-
quired. While antibodies (Abs) have been increasingly used as detection element 
in biosensors, a key challenge remains the immobilization on the biosensor surface. 
This minireview highlights recent approaches to immobilize and study Abs on sur-
faces. We fi rst introduce Ab species used as detection elements, and discuss tech-
niques recently used to elucidate Ab orientation by determination of layer thickness 
or surface topology. Then, several immobilization methods will be presented: non-
covalent and covalent surface att achment, yielding oriented or random coupled Abs. 
Finally, protein modifi cation methods applicable for oriented Ab immobilization are 
reviewed with an eye to future application. 
Antibody Orientation on Biosensor 
Surfaces: a Minireview
This chapter was published as:
Anke K. Trilling, Jules Beekwilder and Han Zuilhof. Analyst.  2013, 138, 1619-1627.
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3.1 INTRODUCTION
In the last decade, a wide variety of diﬀ erent biosensors emerged. Sensor speci-
fi city relies strongly on the properties of the immobilized detection element, which 
has stimulated the use of antibodies (Abs) or fragments thereof. In 1971,1 Abs were 
used for the fi rst time in an enzyme-linked immunosorbent assay (ELISA) to quanti-
tatively detect analytes. Nowadays, antigen–Ab interactions can be detected by a va-
riety of techniques, including quartz  crystal microbalance (QCM), surface plasmon 
resonance (SPR) and electrochemical impedance spectroscopy (EIS).
Abs with bett er aﬃ  nities and higher stabilities have been selected to improve bio-
sensor performance. Further sensor optimization was directed towards surface pre-
paration of biosensors aiming to promote specifi c binding and suppress non-specifi c 
binding. For this purpose site-specifi c coupling and immobilization of proteins are 
of great interest.2–4 
Here, we review recently applied Ab immobilization strategies. In the fi eld of 
proteins, Abs represent a small class of glycoproteins with a well-defi ned structure. 
Since Abs possess only one binding site, it can be highly advantageous to orient these 
molecules to improve biosensor performance, with improvement factors as high as 
220 being reported upon orientation.5 Similar, albeit smaller, eﬀ ects have also been 
reported by several other groups.6–14 The fi rst section of this minireview presents 
diﬀ erent types of Abs applied as detection elements. Next, methods are reviewed 
that are used to elucidate the orientation of immobilized Abs. Then, various recently 
applied non-covalent and covalent methods for Ab immobilization are summarized, 
including oriented and random immobilization of both native and engineered Ab 
species. Finally, we explore to what extent protein modifi cation techniques have 
already been implemented for Abs, and where new opportunities open up to bring 
the advantages of protein orientation closer to application in future biosensors.
3.2 ABS AS DETECTION ELEMENTS
 
There are several types of Ab structures that are currently being focused on in 
biosensing (Fig. 1). Immunoglobulin Gs (IgGs, 150 kDa, 143 x 77 x 40 Å3)15 consist of 
two light and two heavy chains, linked by disulfi de bonds to form the characteristic 
Y-shape. The chains are divided into constant (C) and variable (V) regions. On the 
second heavy chain constant region (CH2), IgGs have carbohydrate moieties (Fig. 
1).16 The variable domain bears three hypervariable regions, known as complemen-
tarity-determining regions (CDRs), which are responsible for the specifi c Ab–an-
tigen interaction. The diversity in this area allows the endless supply of Abs with 
diﬀ erent specifi city and binding strength (aﬃ  nity). 
Molecular engineering enabled the minimization of conventional Abs into smal-
ler and more stable Ab-derived fragments. Examples include Fabs (antigen bin-
43
Antibody Orientation on Biosensor Surfaces
ding fragment), or the even smaller single-chain variable fragments (scFv, 27 kDa), 
both of which still retain antigen-binding specifi city. Further size reduction into mo-
nomeric single domain Abs (sdAbs), the VH or VL, resulted in loss of aﬃ  nity towards 
the antigen,17 making time-consuming selection and aﬃ  nity maturation necessary. 
Apart from IgGs, two other Ab classes are becoming important. First, camelid 
Abs (found in dromedary, llama, alpaca and camel) (Fig. 1).18 These Abs lack the 
light chain and the fi rst constant domain of the heavy chain (CH1), leaving one single 
domain for eﬀ ective antigen binding, known as VHH or nanobody. In VHH, the C-
terminus is situated at the opposite site of the antigen binding region and represents 
an optimal target for functionalization. Second, another novel immunoglobulin with 
one variable domain (VNAR), called novel antigen receptor (IgNAR), was discovered 
in cartilaginous fi sh, such as sharks.19 
VHH, VNAR and sdAbs possess superior stability, and are highly soluble, small 
(15 kDa) monomeric binding domains that are very useful as detection elements in 
biosensors. Their value for biotechnological applications has been recently review-
ed.20–22 Antigen-specifi c Ab fragments can be selected from large libraries by a varie-
ty of methods, reviewed in the literature.23,24
Figure 1. Schematic depiction of natural Abs. (A) Immunoglobulin G (IgG) consists of 2 heavy 
chains (gray/blue) and 2 light chains (green). Antigens bind to the variable regions VL and VH. 
The CH2 domain bears a carbohydrate moiety (orange hexagon); scFv = single-chain variable 
fragment composed of VL and VH; Fab = antigen binding Ig fragment. (B) Camelid heavy-
chain Ab contains only 2 heavy chains, which are composed of one variable (VHH; antigen-bin-
ding unit) and two constant (CH2 and CH3) domains. Abs can be immobilized in an oriented 
or random fashion (see example for IgG).
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ORIENTED?
IMMOBILIZATION
?
ANTIBODIES
Antigen
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3.3 TECHNIQUES TO STUDY ANTIBODY ORIENTATION
Providing information of Ab orientation on the surface is of fundamental interest. 
Immobilized IgG can adopt four exemplary molecular orientations: side-on (one Fc 
and one Fab att ached to the surface), tail-on (Fc att ached to the surface), head-on 
(both Fabs att ached to the surface) or fl at-on (all three fragments att ached to the 
surface) (Fig. 1). For the highest analyte binding, Abs should display free antigen-
binding regions after immobilization. Controlling the orientation will therefore lead 
to bett er analyte binding resulting in improved biosensor sensitivity. 
Many techniques have been used to elucidate the presence and binding func-
tion of immobilized Abs. Fourier transform infrared refl ection (FTIR) spectroscopy 
is used to characterize the presence of specifi c chemical groups, and various fl uore-
scence microscopies help to visualize eﬃ  cient binding of analyte to Ab-functiona-
lized surfaces.25,26 In fact, spectroscopic techniques are predominately used to rough-
ly confi rm an eﬀ ective Ab orientation, with only a relatively small set of studies 
that investigate the orientation of Abs by comparing Abs immobilized in diﬀ erent 
directions. For example, SPR can be used to calculate the Ab coverage, and the rela-
tionship between the adsorbed amount and molecular orientation on the surface has 
been used earlier to distinguish between tail/head-on and side/fl at-on orientation.27 
But minimal direct information about Ab orientation can be deduced with such ap-
proaches. Here we present a selection of the techniques recently applied to characte-
rize Ab orientation in a more direct manner by measuring the layer thickness or by 
scanning of the surface (Fig. 2). It should be kept in mind that this list is not compre-
hensive, that it focuses due to space considerations on a few representative recent 
cases, and that each of these techniques still provides only limited information; to 
get the full picture, several techniques are ideally combined.
3.3.1 Atomic Force Microscopy (AFM)
In atomic force microscopy (AFM), surfaces are scanned by a nano-scale tip, im-
mobilized at the end of a cantilever, yielding resolutions below a nanometer. 3-D 
structures of soft biomaterials such as proteins can be visualized by AFM, resulting 
in a topographical surface map.28 From this information, local properties of the sur-
face such as the degree of coverage, the thickness of the layer, and the shape of the 
proteins can be deduced (Fig. 2). 
AFM is often used to deduce Ab orientation by determining the dimensions of 
the Abs. Sarkar and co-workers29 employed non-contact mode AFM to measure the 
total thickness of a surface coating before and after immobilization of IgG onto a 
protein A-coated surface. The measured change of height after IgG incubation cor-
responded roughly to the long axis of IgG, suggesting tail-on position of IgG.30 Chen 
et al.27 used AFM to measure the height of the Ab layer immobilized on a calixare-
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ne monolayer to distinguish between tail-on and side-on orientation. AFM has also 
been used to investigate Ab orientation by scanning 5 nm Au nanoparticles on sur-
faces as size standard,31 and to measure the width of the IgG arms.32 
Likewise, AFM can be used to elucidate the surface topology. Kim et al.33 com-
pared the surface roughness of Abs captured by cysteine-functionalized protein G 
(Cys-protein G) to that of a surface that captured Abs by native protein G. The more 
uniform height image obtained for Cys-protein G-modifi ed surfaces was interpreted 
Figure 2. Selection of techniques to study antibody orientation. For detailed information see 
text.
Time?of?flight secondary ion
mass spectrometry (ToF?SIMS)
Atomic force
microscopy (AFM)
Neutron?reflectometry (NR)?&
Spectroscopic ellipsometry (SE)
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as more uniformly oriented Abs. AFM was also used to study the time-dependent 
conformational change of Fabs immobilized on gold in the absence and presence of 
stabilizing polyethylene glycol (PEG) layers.34 Directly immobilized Fab fragments 
showed a fast decrease in height accompanied by a decrease of the antigen-binding 
ability. In contrast, Fabs stabilized by the PEG layer displayed a diminished height 
decrease and bett er antigen binding abilities, suggesting a slowed down change of 
conformation or/and orientation by the co-immobilized PEG-layer.
3.3.2 Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS)
High-resolution time-of-fl ight secondary ion mass spectrometry (ToF-SIMS) 
emerged as a powerful method to obtain evidence about the structure of the sur-
face by providing biophysical information about the molecular structure. This tech-
nique combines a high chemical specifi city with a good surface sensitivity (sampling 
depth 1–3 nm) by ion bombardment of a surface with a pulsed primary ion beam.35 
The resulting positively or negatively charged ions are analyzed by a time-of-fl ight 
mass analyzer, yielding a fi ngerprint of the proteins (Fig. 2). As the sampling depth 
is very shallow, these data can be used to interpret the orientation of immobilized 
proteins, and the more recently developed milder bombardments with Ar clusters 
may improve this further. 
ToF-SIMS was used by Baio et al.7 to show intensity diﬀ erences of secondary ions 
originating from asymmetrically located amino acids in the protein. Distinct orien-
tations of a variable fragment (HuLys Fv) were achieved on two diﬀ erent substrates 
– each reacting with a specifi c, tailor-made moiety at one of the termini. Comparison 
of the intensity ratios of specifi c secondary ions suggested that HuLys Fv was inde-
ed oriented in diﬀ erent ways on the two diﬀ erent substrates, although it is diﬃ  cult 
to specify any of these orientations based on the data. In another study ToF-SIMS 
was used to characterize the orientation of randomly biotinylated and site-specifi -
cally biotinylated Abs (IgGs, F(ab‘)2 and Fabs) on streptavidin surfaces.8 ToF-SIMS 
results could not be linked to specifi c locations near the analyte binding site of site-
specifi c biotinylated Abs, but unique peaks were observed in oriented Abs that were 
absent in randomly immobilized controls. This indicated that sites-pecifi c and ran-
domly biotinylated Abs were assembled in distinct orientations. The data analysis 
can be greatly facilitated by principal component analysis (PCA), as shown in an 
analogous study by the group of Lee.36 They showed that random biotinylated IgGs 
at high concentrations yield the same ToF-SIMS spectra as site-specifi c biotinylated 
IgGs. This suggests that with high concentrations orientation was achieved for both 
biotinylated Abs. At the same time Liu et al.37 showed that head-on orientation (by 
immobilizing protein A on the surface) can be distinguished from tail-on orientati-
on (by immobilizing the antigen on the surface) of immobilized Abs by combining 
ToF-SIMS with PCA. Amino acids characteristic of the Fab and Fc fragments could 
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be used to provide an image ´map` of Ab orientations across the patt erned surfaces.
3.3.3 Dual Polarization Interferometry (DPI)
Dual polarization interferometry (DPI), an optical wave-guide based analyti-
cal technique, can be used to obtain information on molecular dimensions (layer 
thickness), packing (layer refractive index, density) and stoichiometry (mass). The 
measured layer thickness can provide information on the arrangement of Abs on 
surfaces when combined with known dimensions of the molecule.
Song et al.38 used dimensions of Abs as determined by X-ray crystallography in 
correlation with layer thickness and surface coverage (or mass) to distinguish bet-
ween possible Ab orientations. The surface coverage of random immobilized Abs 
on a monolayer and oriented Abs on protein G surfaces was determined by DPI 
and compared to the reference values of ´theoretical` saturated surface coverages 
for random and oriented Abs. Tail-on orientation of IgG Abs on a protein G layer 
was further suggested by determining the layer thickness by DPI, which revealed 
a thickness of the Ab layer on protein G corresponding to the long axis of the Y-
shaped Ab.
3.3.4 Neutron Refl ectometry (NR)
Neutron refl ectometry (NR) is a neutron diﬀ raction technique to determine the 
thickness and composition of molecular layers on surfaces with a sensitivity of 2–3 
Å.39 The technique involves directing a beam of neutrons onto a fl at surface, and 
measurement of the intensity of the refl ected radiation as a function of angle or neu-
tron wavelength. Comparison of layer thickness with the molecular dimensions of 
Abs allows diﬀ erentiation between fl at-on, side-on and head-on/tail-on orientations 
of the Abs (Fig. 2). 
Using NR Zhao et al.40 determined the orientation of Abs adsorbed on silicon 
wafers at low concentration. The observed thickness of adsorbed Abs corresponded 
to the short axial length of the Ab, suggesting a fl at-on orientation. In contrast, Abs 
immobilized via the Fc region onto an engineered protein A-like (ZZctOmpA) sur-
face adopt a tail-on orientation.15 
3.3.5 Spectroscopic Ellipsometry (SE)
Spectroscopic ellipsometry (SE) analyses the state of polarized light refl ected 
from multilayer refl ective samples. The layer thickness can be deduced by a model-
based analysis based on how the light interacts with the surface (Fig. 2). This makes 
SE a valuable tool to investigate optical parameters and deposition kinetics of thin 
fi lm structures.
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Bae et al.41 determined the thickness of protein layers consisting of Abs bound to 
thiolated protein G oriented on gold. The measured thickness suggested that Abs are 
immobilized in such a manner that the Fc domain is bound to the protein G surface.
3.4 IMMOBILIZATION STRATEGIES
Strategies for immobilization may result in specifi c or random orientation of the 
Abs. The orientation is dependent on the self-organizing capacity of the antibodies, 
which may be steered by specifi c reactive groups on the surface, on the antibody, 
or on both. Specifi c orientation of immobilized Abs is not easily achieved, since Abs 
usually carry several copies of reactive groups. 
It is essential to immobilize Abs on surfaces without changing their binding ac-
tivity and specifi city. Therefore immobilization strategies should be mild. These 
strategies can usually be made compatible with the surfaces of various materials, 
by functionalizing the surface with specifi c groups. Surfaces can be used either di-
rectly or functionalized with (mono)layers, either as two-dimensional surfaces or as 
three-dimensional matrices. Gold, glass, copper, silicon nitride and silicon surfaces 
or magnetic beads represent only a small selection of surfaces used for Ab immobi-
lization.29,32,42–45 Below we will review several strategies of Ab immobilization. They 
can be distinguished by non-covalent or covalent coupling chemistry.
3.4.1 Non-covalent Immobilization
Immobilization of untreated Abs can be mediated by an intermediate protein 
directly coupled to the surface, such as protein A and protein G. These proteins 
display fi ve and two binding domains specifi c to the Fc portion of Abs, respectively. 
This results predominantly in tail-on orientation. Improvement of biosensor perfor-
mance by orienting Abs with protein A or protein G has been shown in several stu-
dies when compared to their randomly immobilized counterparts.10,25,26,43,46 Further 
improvements have been achieved by orientation of protein A or G. Feng et al.47 op-
timized the approach by forming highly organized aggregates of IgG and protein A. 
Immobilized IgG-protein A aggregates yielded three-dimensional structures on the 
surface with IgGs exposing their analyte binding sites. Johnson and Mutharasan48 
showed that the pH used for protein G adsorption on gold surfaces infl uences the 
protein G orientation and subsequent Ab binding. Often, exposed Cys residues are 
used for oriented immobilization of protein A or G. Thiolated protein G was used for 
immobilization onto a copper surface.42 Lee et al.49 prepared cysteine-functionalized 
protein G multimers to improve Ab immobilization on magnetic silica nanoparticles. 
Recombinant Cys-protein G trimers were engineered by repeated linking of protein 
G monomers via a fl exible linker. The use of such Cys-protein G trimers improved 
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Ab immobilization and enhanced the biosensor sensitivity by 10-fold compared to 
a Cys-protein G monomer setup. Brun et al.15 fused protein A domains genetically 
to a Cys-exposing variant of E. coli protein OmpA, which was embedded in a PEG 
monolayer on a gold surface, and allowed oriented binding and presentation of an-
tibodies. Ko et al.50 fused a gold-binding protein (GBP) to protein A, resulting in 
GBP–ProtA. Compared to native protein A, this fusion protein self-assembled at a 
higher density on gold surfaces and bound more IgG. Tajima et al.11 enzymatically 
conjugated protein A onto a substrate to achieve a ´super-oriented IgG` bound to 
oriented protein A. The strict control of the IgG orientation resulted in an approxi-
mately 100-fold higher aﬃ  nity than the partially oriented IgG, when protein A was 
physisorbed on the surface. 
Classically, non-covalent binding of Abs on surfaces is achieved by physical ad-
sorption, avoiding an intermediate protein. Making use of ionic bonds, electrosta-
tic and hydrophobic interactions and van der Waals forces results in non-covalent 
immobilization. Physical adsorption gives low control over the orientation of the 
Abs, even though immobilization of Abs using a pneumatic nebulizer is fast and 
reproducible.51 Zhao et al.52 studied how solution pH, salt concentration and surface 
chemistry aﬀ ect Ab adsorption onto silica surfaces. The salt concentration and pH 
did infl uence the amount of adsorbed Ab and analyte binding, but did not infl uence 
the orientation of immobilized Abs. Abs predominantly adopted fl at-on orientati-
on on the investigated surfaces. Um et al.53 introduced tail-on orientation in bound 
Abs by the electrochemical immobilization onto poly-(2-cyano-ethylpyrrole)-coated 
gold electrodes. Induction by cyclic voltammetry favored electrostatic interactions 
between the cyano group on the surface and the hydroxyl group of the Ab present 
in the Fc region. Electrochemically immobilized Abs showed an improved analyte 
binding compared to physisorbed Abs, which was att ributed to orientation eﬀ ects. 
Abs adsorbed on hydroxyapatite nanoparticles mainly orient themselves in the tail-
on position due to steric hindrance on the round surface.54 The group of Harmsen14 
showed improved orientation of adsorbed VHHs due to genetic fusion of peptide 
tags to the C-terminus, situated opposite to the analyte binding site. It was sugges-
ted that these tags trigger oriented binding on polystyrene surfaces by hydrophobic 
interactions with the surface. Nevertheless, physical interactions are generally weak 
and sensitive to changes in condition such as pH, temperature or salt concentration. 
Typically, biosensors using non-covalent binding may therefore suﬀ er from poor 
analytical performance due to lower operational and storage stability. Specifi c direc-
tional interactions between the surface and part of the Ab therefore provide a step 
forward, and are an intermediate towards covalent and fully irreversible immobili-
zation. As an example, a more stable immobilization resulting in orientation can be 
achieved when the thiol group is utilized for Ab immobilization on surfaces such 
as gold. Disulfi de bonds are a common feature of intact Abs and thiol groups can 
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be obtained under mild reduction conditions (Fig. 3). Balevicius et al.55 showed that 
oriented Ab fragments can bind 2.5 times more analyte than the intact Ab immobi-
lized in a random fashion using amine groups. An elegant light-assisted approach 
for Ab immobilization was shown by Ventura et al.56 Disulfi de bonds were broken 
upon absorption of UV light by nearby aromatic amino acids, yielding reactive thiol 
groups that are eﬀ ective for oriented binding onto gold electrodes.
Adsorption of thiol-exposing Fab fragments onto gold was also used to show 
that co-immobilization of densely packed polyethylene glycol layers improved 
the time-dependent analyte binding ability of immobilized Fab fragments.34 Albeit 
being site-specifi c, this method yields monovalent Abs, and too harsh reduction con-
ditions might inactivate Ab fragments due to the unintentional reduction of internal 
disulfi de bonds. Another immobilization method introducing orientation involves 
the fusion of a polyhistidine (His6) aﬃ  nity-tag on the C- or N-terminus of the recom-
binant protein. The His6 tag shows a high aﬃ  nity (K = 107 M-1) to Ni2+, Co2+ and Cu2+ 
surfaces. The tetradentate ligand nitriloacetate (NTA) forms hexagonal complexes 
with divalent metal ions, leaving two binding sites available for chelation with a 
histidine residue. The His6 tag on the C-terminus of a variable fragment (HuLys Fv) 
was used to control orientation onto a gold substrate.7 When compared to HuLys 
Fv immobilized onto maleimide-terminated monolayers via an N-terminal cystei-
ne, binding via the C-terminal His6 tag to Ni-loaded NTA-terminated monolayers 
showed a 10-fold higher SPR signal upon analyte binding. However, because the 
binding aﬃ  nity of the His6 tag is for several approaches still not high enough, these 
experiments might suﬀ er from undesired protein dissociation. 
Stronger non-covalent protein immobilization can be achieved by the use of the 
streptavidin–biotin interaction, one of the strongest non-covalent interactions known 
in biology. Depending on the applied biotinylation method, Abs can be immobilized 
in a random or oriented fashion. Abs randomly biotinylated at the amine groups 
were compared to oriented Abs, site-specifi cally biotinylated at the hinge region.36 
With increased immobilization concentration both biotinylated Abs adopted tail-on 
orientation, while site-specifi c biotinylated IgG became oriented at a slightly faster 
rate. Cho et al.8 compared the binding signal of random and site-specifi c biotinylated 
IgG and Fab on distinct streptavidin-coated surfaces. In a sandwich-type immuno-
assay, the group reported a 2 to 3 times higher binding signal for site-specifi cally 
biotinylated Ab species. Several other approaches to add a biotin moiety site-specifi -
cally to Abs have been employed lately. Biotinylation specifi cally at the C-terminus 
of the Ab was achieved using the enzyme carboxypeptidase Y.57 Kang and co-wor-
kers58 achieved site-specifi c biotinylation of Abs using a sugar moiety. Oxidation of 
sugar chains yielded aldehydes reactive towards hydrazine-biotin. Further, in vivo 
biotinylation of VHH was successfully explored by our group using the Avi-tag.5 This 
tag is recognized by the BirA enzyme, and biotinylation occurs at the lysine position 
of the tag. This in vivo biotinylation is somewhat time consuming, but is also extre-
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mely eﬀ ective as it improved the analyte binding by more than a 200-fold.
3.4.2 Covalent Immobilization
Covalent immobilization does, in principle, provide the best entry point to com-
bine longevity of the Ab-modifi ed surface with a high sensitivity due to a specifi c 
orientation. Therefore, a lot of eﬀ orts are currently undertaken to investigate and 
improve this area, including both by now well-known reactions of naturally present 
moieties and the developments of tailor-made, i.e. man-made, modifi cations thereof. 
So far the chemistry deployed to immobilize Abs has been limited to classical 
protein chemistries. Amine (NH2) groups present in the lysine amino acid side-chain 
on the Ab surface can be used for covalent immobilization in a random fashion (Fig. 
3). Widely used, e.g. for SPR studies, is the immobilization of Abs onto carboxy-
methylated dextran layers on gold surfaces.5,46,55 Recently, it has been shown that this 
immobilization is not completely random. Prior to covalent conjugation, Abs need 
to undergo physisorption. Orientation during physisorption depends on the surface 
pKa, isoelectric point of the Ab and the pH of the used immobilization buﬀ er, by 
optimizing the conditions one orientation can be favored.59,60 By att aching antibodies 
via the amine group to protein-repellent zwitt erionic polymer brushes Nguyen et 
al.44 prepared surfaces recognizing the antigen while preventing non-specifi c ad-
sorption of other proteins. Epoxide-functionalized polymer brushes allow another 
possibility to immobilize Abs via the amine group.61 Similarly, immobilization via 
the amine group can be achieved by the use of glutaraldehyde-functionalized sur-
faces.13,26
Another covalent approach to orientation makes use of a unique carbohydrate 
moiety at the Fc part of Abs (Fig. 3). Specifi c oxidation on the carbohydrate vicinal 
hydroxyl group via the use of periodate sodium generates aldehydes. These alde-
hydes are reactive towards aminated surfaces13 or hydrazine-functionalized dend-
rimers on surfaces,62 resulting in oriented covalent Ab coupling. Ho et al.63 used a 
boronic acid presenting surface to orient Abs via the carbohydrate moiety. Boronic 
acids form cyclic boronate esters with 1,2- and 1,3-diols present in carbohydrates of 
Abs, and thus provide an additional anchoring point, with chemistry that is largely 
orthogonal to other methods discussed in here.
Also the Fc region itself is used for oriented immobilization. Batalla et al.64 used 
heterofunctionally activated agarose matrices displaying metal chelate groups. The-
se lead to oriented non-covalent att achment of the Ab via the histidine rich Fc por-
tion of the Ab. Then, reaction of exposed amine groups with matrix-bound glyo-
xyl groups was promoted by a change of pH. The formed reversible Schiﬀ ‘s base 
bonds can then be mildly reduced by e.g. NaB(CN)H3 to obtain irreversible oriented 
and covalently att ached Abs. Another possibility to immobilize Abs via the Fc part 
makes use of intermediate proteins described before. To circumvent stability prob-
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lems of the non-covalent interaction between protein A/protein G and the Fc region, 
chemical crosslinking was successfully applied using cyanamide,65 dimethyl pime-
limidate (DMP)66 or the homobifunctional linker bis(sulfosuccinimidyl) suberate.38 
Analogously, thiol groups were explored for covalent oriented coupling of Abs, via 
reduction of the disulfi de group present in the hinge region of Abs (Fig. 3), and sub-
sequent coupling to a maleimide-functionalized surface.67
Another possibility to covalently immobilize Abs in an oriented manner makes 
use of the conserved nucleotide binding site (NBS) present in the conserved region 
of the variable domain of all Ab isotypes. This region, which has not been removed 
so far from the antigen-binding site, is rich in specifi c aromatic amino acids, and dis-
plays an aﬃ  nity for indole-3-butyric acid. Exposure to 254 nm light allows irrever-
sible photo-cross-linking of Abs onto an indole-3-butyric acid-terminated surface, 
while leaving the antigen binding site unaﬀ ected.68
These examples show the success of covalently att ached Abs, but also point to 
the potential of using and developing milder (non-denaturing), bio-orthogonal reac-
tions that allow control over the Ab direction. Today, protein coupling can be achie-
ved by a range of highly reliable chemistries. However, most of these have not been 
deployed for Abs since they rely on protein engineering and recombinant produc-
tion. Currently, bioorthogonal chemistries such as Diels–Alder reaction or Staudin-
ger ligation are widely applied for protein immobilization or functionalization, but 
Figure 3. Functional groups used for random and oriented Ab immobilization onto surfaces.
ORIENTED?IMMOBILIZATION
RANDOM?IMMOBILIZATION
reacted?with:
1. amine?group? carboxy?methylated?dextran?layers5,?46
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epoxide?functionalized?polymer?brushes61
NHS?activated?biotin*36
2. sugar?chain boronic?acid?presenting?surfaces63
hydrazine?biotin*58
aminated?surfaces13
hydrazine?functionalized?dendrimers?on?surfaces62
3. C?terminus enzyme?yielding?biotinylation*57
4. protein?A?and?G?(non?covalent)?6,?9,?15,?25,?26,?42,?43,?46,?47,?49,?50?
protein?A?and?G,?then?chemical?crosslinking?(covalent)38,?65,?66
5. thiol?group gold34,?55,?56?
maleimide?functionalized?biotin*36
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6. nucleotide?
binding?site
Indole?3?butyric?acid?followed?by?photo?cross?linking?with?UV?light68
*followed?by?immobilization?on?streptavidin?functionalized?surfaces
reduced?with:
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functional groups are often introduced via the amine group of lysine side-chains or 
the thiol group of cysteines, making such approaches unsuitable for the site-specifi c 
immobilization of Abs. Here we will limit the discussion to a selection of methods 
that would lead to site-specifi c introduction of functional groups. 
Stamos et al.69 immobilized various proteins site specifi cally via the Diels–Alder 
cycloaddition reaction70 between an O-iminoquinone group in the protein and an 
acryloyl linker on the surface. To this end, site-specifi c genetic incorporation of the 
3-NH2Tyr amino acid into proteins was performed.
The Staudinger ligation reported by Saxon and Bertozzi involves the reaction 
between an azide and a phosphine containing ester or thioester yielding a covalent 
amide bond.71 Introduction of a functional azide-group into the protein can be achie-
ved by the use of the methionine analogue azidohomoalanine.72 Unfortunately, this 
approach is only site-specifi c if no more than one methionine is surface accessible. 
To guarantee specifi city, engineering of the protein is often required. Another tech-
nology to truly site-specifi cally incorporate azides was developed by the group of 
Schulz.73 Functionally unique unnatural amino acids such as p-azido-L-phenylalani-
ne can be incorporated into proteins such as green fl uorescent protein by expressing 
orthogonal tRNAs and aminoacyl-tRNA synthetases.74 Using this approach azides 
can be incorporated into antibodies in response to amber nonsense codons at the 
preferred protein position. Another approach to introduce an azide specifi cally at 
the N- or C-terminus uses expressed protein ligation (EPL).75 EPL generates recom-
binant protein thioesters by thiolysis of intein fusion proteins reactive towards syn-
thetic peptides bearing an N-terminal cysteine, which yields a native amide bond. 
EPL has been employed in combination with a synthetic azide-containing reagent to 
produce azide-functionalized RNase A (azido-RNase A).76 Azido-RNase A was then 
site-specifi cally immobilized onto phosphine-terminated surfaces by a Staudinger 
ligation.
Sulfonylazides react with terminal alkynes under the catalysis of Cu(I) to form N-
acylsulfonamides. This ´click sulfonamide reaction` (CSR)77,78 is related to the Cu(I)-
catalyzed [3 + 2] azide–alkyne cycloaddition (CuAAC). Both reactions displayed 
specifi city during protein immobilization using alkyne-modifi ed mCerry-Ypt7 pro-
tein (at the C-terminus by ELP) on sulfonylazide- and azide-functionalized surfaces, 
respectively.79 A potential disadvantage of CuAAC is the used copper(I) catalyst. In 
contrast, the strain-promoted alkyne–azide cycloaddition (SPAAC) with cycloocty-
nes requires no additional reagent, but reacts spontaneously with azides. Diﬀ erent 
cyclooctyne variants used for surface functionalization and/or bioconjugation have 
been reviewed.80–82 Taking advantage of these mild and bioorthogonal reactions will 
most likely open up new approaches for the site-specifi c immobilization of Abs on 
surfaces. For example, Witt e et al.83 prepared anti-GFP VHH with azide or cycloocty-
ne moieties at the C-terminus using a combined shortage-click strategy to prepare 
VHH dimers. Such functionalized VHHs could also be covalently immobilized using 
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SPAAC onto cyclooctyne- or azide-functionalized surfaces, respectively.
3.5 OUTLOOK
The approaches for Ab immobilization as presented in this chapter show that a 
wide variety of immobilization methods are available for various surfaces and dif-
ferent Ab species. However, the variety of available methods also illustrates that a 
universal method is not yet available.
The limited amount of studies in which oriented Ab immobilization was quanti-
tatively compared to random Ab immobilization shows that orientation can signifi -
cantly (up to two orders of magnitude) improve the analyte binding signal. Therefo-
re, the ever increasing demands in sensitivity should lead future eﬀ orts to oriented 
immobilization of Abs. The currently most widely used method, adsorption onto 
protein-coated surfaces, is eﬀ ective, but also limited given the heterogeneous nature 
of such surfaces. Further improvements in orientation and therefore likely in sensor 
sensitivity will require involvement of tailor-made Ab modifi cations and/or novel 
bioorthogonal surface-bound or Ab-directed chemistries. Specifi cally the ongoing 
exploration in protein coupling techniques is expected to hold signifi cant promises 
for the fi eld of Ab orientation in the future. 
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CHAPTER 4
ABSTRACT
Background: Recombinant antibodies are powerful tools in engineering of novel 
diagnostics. Due to the small size and stable nature of llama antibody domains 
selected antibodies can serve as a detection reagent in multiplexed and sensitive 
assays for Mycobacterium tuberculosis (M. tb).
Methodology/Principal Findings: Antibodies for M. tb recognition were raised 
in Alpaca, and, by phage display, recombinant variable domains of heavy-chain 
antibodies (VHH) binding to M. tb antigens were isolated. Two phage display 
selection strategies were followed: one direct selection using semi-purifi ed protein 
antigen, and a depletion strategy with lysates, aiming to avoid cross-reaction to other 
mycobacteria. Both panning methods selected a set of binders with widely diﬀ ering 
complementarity determining regions. Selected recombinant VHHs were produced in 
E. coli and shown to bind immobilized lysate in direct Enzymelinked Immunosorbent 
Assay (ELISA) tests and soluble antigen by surface plasmon resonance (SPR) 
analysis. All tested VHHs were specifi c for tuberculosis-causing mycobacteria (M. 
tuberculosis, M. bovis) and exclusively recognized an immunodominant 16 kDa 
heat shock protein (hsp). The highest aﬃ  nity VHH had a dissociation constant (KD) 
of 4×10-10 M.
Conclusions/Signifi cance: A broad set of diﬀ erent llama antibodies specifi c for 16 
kDa heat shock protein of M. tuberculosis is available. This protein is highly stable 
and abundant in M. tuberculosis. The VHH that detect this protein are applied in a 
robust SPR sensor for identifi cation of tuberculosis-causing mycobacteria.
A Broad Set of Diﬀ erent Llama Antibodies 
Specifi c for a 16 kDa Heat Shock Protein 
of Mycobacterium tuberculosis
This chapter was published as:
Anke K. Trilling, Hans de Ronde, Linda Noteboom, Adele van Houwelingen, Margriet Roel-
se, Saurabh K. Srivastava, Willem Haasnoot, Maarten A. Jongsma, Arend Kolk, Han Zuilhof 
and Jules Beekwilder. PLoS ONE.  2011, 6, e26754.
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Chapter 4
4.1 INTRODUCTION
For centuries, Tuberculosis (TB) has been a severe health problem all over the 
world. Currently, it is estimated that the microbe Mycobacterium tuberculosis 
causes 9.4 million new cases of TB each year.1 Recent and alarming developments 
around TB comprise the appearance of multidrug-resistant strains and co-infection 
with HIV, both of which reduce the lifetime of tuberculosis patients signifi cantly. 
Accurate and rapid diagnosis of active TB is essential for both control of disease 
epidemic, and treatment of infected patients. Current diagnostic methods for TB 
include DNA-based, biochemical and serological approaches,2-6 but none of these 
methods is yet appropriate for the high-throughput, rapid, reliable and low-cost 
detection of TB in an aﬀ ordable near-patient test.
Classical detection methods for infectious diseases such as TB rely on rapid im-
munological detection. Use of recombinant antibodies may facilitate multiplex de-
sign of protein chips for diagnosing several potential pathogens in parallel.7 Fur-
thermore, they can be deployed in novel bio-sensing systems such as nanowires 
with very high sensitivity and potential for near patient testing.8 Llama antibody 
fragments (VHHs) are particularly suited for these applications due to their compact 
size (15 kDa)9 and remarkable physicochemical stability.10-12 Furthermore, they were 
shown to display many additional advantages over other recombinant antibodies, 
regarding cost of production, specifi city, aﬃ  nity, and especially stability under con-
ditions of diagnosis in the fi eld, which would make them suitable as detection units 
in biosensors.13
In the present study, our objective was to select and produce VHHs capable of 
recognizing Mycobacterium tuberculosis antigens. VHHs were selected by phage dis-
play from a library generated from an immunized alpaca, and characterized. All 
characterized VHHs bound to the same target - the immunodominant 16 kDa heat 
shock protein of M. tuberculosis - despite having highly diverse sequence profi les. 
The utility of the selected VHHs in sensor devices were demonstrated using a surface 
plasmon resonance set-up as model biosensor.
4.2 RESULTS
4.2.1 Generation of Recombinant Antibodies
Recombinant antibodies for M. tuberculosis detection were obtained by phage
display. A VHH phage display library with 107 clones was constructed from the lym-
phocyte RNA of an alpaca immunized with M. tuberculosis lysate. This library was 
subjected to two diﬀ erent methods of phage display selection: The fi rst method de-
ployed a direct selection on M. tuberculosis protein, enriched for 16 kDa, 24 kDa 
61
A Broad Set of Diﬀ erent Llama Antibodies
Figure 1. Whole and enriched protein lysate of M. tuberculosis. Lysate enriched for 16 kDa, 
24 kDa and 70 kDa M. tuberculosis protein (lane 1) and whole M. tuberculosis lysate (lane 2). 
Shown is a 15% SDS PAGE gel, stained by SYPRO ruby. Indicated are the positions of relevant 
size markers in kDa.
and 70 kDa proteins (Fig. 1). The second method used a depletion strategy, where 
non-specifi c phages were removed using total protein of non-tuberculosis mycobac-
teria, and positive binders were selected on lysate of M. tuberculosis. Both selection 
methods were carried out for three selection rounds. After the last selection, VHH-en-
coding DNA inserts from both selection methods were mass-excised and transferred 
into an expression vector.
For each selection method DNA sequences of 96 clones were analyzed. Ninety-
two of the 192 sequences were rejected because they suﬀ ered from premature stop 
codons or the technical quality of the sequencing reactions was poor. After removal 
of redundant seque nces, 62 unique protein sequences remained, which are shown 
in Figure 2.
Based on protein similarity, VHH sequences could be clustered into 6 groups (A, B, 
C, D, E and F) consisting of 29, 8, 6, 5, 2 and 3 members respectively (Fig. 2), while 9 
sequences could not be grouped. Both panning methods raised antibodies belonging 
to the groups A, B and D, suggesting the presence of a dominant antigen either du-
ring alpaca immunization or in vitro selection. Grouping was mainly based on the 
antigen binding regions (CDRs), where most sequence variation occurs. The length 
of the CDR3 region represents the dominant diﬀ erence between all single sequen-
ces and sequence groups, ranging from fi ve residues in group A to 27 residues in 
sequence B-B2 (Fig. 2). The variations in protein sequence and length of the antigen 
62
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Chapter 4
binding regions suggests that proteins from diﬀ erent origins with a broad range of 
sequence diversity were selected.
Sequence groups were inspected for amino acid substitutions which could clas-
sify them as VHHs, and distinguish them from canonical antibodies with heavy and 
light chain. Most of these substitutions (at positions 42, 49, 50 and 52: underlined in 
Fig. 2) could be regarded as adaptations to the absence of a light chain14, 15 resulting 
in a more soluble VHH fragment. Most prominently, the hydrophobic leucine at po-
sition 50 has changed to a water-soluble arginine in 87% of the inspected sequences. 
Other typical VHH substitutions occur at a lower frequency (15% V42->F; 64% V42-
>Y; 50% G49->E; 1.6% L50->C; 63% W52->L and 1.6% W52->G).
4.2.2 Specifi city of the Selected Antibodies
To characterize their properties into more detail, 12 clones (A-23, A-28, A-44, 
A-50, A-89, A-93, B-A1, B-B12, B-D8, B-D10, B-F9 and B-F10), representing the 6 
groups and 3 single sequences, were expressed in E. coli at 1 liter scale. Reactivity to 
M. tuberculosis protein - already used for coating in phage display - was assessed 
in a direct ELISA. All tested VHHs reacted with M. tuberculosis protein, but not with 
E. coli protein (not shown), indicating that the selected antibodies could specifi cally 
recognize M. tuberculosis. The four clones with highest binding capability in ELISA 
(A-23, A-44, A-50 and B-F10) were used for further analysis.
To investigate the capability of the VHH antibody fragments to distinguish M. 
tuberculosis from other mycobacteria, further direct ELISA experiments were car-
ried out. For this purpose diﬀ erent lysates of M. tuberculosis substrains as well as 
other Mycobacterium species and respiratory pathogens were tested. VHH antibody 
fragments reacted well with all M. tuberculosis substrains and M. bcg in diﬀ erent 
intensities, but not with M. avium, M. kanssasi, M. smegmatis, S. pneumoniae and 
H. infl uenzae (Fig. 3B). Thus, the selected antibodies displayed selectivity for M. 
tuberculosis.
4.2.3 Characterization of VHH Antibody
The subcellular localization of the antigen recognized by the four selected VHHs 
(A-23, A-44, A-50 and B-F10) was further investigated. To this end, M. tuberculosis 
whole cells, M. tuberculosis cell lysate and the media in which M. tuberculosis bac-
teria had grown was tested in direct ELISA. In all experiments signal was calibra-
ted with those of the media (Middlebrook 7H9) or the buﬀ er (phosphate-buﬀ ered 
saline). It appeared that the VHHs bind most strongly to the M. tuberculosis protein 
lysate (Fig. 3A), indicating that they recognize an intracellular antigen.
To identify the target protein of the four selected VHH antibody fragments, wes-
tern blot analysis of M. tuberculosis lysate was carried out. As exemplifi ed in Figure 
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4A for VHH A-23, all four tested clones (A-23, A-44, A-50 and B-F10) showed binding 
to a protein of 16 kDa size. Testing of a number of other selected VHH antibodies (A-
28, A-89, A-93, B-A1, B-B12, B-D8, B-D10 and B-F9) revealed that all VHHs bind to a 
16 kDa protein (data not shown).
A 16 kDa heat shock protein of M. tuberculosis has been reported before to re-
Figure 3. Direct ELISA to confi rm specifi c binging of VHH antibody fragments to tuberculosis 
lysate. VHH antibody fragments A-23 and B-F10 with A) M. tuberculosis whole cells, M. tu-
berculosis cell lysate and media in which M. tuberculosis bacteria were grown. B) diﬀ erent 
M. tuberculosis lysates as well as lysates of M. bcg, M. avium, M. kansasii, M. smegmatis, S. 
pneumoniae and H. infl uenzae. Measurements were performed in duplicate, expressed as 
means ± SD.
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present an immunodominant protein and its gene was cloned.16-20 To confi rm that 
the band on the western blot corresponded to the 16 kDa hsp reported in the litera-
ture, two experiments were performed. Firstly a western blot analysis was perfor-
med, testing the VHH A-23 side-by-side to the mouse monoclonal antibody MoAb 
F24, which specifi cally recognizes the 16 kDa hsp.21 Both tested antibodies bound 
an identical patt ern of bands with a major band around 16 kDa (Fig. 4B, lane 1 and 
2). Secondly, the gene encoding the 16 kDa hsp of M. tuberculosis was cloned and 
expressed in E .coli. Purifi ed 16 kDa heat shock protein of E. coli was analyzed by 
western blott ing. VHH A-23 showed reactivity to the recombinant 16 kDa hsp (Fig. 
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Figure 4. Western blot to discover antigen of VHHs. A) Western blot using VHH A-23 as a probe. 
9 μg M. tb 1 lysate were run on a 15% SDS-PAGE gel in lanes 1–4, and transferred to a nit-
rocellulose membrane. Lane 1: incubated with VHH A-23 and detected using anti-VSV-HRP; 
Lane 2: incubated with VHH A-23 and detected using anti-His6-HRP; Lane 3: incubated with 
detection antibody anti-VSV-HRP; Lane 4: incubated with detection antibody anti-His6-HRP. 
B) Western blot analysis to confi rm the specifi city of VHH A-23. Lane 1: 9 μg M. tb 22 lysate 
detected by monoclonal mouse 16 kDa antibody, using anti-mouse-HRP secondary antibody; 
Lane 2: 9 μg M. tb 22 lysate detected by VHH A-23, using anti-VSV-HRP secondary antibody. 
Lane 3: 3 μg of purifi ed recombinant 16 kDa protein detected by VHH A-23, using anti-VSV-
HRP secondary antibody. Due to the tags added for purifi cation and detection purposes the 
calculated mass of the recombinant 16 kDa protein is 21 kDa. Indicated are the positions of 
relevant size markers in kDa. C) Western blot analysis of native PAGE analysis. Lane 1: 5 μg 
M. tb 27 lysate; Lane 2: 1 μg of purifi ed recombinant 16 kDa protein. Detection was by VHH 
A-23, using anti-VSV-HRP secondary antibody.
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4B, lane 3). Similar results were obtained for the other VHHs tested (A-28, A-89, A-93, 
B-A1, B-B12, B-D8, B-D10 and B-F9). Both tests confi rm that the 16 kDa hsp from M. 
tuberculosis is the antigen recognized by these VHHs. When, prior to western blot, 
antigen preparations were not subjected to denaturing, the reactivity of the antigen 
was not altered (Fig. 4C).
The ability of the VHHs to recognize soluble antigen in a biosensor set-up was tes-
ted in a surface plasmon resonance analysis. VHH A-23 was immobilized at 3818 RU 
in Fc4 on a CM5 sensor chip. As a reference, VHH M200, selected for recognition of 
Foot-and-mouth disease (FMD)22, was used for immobilization at 3851 RU in chan-
nel Fc3. Diﬀ erent concentrations of Mycobacterium lysates (M. tb 1, M. tb 27 and M. 
smeg) were run over both fl ow cells. M. tb 1 and M. tb 27 bound to VHH A-23 on the 
CM5 sensor chip, whereas it did not bind to the reference Fc3 (not shown). Lysate 
of M. smeg showed neither binding to VHH A-23 nor to VHH M200. These results are 
in agreement with the results obtained by ELISA and demonstrate that VHH A-23 is 
capable of specifi cally bind the soluble M. tuberculosis antigen (Fig. 5A, shown for 
M. tb 1 and M. smeg).
The reproducibility of antigen detection by the A-23 biosensor was investigated 
using whole M. tuberculosis lysate M. tb 1. The lysate was injected at highest con-
centration following approximately 8 cycles of antigen binding and regeneration. 
The maximal RU signals were constant over 31 cycles with a mean of 234 ± 2 sugges-
ting that regeneration conditions (10 mM HCl) do not aﬀ ect the quality of the immo-
bilized VHH (Fig. 5B). The binding between purifi ed recombinant hsp and a selection 
of VHH (A-23, A-44, A-50, A-89, B-A1, B-B12, B-D8, B-D10, B-F9 and B-F10) was in-
vestigated. Among these, the binding by A-23, A-50, A-44 and B-F10 was found to be 
the strongest, and binding constants were determined for these VHH. The KD value of 
B-F10 was found to be best (4×10−10 M), while A-23, A-50 and A-44 had slightly lower 
aﬃ  nities (2.4×10−9 M, 2.2×10−9 M and 3.7×10−9 M, respectively).
To quantify the antigen present in M. tuberculsosis lysates, diﬀ erent concentra-
tions of recombinant 16 kDa antigen (24 ng/mL to 50 μg/mL) were injected for calib-
ration. By plott ing the lower concentrations of 16 kDa antigen against the responses 
in the biosensor, a linear calibration curve was obtained from a level above the limit 
of detection of 24 ng/mL (Fig. 5C). The signal in the VHH coated fl ow cell was almost 
linear up to the concentration of 780 ng/mL and an RU of 119.5. At higher concent-
rations the response leveled oﬀ . For accuracy, only values below 120 RU were used 
to calculate the % of antigen in the lysate. From the obtained calibration curve, the 
amount of antigen in the whole protein content of the lysate was determined to be 
6.6 ± 0.6% in M. tb 1 and 11.7 ± 0.4% in M. tb 27 whereas M. smeg contained 0% of 
the 16 kDa antigen.
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Figure 5. Surface plasmon resonance analysis to show specifi c binding of VHHs to soluble 
antigen. A–C) VHH A-23 immobilized at 3818 RU on a CM5 sensor chip in Fc4 and VHH M20022 
immobilized at 3851 RU in the reference channel Fc3. Sensorgrams were corrected by subtrac-
ting the signal from the reference fl ow channel Fc3. A) Sensorgrams obtained after injection 
of M. tuberculosis (left) and M. smegmatis (right) lysate. 50 μL lysate at concentration of 3.8 
(lowest), 7.5, 15, 30 and 60 (highest) μg/mL were injected at a constant fl ow (10 μL/min.). 
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4.3 DISCUSSION
The present study describes the successful selection of recombinant VHHs specifi c 
for Mycobacterium tuberculosis. A panel of recombinant antibodies was selected, 
which distinguish a number of M. tuberculosis strains from non-tuberculosis my-
cobacteria. One of the selected VHH molecules was successfully incorporated into an 
SPR-biosensor to detect and identify M. tuberculosis. To our knowledge this is the 
fi rst description of recombinant llama antibody fragments specifi c for infectious M. 
tuberculosis.
Two diﬀ erent phage display selection methods were used, one by depleti-
on of the library from non-tuberculosis lysates, and another by using a partially 
purifi ed protein preparation. The depletion method aimed to select highly speci-
fi c M. tuberculosis VHH antibody fragments against potentially a very wide range 
of antigens from the lysate, whereas the direct panning method aimed to select 
VHH antibody fragments specifi c for the three dominant proteins in the sample. 
We expected a large sequence variety, and indeed, a broad spectrum of 68 unique 
sequences was obtained. Out of which six sequences were found to be the same from 
both selection methods, suggesting that both procedures overlapped in their selecti-
vity for an epitope. Investigations by ELISA with a range of diﬀ erent mycobacteria 
revealed that the selected llama antibody fragments allowed specifi c detection of 
all tested tuberculosis-causing species, and distinguish them from non-infectious 
mycobacteria such as M. kansasii, M. avium and M. smegmatis and other respirato-
ry pathogens such as S. pneumoniae and H. infl uenzae (Fig. 3B). Apparently, both 
selection methods lead to antibodies that specifi cally recognize the Mycobacterium 
tuberculosis complex.
Earlier, selection of several mouse single-chain fragments (scFvs) reactive with 
M. tuberculosis culture proteins by phage display was reported,23 and very recently 
B) Sensorgrams obtained after repeated injection of M. tuberculosis lysate. 50 μL lysate at 
concentration of 60 μg/mL were repeatedly injected at a constant fl ow (10 μL/min.). Sensor 
was regenerated with 5 μL of a 10 mM HCl solution at 10 μL/min after each run. C) Left: 
Sensorgrams achieved after injection of purifi ed recombinant 16 kDa antigen. 50 μL lysate at 
concentration of 24 (lowest), 49, 98, 185, 391, 781, 1.6×103, 3.1×103, 6.3×103, 12.5×103, 25×103 and 
50×103 (highest) ng/mL were injected at a constant fl ow (10 μL/min.). Right: Calibration curve 
of purifi ed recombinant 16 kDa antigen as obtained by BIAevaluation using the 4 parameter 
fi t. D) Sensorgrams achieved after injection of VHH A-23. Purifi ed recombinant 16 kDa antigen 
was immobilized at 4100 RU on a CM5 sensor chip in Fc2 and inactivated Fc1 was used as 
reference. 100 μL VHH at concentration of 0.025 (lowest), 0.05, 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.3 and 
12.5 (highest) μg/mL were injected at a constant fl ow (50 μL/min.). Sensorgrams were correc-
ted by subtracting the signal from the reference fl ow channel Fc1. To obtain the dissociation 
equilibrium constant (KD) the sensorgrams were fi tt ed by a global Langmuir 1:1 model (BI-
Aevaluation software) using the six lowest VHH concentrations.
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also chicken scFv antibodies for 16 kDa hsp.24 In the present work, VHH was prefer-
red over scFv, because scFvs are larger, and often suﬀ er from poor stability, unless 
genetically engineered,25, 26 while VHHs often display high stability over long periods 
of exposure to ambient temperature,10 which allowed for extensive re-use of the SPR 
chip.
Surprisingly, western blot analysis showed that all 12 tested VHHs from diﬀ erent 
clusters bind to the species-specifi c 16 kDa hsp (Fig. 4B), despite the high sequence 
diversity among the clusters (Fig. 2). Apparently also in alpaca the 16 kDa hsp beha-
ves as an immunodominant antigen, and possibly there are several diﬀ erent epito-
pes. The specifi city for the 16 kDa hsp is consistent with studies into the conservati-
on of this protein among mycobacteria. Southern blot analysis of genomic DNA of 
several mycobacteria, using the coding sequence of the 16 kDa hsp gene as a probe,27 
showed the absence of a homologue of the 16 kDa hsp in non-tuberculosis species. 
Only the tuberculosis related M. bovis bacillus Calmett e-Guérin (BCG) strain show-
ed a specifi c hybridization, which is in agreement with our observation that 16 kDa 
hsp specifi c VHHs (A-23, A-44, A-50 and B-F10) showed binding to M. tuberculosis 
and M. bovis BCG but not to any other tested Mycobacterium species in ELISA (Fig. 
3B). Similar results were observed by Coates et al.28 for the mouse monoclonal anti-
body TB68, which binds to the 16 kDa hsp of all tested strains of M. tuberculosis and 
M. bovis species.29
The 16 kDa hsp is known under several names (Hsp16.3, sHsp16 and Acr)30 and 
shares a low sequence homology with the α-crystallin-related small heat shock pro-
tein family.31 It has been suggested that this antigen acts in vitro as an adenosine 
triphosphate-independent chaperone and may occur as a dodecamer, or as mono-
mers.17, 32 The form of antigen that is recognized by the VHH is probably the monome-
ric structure. The hsp was isolated from bacteria by a denaturing treatment, which 
would cause monomer formation, and reactivity of the antigen is not very diﬀ erent 
after western blott ing from a native gel or a denaturing gel (Fig. 4). Also heat dena-
turing of antigen hsp did not change its mobility in native gels (not shown). Thus, 
probably the antigen is recognized in monomeric form, while we have no dodeca-
meric form available for testing its reactivity.
Several murine monoclonal antibodies against the prominent hsp antigen of 
M. tuberculosis have been selected in the past.21, 29, 33 It has been subcloned, overex-
pressed and purifi ed.17, 20 The results of the SPR experiments comparing the Myco-
bacterium lysates to purifi ed recombinant 16 kDa hsp show that 7 to 12% of cellular 
protein consists of 16 kDa hsp. This would correspond to ± 6 million copies of 16 
kDa hsp per cell, taking into account its molecular weight, and an estimated 160 fg 
total protein per cell.34 The concentration of hsp in the total protein content of M. 
tuberculosis is comparable with Lipoarabinomannan (LAM), the major glycolipid of 
the outer cell wall which may represent up to 15% of the total bacterial weight35 and 
is used for tuberculosis detection in urine samples.36 Due to its rich presence in bac-
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teria lysate, the highly expressed 16 kDa hsp seems to be a relevant biological target 
for TB diagnostic assays.34 Nevertheless it may be worthwhile to develop stable and 
high aﬃ  nity VHH antibodies to secreted M. tuberculosis proteins such as the 24 kDa 
protein for diagnosis.37
The 16 kDa hsp is a cytosolic protein, as hardly any ELISA signal of the VHHs to 
whole cells or culture medium of the M. tuberculosis cultures could be observed, 
while a strong signal occurred in the cell lysate (Fig. 3A). These observations are in 
agreement to reports of others, who report that the 16 kDa hsp is not released into 
the culture supernatant,38, 39 but is peripherally associated with the membrane.40 One 
consequence of this subcellular localization is that lysis of bacteria will be necessa-
ry before detection in sputum. One might argue that a secreted antigen like the 24 
kDa protein,37 would be more convenient for immunological detection. On the other 
hand, most tuberculosis-detection methods based on nucleic-acid amplifi cation also 
require vigorous disruption of sputum and mycobacterial cells and a secreted anti-
gen may be too dilute in sputum.41
Most serological tests for tuberculosis screen for reactivity in the patient‘s serum 
to specifi c M. tuberculosis antigens, such as the 16 kDa hsp.20, 42, 43 However, such 
serum-reactivity tests have limited value, as antibodies remain present after BCG 
vaccination, after successful treatment of the infection and during latent infection, 
which complicates the diagnosis of active TB disease. Therefore, more eﬀ orts have 
been directed towards direct detection of M. tuberculosis antigens in sputum, se-
rum, urine and cerebrospinal fl uid of patients, and there VHH antibodies against the 
16 kDa hsp may represent a useful tool for the development of diagnostic tests.
An SPR biosensor using one of the selected VHHs allowed detection of recom-
binantly produced 16 kDa hsp antigen of M. tuberculosis. Moreover, the SPR sensor 
was able to positively identify crude lysates of M. tuberculosis, enabling the speci-
fi c detection of tuberculosis-causing infectious agent. The sensor system proved to 
provide reproducible results after a signifi cant number of regenerations, which is an 
important att ribute for a sensing device. Importantly, further experiments should 
prove the value of an SPR sensor in the identifi cation of M. tuberculosis in patient‘s 
material. At its current sensitivity (24 ng of 16 kDa hsp per mL; Fig. 5C), the limit 
of detection would be about 106 cells per mL, when taking into account that 16 kDa 
makes up approximately 10% of total Mycobacterium protein and a cellular protein 
content of 150 fg/cell.34 The current limit of detection using microscopy is around 
10,000 cells per mL.
Sensitivity of the SPR system could be greatly enhanced by immobilization of 
VHHs in an oriented way, leading to increased exposure of antigen-binding sites. 
Such orientation of antibodies like VHH could be achieved by site-specifi c biotinyla-
tion of the VHH, or other, covalent immobilization methods.44 SPR results indicated a 
dissociation constant of 4×10-10 M for B-F10. Whereas other VHH with 10-fold higher 
aﬃ  nity have also been reported,45 aﬃ  nity maturation of the VHH by rounds of mu-
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tagenesis and selection could signifi cantly improve the aﬃ  nity of the antigen, and 
thereby the sensitivity of the sensor46 and fi nally multivalent and multispecifi c VHHs 
could be engineered for strongly enhanced aﬃ  nity for the antigen. VHHs against a 
broad range of antigen targets could be selected by tuning the phage display selec-
tion method and the specifi city and sensitivity of M. tuberculosis detection could be 
greatly enhanced by the combination of VHHs for rapid, near patient multiplexing in 
the near future.
SPR is one of the more established biosensor principles. Other methodologies, 
such as piezoelectronic immunosensors or fl uorescent nanoparticles coupled with 
fl ow cytometry, and nanowires are further away from application in practice.8, 47, 
48 Still, SPR equipment is hardly compatible with fi eld sett ings in countries where 
tuberculosis diagnosis is needed most. Recent eﬀ orts to implement portable SPR 
devices in tuberculosis diagnostics49 may contribute to the solution of this problem.
4.4 MATERIALS AND METHODS
4.4.1 Bacteria Samples
All mycobacteria (Royal Tropical Institute, Amsterdam, The Netherlands) were 
grown in Middlebrook 7H9 medium (Difco, BD, Sparks, MD, USA) supplemen-
ted with 10% OADC (BBL, BD) until mid-log phase and heat-killed at 80°C for 20 
min. Other respiratory pathogens (Streptococcus pneumoniae D39 and non-typable 
Haemophilus infl uenzae R2866 [Radboud University Nijmegen Medical Center 
CUKZ, Nijmegen, The Netherlands]) were grown on chocolate agar. Heat-inacti-
vated bacteria were used as ‘whole cells` to test binding of antibodies to surface 
proteins. To obtain the lysate of Mycobacterium as antigen source, bacteria were 
centrifuged at 13,000 g for 5 min after heat killing. After 2 washing steps with phos-
phate-buﬀ ered saline (PBS) to remove all media the bacteria pellet was resuspended 
in PBS. 500 μL of bacterial suspension was lysed with 0.6 g zirkonia/silica 0.1 mm 
(BioSpec Products Inc, Bartlesville, OK, USA) in a Retch MM 301 (Retch GmbH, Ger-
many) for 15 min at 30 hertz . To remove soluble particles, the lysate was centrifuged 
for 5 min at 13,000 g. The obtained supernatant was used as cell lysate. Protein con-
centration of Mycobacterium samples were determined with the Pierce 660 nm Pro-
tein assay using Nanodrop and albumin as reference protein for the standard curve.
To obtain enriched lysate 2 mL of centrifuged M. tuberculosis lysate was brought 
into 20 mM ethanolamine (pH 9.0) and loaded on a 1 mL HiTrap MonoQ column 
(Pharmacia). After washing extensively with 20 mM ethanolamine (pH 9.0), a linear 
gradient from 0 to 1 M NaCl in 20 mM ethanolamine (pH 9.0) was applied, and 1 mL 
fractions were collected. Around 0.4 mM NaCl, a fraction eluted in which proteins 
of 16 kDa, 24 kDa and 63 kDa were overrepresented, and this fraction was used for 
subsequent selections.
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4.4.2 Library Construction
A VHH library was formed from lymphocyte RNA from a 3-year old female alpaca 
(GDL, Utrecht University, The Netherlands) as previously described.10 Experiments 
with alpacas were approved by the Dutch Animal Ethical Commission (Dier Expe-
rimenten Commissie, DEC; permit 06/284) of the Utrecht University, following the 
Dutch Law on animal experiments (‘Wet op de Dierproeven` : htt p://wett en.over-
heid.nl/BWBR0003081/geldigheidsdatum_05-09-2011). 100 μg of M. tuberculosis ly-
sate was used for the immunization. VHHs were amplifi ed from fi rst-strand cDNA 
with VHH specifi c primers lam07, lam08 and lam17.50 Amplifi ed fragments were 
pooled and ligated into the pHEN2 phagemid vector51 in frame with the M13 gene 
3 for expression of VHH-g3p fusion protein. Electroporation of recombinant plasmid 
into competent Escherichia coli TG1 cells resulted in about 107 individual recom-
binants. Phage particles were produced in E. coli as described earlier.10
4.4.3 Selection
The library containing approximately 107 individual clones was panned separa-
tely using two diﬀ erent panning strategies.
4.4.3.1 Direct Panning Method
The fi rst selection was carried out by panning of the VHH-displayed phage libra-
ry directly against the M. tuberculosis lysate, enriched for 16 kDa protein, 24 kDa 
protein and another high-molecular weight protein around 70 kDa (Fig. 1). Wells 
of microtiter ELISA plates (GreinerBioOne, The Netherlands) were coated with 100 
μL lysate (10 μg/mL in 0.1 M Sodium Carbonate Solution pH 9.6) overnight at 4°C. 
Plates were emptied the next day and washed 1 time with 200 μL PBS and unspeci-
fi c binding sites were blocked for 1 h with 250 μL PBS containing 2% (w/v) nonfat 
powdered milk (2% PBSM). 100 μL phages (1011 cfu/mL) were blocked for 30 min 
with 50 μL PBS containing 10% nonfat powdered milk (w/v) (10% PBSM) before 100 
μL of this mix was applied to the wells and incubated for 1 h on a shaker. Excess 
phages were washed away with 5 washes of 200 μL 0.05% Tween-20 in PBS (0.05% 
PBST) and 5 washes of 200 μL PBS. Phages from the Mycobacterium selection were 
eluted with 100 μL of 0.1% trypsin in PBS for 15 min. Eluted phages were then used 
to infect E. coli TG-1 cells. The phage populations were amplifi ed and rescued by 
VCSM13 helper phage to generate phage displaying VHH to be used for the next 
round of panning. To raise the selection stringency, the number of washing steps be-
fore trypsin elution was increased by 5 after each panning round. After three rounds 
of panning, the in- and output were titrated to monitor the success of the selection.
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4.4.3.2 Depletion Panning Method
Targets were immobilized overnight at 4°C in microtiter ELISA plate wells 
(GreinerBioOne, The Netherlands) using the following conditions: 6 wells were coa-
ted with 100 μL Mycobacterium mix (lysate of M. kansasii, M. avium, M. fortuitum 
and M. chelonae, 3 μg/mL) in PBS and one well with 100 μL lysate of M. tuberculosis 
(3 μg/mL) in PBS. The next day, plates were emptied and washed one time with 200 
μL PBS and blocked for 1 h with 250 μL 2% PBSM. 300 μL phages (1011 cfu/mL) were 
blocked for 30 min with 100 μL 10% PBSM before 100 μL of this mix were applied to 
the emptied lysate-containing (Mycobacterium mix) well and incubated for 15 min 
on a microtiter plate shaker. The supernatant was then transferred to the next lysate-
containing (Mycobacterium mix) well and incubated for 15 min under shaking. This 
procedure was repeated for the remaining 4 wells coated with the Mycobacterium 
mix lysate. Finally the supernatant was transferred to the well coated with M. tuber-
culosis lysate and incubated for 30 min on the shaker. Excess phages were washed 
away with 5 washes of 200 μL 0.05% PBST and 5 washes of 200 μL PBS. Phages from 
the Mycobacterium selection were eluted with 100 μL of 0.1% trypsin in PBS for 15 
min. Eluted phages were then amplifi ed, rescued and re-used. In additional panning 
rounds stringency was increased by increasing the number of washing steps by 5 
after each panning round.
4.4.4 Recloning of Selected VHHs for Expression
For both panning methods, plasmids from selected phage pools were extracted 
using QIAprep Spin Miniprep Kit (250) (QIAGEN, The Netherlands). DNA was cut 
using the unique PstI and NotI restriction sites and then purifi ed using the Jetquick 
gel extraction kit (Genomed, Germany). VHH sequences were then bulk-ligated into 
a PstI and NotI digested PRI-VSV expression vector, a strong expression vector for 
expression in the periplasm, based on the backbone of the pRSET-A vector (Invitro-
gen, The Netherlands). Expression of the recombinant VHH was under control of the 
T7 promoter. The C-terminus of the VHH was fused to a VSV-tag (YTDIEMNRLGK) 
for detection purposes along with a His6 tag for purifi cation purposes followed by a 
stop codon. For cloning purposes a NotI restriction site was introduced between the 
VHH and the VSV-tag.
Constructs were introduced into E. coli XL-1 blue. 96 randomly picked colonies 
were used for colony PCR with the primer T7 (5′- TAATACGACTCACTATAGG -3′) 
and AS2 (5′- GCTAGTTATTGCTCAGCGG -3′). Sequencing of 96 colonies from the 
fi rst panning method resulted in 34 unique VHH protein sequences (labeled A-x, with 
x = 1–96), for the depletion method in 34 unique full length protein sequences (la-
beled B-yx, with y = A-F and x = 1–12). All duplicate sequences were omitt ed. The 
remaining 62 non-redundant VHH sequences were aligned according to ImMunoGe-
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neTics system52 for immunoglobulins and classifi ed into diﬀ erent groups. As VHHs 
had unusual long CDRs, additional gaps were introduced in the numbering at the 
end of CDR1 and CDR2 and labeled with lett ers A and a to e, respectively.
Sequences for 12 representatives which were used for further analysis have been 
submitt ed to Genbank under accession numbers JN234011–JN234022.
4.4.5 Expression and Purifi cation of Recombinant VHHs
Representative sequences from each panning method were selected from diﬀ e-
rent groups for expression in E. coli BL21-AI, a strain which carries a chromosomal 
insertion of the T7 RNA polymerase gene in the araB locus of the araBAD operon, 
allowing the expression of recombinant VHH in the presence of L-arabinose. Bacteria 
were induced to express the VHH and urea-lysed as described previously10 using PBS 
as buﬀ er. VHHs were purifi ed using Ni-NTA Superfl ow resin (QIAGEN, Germany) 
as reported before.10 Eluates were dialyzed against 8 liter of PBS in two steps after 
Ni-NTA metal-aﬃ  nity chromatography and samples were stored in 1.5 mL batches 
containing a fi nal concentration of 15% glycerol at −20°C. Protein concentration was 
determined using Bradford test53 while successful expression and purifi cation was 
verifi ed on a 15% sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-
PAGE) gel. As previously shown by Beekwilder et al.10 the expressed VHHs were the 
dominant proteins in the E. coli cell pellets (data not shown).
4.4.6 Direct ELISA
Wells of fl at-bott om ELISA plates (medium-binding, GreinerBioOne, The Nether-
lands) were coated with 2 μg/mL lysate of Mycobacterium species or other respira-
tory pathogens (S. pneumoniae and H. infl uenza) in PBS and incubated at 4°C over-
night. Antigen-coated wells were emptied and washed one time with 200 μL PBS 
and then blocked with 150 μL PBS containing 4% nonfat powdered milk (w/v) (4% 
PBSM) for 1 h at room temperature. Wells were emptied and 100 μL VHH (0.5 mg/mL) 
in 2% PBSM was added and binding was allowed to occur for 1 h. Excess VHHs were 
removed by washing three times with 200 μL PBST, and anti-VSV-HRP conjugate 
(Sigma Aldrich, Missouri, USA) was added at a 1:2000 dilution for 1 h in 2% PBSM. 
Excess conjugate was washed oﬀ  three times with 200 μL PBST and three times with 
200 μL PBS. Subsequently HRP activity was determined by adding 1-StepTM Ultra 
TMB-ELISA substrate (Pierce, Rockford, IL). The reaction was allowed to proceed 
in the dark for 10 min and then stopped with 1 M sulphuric acid and the OD was 
measured at 415 nm in a microtiter plate-reader (TECAN SpectraFluor Microplate 
Reader).
Similar method was employed for direct ELISA of whole cells and supernatant 
by using 100 μL for coating.
76
Chapter 4
4.4.7 Western Blot Analysis
Cell lysates containing approximately 9 μg total protein were fi rst boiled and 
reduced in buﬀ er and electrophoresed on a 15% SDS-PAGE gel and SYPRO ruby 
(Bio-Rad, Hercules, CA) stained to ensure the full complement of proteins was resol-
ved. For western blott ing, proteins were transferred from an unstained gel to nitro-
cellulose membranes (Trans-Blot, Bio-Rad, Hercules, CA). Membranes were blocked 
overnight at room temperature in 4% PBSM on a shaker. The membrane was then in-
cubated with purifi ed VHH (0.1 mg/mL in 2% PBSM) for 1 h at room temperature on 
a shaker. Membranes were washed once in 2% PBSM and three times in 0.1% PBST. 
Subsequently, membranes were incubated with HRP-conjugated anti-VSV-tag an-
tibodies (1:2000 in 2% (w/v) PBSM, Sigma Aldrich, Missouri, USA) or anti-HIS6 tag 
(1:5000 in 2% (w/v) PBSM, Roche, Mannheim, Germany) for 1 h at room temperature 
on a shaker. Membranes were washed once with 2% PBSM followed by two washing 
steps with TBS containing 0.1% Tween 20 and two washing steps with TBS. Binding 
was detected with 3,3′,5,5′-Tetramethylbenzidine (TMB) liquid substrate system for 
membranes (Sigma-Aldrich, The Netherlands). Molecular weight standard was Pre-
cision Plus Kaleidoscope (BioRad, Hercules, CA).
4.4.8 Recombinant 16 kDa Protein
The 16 kDa protein was PCR-amplifi ed from M. tuberculosis lysate using the primer 
HSP16.3-PstI-FW (5′-AAAAAAACTGCAGAAAATGGCCACCACCCTTCCC-3′) 
and HSP16.3-NotI-RV (5′- AAAAAAAAGCGGCCGCGTTGGTGGACCGGATCTG-
AA-3′) (PstI and NotI restriction sites are underlined). The digested fragment was 
inserted in a PstI-NotI cut PRI-AVI expression vector. This vector is similar to the 
earlier described PRI-VSV expression vector, but the C-terminus of the protein is 
fused to an AVI-tag™ (Avidity, LLC, Denver, Colorado) and a His6 tag for purifi -
cation purposes followed by a stop codon. The construct was transformed into E. 
coli XL-1 blue for multiplication. The cloned hsp sequence is identical to GenBank 
accession number S79751. Isolated plasmid DNA was transformed into E. coli strain 
BL21-AI for expression. Expression and Ni-NTA metal-aﬃ  nity chromatography pu-
rifi cation was performed as described for VHH. The calculated mass of the recom-
binant 16 kDa protein was determined to be 21 kDa.
4.4.9 Surface Plasmon Resonance (SPR)
The BIAcore 3000, carboxymethyl dextran sensor chips (CM5), HBS-EP buﬀ er 
(pH 7.4, consisting of 10 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonicacid, 
150 mM sodium chloride, 3 mM ethylenediaminetetraacetic acid, 0.005% v/v sur-
factant polysorbate 20), the amine coupling kit (containing 0.1 M N-hydroxysucci-
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nimide [NHS], 0.4 M 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochlori-
de [EDC] and 1 M ethanolamine hydrochloride [pH 8.5]) were purchased from GE 
Healthcare (Uppsala, Sweden).
Selected VHHs were immobilized onto a CM5 surface by the use of the amine cou-
pling kit and the Surface Preparation Wizard as present in the BIAcore 3000 control 
software. The biosensor surface was activated by injecting (35 μL at a fl ow rate of 
5 μL/min) a mixture of EDC and NHS (1:1; v/v) into one of the four fl ow channels 
(Fcs). Then VHH (50 μg/mL diluted in coupling buﬀ er [10 mM sodium acetate, pH 
4.0]) was injected and bound to the activated carboxymethylated dextran surface via 
its primary amine groups, aiming for an immobilization level of 5000 response units 
(RU). After coupling, the remaining active groups were blocked with ethanolamine 
hydrochloride (1 M).
In the experimental set-up, a reference (non-tuberculosis binding, M200)22 VHH 
was immobilized in the reference Fc3 and the tuberculosis specifi c VHH was immobi-
lized in Fc4, both with a fi nal response of approximately 3800 RU. The BIAcore 3000 
operated at a constant temperature of 25°C and a constant fl ow of 10 μL/min. 50 μL 
Mycobacterium lysates in HBS-EP buﬀ er, each of diﬀ erent concentration, were in-
jected over the two serially connected Fcs. Regeneration of sensor surface was done 
with 5 μL of a 10 mM hydrogen chloride (HCl) solution at 10 μL/min after each run. 
For quantitative analysis, a calibration graph was prepared by using diﬀ erent con-
centrations of purifi ed 16 kDa antigen in HBS-EP. All sensorgrams were referenced 
by subtracting the signal from the reference fl ow channel (Fc3) from Fc4 and were 
evaluated using the BIAevaluation software.
To check the aﬃ  nity of diﬀ erent representative VHHs (A-23, A-44, A-50, A-89, 
B-A1, B-B12, B-D8, B-D10, B-F9 and B-F10) against the 16 kDa hsp, the antigen was 
immobilized at 4100 RU on a CM5 sensorchip in Fc2 using the amine coupling me-
thod. A second fl ow cell (Fc1) was treated with the same chemical procedure wit-
hout antigen and used as a reference. At a constant fl ow rate of 50 μL/min diﬀ erent 
concentrations of 100 μL VHH ranging from 12.5 to 0.025 μg/mL in HBS-EP were 
injected 120 s over the two fl ow cells and followed by a dissociation step of 400 s. 
The sensor surface was regenerated with 25 μL of a 20 mM HCl solution. The re-
sulting sensorgrams were referenced by subtracting the signal from the reference 
fl ow channel (Fc1) from Fc2. To obtain the dissociation equilibrium constant (KD) the 
sensorgrams were fi tt ed by a global Langmuir 1:1 model (BIAevaluation software) 
using the six lowest VHH concentrations.
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CHAPTER 5
The Eﬀ ect of Uniform Capture Molecule  
Orientation on Biosensor Sensitivity: 
Dependence on Analyte Properties
ABSTRACT
Uniform orientation of capture molecules on biosensors has been reported to 
increase sensitivity. Here it is investigated which analyte properties contribute to 
sensitivity by orientation. Orientation of capture molecules on biosensors was in-
vestigated using variable domains of llama heavy-chain antibodies (VHHs) as cap-
ture molecule, and a surface plasmon resonance (SPR) chip as biosensor. Two VHHs 
were tested in this study: one recognizing foot-and-mouth disease virus (FMDV) 
and another recognizing the 16 kDa heat-shock protein of Mycobacterium tubercu-
losis. SPR chips with randomly immobilized biotinylated VHHs were compared to 
streptavidin-coated SPR chips, on which similar quantities of oriented biotinylated 
VHHs were non-covalently immobilized. Analytes that diﬀ er in molecular weight, 
epitope number and epitope aﬃ  nity were compared using the FMDV-recognizing 
VHH. When binding of intact FMDV particles (146S; 8200kDa) or pentameric FMDV 
coat protein aggregates (12S; 282kDa) was detected, a modest (1–2-fold) increase in 
sensitivity was observed. When a 26-residue peptide (3 kDa) containing the epitope 
for VHH recognition was tested, much larger eﬀ ects of capture molecule orientation 
(14-fold) on signal were observed. A 20–227-fold improvement was also observed 
when the epitope peptide was covalently linked to bovine serum albumin (67kDa) 
or R-phycoerythrin (240kDa). The results indicate that orientation of the capture mo-
lecule hardly aﬀ ects high-aﬃ  nity interactions, while it leads to strong improvements 
in sensitivity for lower-aﬃ  nity interactions.
This chapter was published as:
Anke K. Trilling, Michiel M. Harmsen, Vincent J. B. Ruigrok, Han Zuilhof and Jules Beekwil-
der. Biosensors and Bioelectronics.  2013, 40, 219-226.
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5.1 INTRODUCTION
The ongoing need for miniaturization of diagnostic elements such as biosensors 
implies that space for the actual detection components will be strongly limited. To 
compensate for this reduction in surface area, the biological detection elements need 
to be optimized. This optimization may include correct and uniform orientation at 
high density, in order to enhance analyte binding and to increase sensitivity of the 
device.1
Sensitivity and specifi city of biosensors depend on high-aﬃ  nity and specifi c cap-
ture molecules. Antibodies are generally used as biological capture molecules in im-
munoassays such as ELISAs, as they form highly specifi c and high aﬃ  nity interac-
tions. Nowadays, many biosensors deploy antibodies as capture molecules.1d, 2 One 
of the challenges faced in the design of multiplex biosensors is to reach, on a single 
sensor, a high sensitivity for a large number of targets. One solution may be to achie-
ve a high number of binding units per mm2, ideally all oriented in the same way. 
Conventional antibodies, with a typical molecular weight of 150 kDa and a size of 14 
nm × 9 nm × 4 nm,3 are big in size. Due to the presence of many exposed reactive resi-
dues, site-specifi c functionalization of these molecules is challenging. Therefore, the 
truly oriented printing of antibodies on biosensor surfaces is not straightforward. To 
deploy antibody-like molecules of smaller size, diverse formats were exploited for 
use in biosensors.1d One such format is the variable domain of heavy-chain antibo-
dies of llamas, which are naturally devoid of light chain (VHH). VHHs oﬀ er advantages 
in terms of size,4 stability,5 expression yields6 and ease in protein engineering. 
Various covalent and non-covalent immobilization strategies for proteins have 
been employed to att ach capture molecules to a surface.7 The extraordinarily high 
aﬃ  nity of streptavidin to biotin was frequently used to immobilize biotinylated an-
tibodies on streptavidin-modifi ed surfaces.8 Site-specifi c in vivo biotinylation at the 
C-terminus of VHHs can be achieved by introducing a specifi c tag sequence, which is 
biotinylated by the BirA enzyme of Escherichia coli.9 This approach can be used for 
the orientation of VHH capture molecules onto surfaces. Such orientation provides 
potential for higher binding capacity of the analyte: whereas in random immobili-
zation, analyte-recognition sites are poorly exposed to the surface, orientation can 
be tuned for maximal exposure of the capture molecule to the analyte (Fig. 1). Tech-
niques like circular dichroism spectroscopy,10 total internal refl ection ellipsometry,11 
time-of-fl ight secondary ion mass spectrometry12 and atomic force microscopy13 
were used to display the antibody orientation in a direct manner. As an alternative, 
and in fact more directly linked to the application, the signal increase of oriented 
antibodies can be used as indirect method to determine the successful orientation of 
antibodies. Increased sensitivity after orientation of antibodies is well documented.14 
However, reported improvements are highly variable, and the impact of analyte 
properties on the detection limit in uniformly and randomly oriented capture mole-
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Figure 1. Schematic illustration of immobilized VHHs on a carboxymethyl dextran sensor chip 
(CM5). A: Heavy-chain antibody IgG. Biotin was introduced at the C-terminus of the VHH, the 
opposite site of the analyte binding site. B: Biotinylated VHHs non-covalently immobilized in 
a uniform orientation onto streptavidin-coated CM5 sensor chips. C: Biotinylated VHHs cova-
lently coupled in random orientation via the amine groups onto CM5 sensor chips. VHHs can 
be immobilized via the ɛ-amines, present in lysine side chains, or via the α-amine, present at 
the N-terminus of the protein. D: Set-up of SPR sensor chip with 4 fl ow channels (Fc). VHH 
M200 was immobilized randomly oriented in Fc1 and uniformly oriented in Fc3 and VHH A23 
was immobilized randomly oriented in Fc2 and uniformly oriented in Fc4. For measurements 
analyte was injected in series over Fc1, Fc2, Fc3 and Fc4. 
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cules has not been reported.
In a previous study we showed the use of VHHs as capture molecule using surface 
plasmon resonance (SPR).15 In the current study, as a next step, two diﬀ erent VHHs 
were engineered using a tag sequence to obtain site-specifi c biotinylation.9 These 
two tailor-made VHHs were subsequently immobilized on the sensor surface in two 
ways: in a randomly oriented, covalent manner (via coupling of amine moieties with 
the activated surface), and in a uniformly oriented, non-covalent way by the use of 
streptavidin-coated surfaces and the non-covalent biotin-streptavidin interaction. 
The sensitivity of the resulting surfaces was studied towards a wide range of ana-
lytes. This has led to a high sensitivity enhancement upon uniform orientation (up 
to factor 227). Finally, we will develop a hypothesis to understand which analyte 
properties seem to govern the eﬀ ects of uniform capture molecule orientation on the 
sensitivity of the sensor, with a specifi c focus on analyte molecular weight, avidity 
and specifi cally aﬃ  nity.
5.2 RESULTS
5.2.1 Biotinylated VHHs 
Two VHHs, M200 and A23 were used. A strategy was used to allow site-specifi c 
biotinylation of the VHHs, without aﬀ ecting their binding properties. The X-ray struc-
ture of VHHs reveals that the C-terminus is positioned at the opposite of the analyte-
binding site,16 and biotinylation at the C-terminus is therefore not expected to in-
terfere with analyte binding. Therefore, both VHH genes were fused to a C-terminal 
AviTag, followed by a His6 tag for purifi cation. Both VHHs were subsequently produ-
ced in E. coli, where it was co-expressed with the BirA enzyme. After Ni-NTA purifi -
cation of the VHHs from the E. coli lysate, VHHs were analyzed using western blott ing 
(Fig. 2A). The produced proteins displayed a single band on the western blot, either 
detected by an anti-His6-Peroxidase antibody, or by Streptavidin-Peroxidase, indi-
cating that the major biotinylated protein in the capture molecule preparation was 
the VHH.
5.2.2 Analyte Collection
VHH A23 detects the 16 kDa heat-shock protein in Mycobacterium tuberculosis. 
Two lysates of M. tuberculosis (M. tuberculosis 1 & M. tuberculosis 27) were used, 
which positively react to A23, and compared to a lysate of M. smegmatis which is 
not recognized by A23.15 
VHH M200 recognizes the foot-and-mouth disease viral particle (FMDV) of the O1 
Manisa strain.17 For an overview of VHH M200 analytes see Table 1. Intact FMDV par-
ticles (8200 kDa)18 are icosahedral and are composed of 60 copies of coat proteins.19 
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VHH M200 is specifi c for the GH-loop of coat protein VP1.17 Intact FMDV are also 
referred to as 146S particles based on its sedimentation behavior in sucrose density 
gradients.20 Mildly acidic conditions were used to breakdown the intact 146S particle 
into stable 12S particles. 12S particles (265-282 kDa21) include 5 copies of VP1,22 and 
thus expose 5 epitopic sites for M200.21 The 3 kDa small peptide PAT49 (YGDGT-
VANVRGDLQVLAQKAARALPC), corresponding to amino acid residues 136–160 
of the GH-loop of structural protein VP1, represents the epitope of FMDV that is 
recognized by VHH M200.17 To examine the eﬀ ect of diﬀ erent analytes on oriented 
Figure 2. Analysis of purifi ed VHHs and BSA-PAT49. A: Western blot analysis of biotinylated 
VHH M200. 1.5 μg of Ni-resin-purifi ed VHH was used for separation on SDS-PAGE gel. Lane 
1: detected with anti-His6-Peroxidase. Lane 2: detected with Streptavidin-Peroxidase. B: Eva-
luation of molecular weight shift for BSA upon coupling with PAT49 on SDS-PAGE. Lane1: 
maleimide-activated BSA starting material. Lane2: BSA-2xPAT49 product after coupling re-
action of starting material with 5 molar equivalents peptide PAT49 and blocking of unreacted 
maleimide-moieties with cysteine, not purifi ed. Lane3: BSA-14xPAT49 product after coupling 
reaction of starting material with 20 molar equivalents peptide PAT49 and blocking of unre-
acted maleimide-moieties with cysteine, not purifi ed. Indicated are the positions of relevant 
size markers in kDa. C: Aligned amino acid sequences of VHH M200 and A23 as produced in E. 
coli. K (green and red) represents amino acid lysine. Underlined sequence at the C-terminus 
shows AviTag containing one lysine (green) used by enzyme BirA to att ach a single biotin 
molecule. His6 tag for purifi cation and detection purpose at the C-terminus is shown in blue. 
Dashes (-) indicate gaps introduced for alignment.
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capture molecules, proteins exposing multiple copies of peptide PAT49 were pre-
pared. To this end bovine serum albumin (BSA)-PAT49 and R-phycoerythrin-PAT49 
were synthesized by coupling the cysteine-containing peptide PAT49 to maleimide-
activated proteins. Maleimide-activated proteins possess more than one maleimide-
linker, and the coupling reaction with 5 and 20 molar equivalents of peptide PAT49 
results in multiple epitope sites exposing analytes. Size shift of BSA-PAT49 on SDS-
PAGE (Fig. 2B) indicated that ca. 14 peptides (20 equivalents PAT49) or 2 peptides (5 
equivalents PAT49) were bound per BSA molecule, resulting in BSA-14xPAT49 and 
BSA-2xPAT49, respectively. 
5.2.3 A Surface Plasmon Resonance Chip Functionalized with Uniformly Oriented 
and Randomly Oriented Biotinylated VHHs.
A SPR chip was designed to test the eﬀ ect of uniform orientation of VHHs on 
analyte detection. To exclude any infl uence of the biotinylation of VHH to analyte bin-
ding, VHHs were used both in a uniformly oriented and randomly oriented fashion. 
To this end, two ‘uniform orientation` fl ow channels (Fc3 and Fc4; Fig. 1B and D) of 
Table 1. Properties of VHH M200 analytes. For further explanation see text. n.d.: not deter-
mined. w/o: without. KD: aﬃ  nity constant. 
?
Properties?of?VHH M200?analytes?
? analyte? size? epitope?
epitope?
number?
per?analyte?
KD?per?
antigen?
KD?per?
epitope?
FMDV?(146S)?
intact?food?and?mouth?
disease?virus?particle?
8200?kDa18? GH?loop? 60? 0.012?μM? 0.72?μM?
12S?
pentameric?subunits?of?
FMDV?
265?282?kDa21? GH?loop? 5? 0.19?μM? 0.98?μM?
peptide?PAT49?
synthetic?peptide?
representing?residues?
136–160?of?GH?loop?of?
structural?protein?VP1?
3?kDa?
synthetic?
peptide?
1? 30?μM? 30?μM?
BSA?14xPAT49?
(20?equivalents?
peptide)?
14?peptides?PAT49?
coupled?to?BSA?
103?kDa?
synthetic?
peptide?
ca.?14? n.d.? n.d.?
BSA?2xPAT49?
(5?equivalents?
peptide)?
2?peptides?PAT49?
coupled?to?BSA?
72?kDa?
synthetic?
peptide?
ca.?2? n.d.? n.d.?
R?phycoerythrin?
PAT49?
peptides?PAT49?coupled?
to?R?phycoerythrin?
n.d.?
(240?kDa?w/o?
peptide?PAT49)?
synthetic?
peptide?
n.d.? n.d.? n.d?
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a CM5 chip were coated with streptavidin, onto which biotinylated VHH was non-
covalently immobilized. The other two ‘random orientation` fl ow channels (Fc1 and 
Fc2; Fig. 1C and D) were functionalized with biotinylated VHHs by covalent carbodi-
imide chemistry directly onto the CM5 chip, without the use of streptavidin. M200 
was immobilized with a uniform orientation in Fc3 and was randomly oriented in 
Fc1; A23 was immobilized with a uniform orientation in Fc4 and was randomly ori-
ented in Fc2 (Fig. 1D). This set-up allows binding of an analyte sample to uniformly 
oriented and randomly oriented VHHs in one experiment. To ensure comparability, it 
was aimed for the same coupling density of VHHs in uniformly oriented and random-
ly oriented fl ow channels. Coupling density of antibodies resulted in VHHs immobi-
lized at a level of 3268 ± 391 RU (average of 12 fl ow channels) over each of the fl ow 
channels. To investigate the strength of the diﬀ erent immobilization strategies (co-
valent versus non-covalent immobilized), repeated cycles of M.tuberculosis 1 lysate 
injection and regeneration with 5 μL 10 mM HCl were performed. Non-covalently 
immobilized VHH (streptavidin-biotin bond) shows a signal loss of 32% after 30 cyc-
les, whereas covalently immobilized VHH (amine group coupled to carboxyl group) 
shows a signal loss of 10% after 30 cycles (Fig. 3A). In further experiments, binding 
of analyte was only compared within a cycle rather than between cycles. 
5.2.4 Eﬀ ect of Uniform Orientation of Capture Molecules 
5.2.4.1 VHH A23 Binding
To explore the eﬀ ect of the uniform VHH orientation on analyte binding, diﬀ erent 
concentrations of analyte were run over all four fl ow cells of the sensor chip as de-
signed above, using the M200 channels as reference. As expected, M. tuberculosis 
27 lysates showed binding to VHH A23 (Fc2 and Fc4), while negative controls (M. 
smegmatis binding to A23) did not (data not shown). Uniformly oriented VHH A23 
showed a signal for M. tuberculosis 27 lysates that was about fi ve times higher com-
pared to randomly oriented VHH A23 (Fig. 3B).
5.2.4.2 VHH M200 Binding
5.2.4.2.1 Impact of Analyte Size
M200 VHH allows us to test the eﬀ ect of the molecular weight of the analyte (Table 
1), as it binds to both FMDV (8200 kDa) and peptide PAT49 (3 kDa). To this end, 
these analytes of diﬀ erent size were injected over all four fl ow channels. As expec-
ted, FMDV and peptide PAT49 injections showed binding to VHH M200 (Fc1 and 
Fc3). When binding was compared between the uniform orientation and the random 
orientation, orientation yielded a two-fold higher binding of intact FMDV particles 
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(Fig. 4A). Surprisingly, detection of viral peptide PAT49 benefi ted much stronger 
from orientation: a 14 times higher signal was observed when VHHs were uniformly 
oriented (Fig. 4B). 
To investigate the relation between analyte molecular weight and observed sig-
nal diﬀ erence, 12S particle (265-282 kDa) and R-phycoerythrin-PAT49 (240 kDa w/o 
peptide PAT49) (Table 1) were injected over all four fl ow channels. Although the mo-
lecular weight of both analytes is similar, only detection of R-phycoerythirin-PAT49 
benefi ted from orientation: a 55 times higher signal was observed when VHHs were 
uniformly oriented (Fig. 4C and D). 
Figure 3. SPR analysis of A23 capture molecule. A: Signal loss of immobilized capture mo-
lecules. Samples of M. tuberculosis 1 lysate (50 μg/mL) were simultaneously analyzed on 
covalent (left panel) and non-covalent (right panel) immobilized channels, before (black) and 
after (red) 30 cycles of binding and regeneration by 5 μL 10 mM HCl. B: Signal increase on 
uniformly oriented capture molecules. Samples of M. tuberculosis 27 lysate (50 μg/mL) were 
simultaneously analyzed on randomly oriented (left panel) and uniformly oriented (right pa-
nel) channels. Samples contained increasing concentrations of analyte (0.4 x 103, 0.8 x 103, 1.6 
× 103, 3.1 × 103, 6.3 × 103, 12.5 × 103, 25 × 103 and 50 × 103 ng protein/mL). 
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Figure 4. Signal increase by orientation of M200 for analyte with diﬀ erent molecular weight. 
Sensorgrams obtained after injection of 12.5 μg/mL FMDV (A), 1.25 μg/mL peptide PAT49 (B), 
50 μg/mL R-phycoerythrin-PAT49 (C) and 40 μg/mL 12S particle (D). Signal measured by ran-
domly oriented M200 shown in black, measured by uniformly oriented M200 shown in red.
5.2.4.2.2 Impact of Avidity
Comparison of analytes with similar size (R-phycoerythrin and 12S) showed a 
strong diﬀ erence in signal increase upon using a uniform orientation of VHHs (Fig. 
4C and D), suggesting that other parameters caused the observed signal diﬀ erence. 
Another analyte property infl uencing the binding behavior between analyte and 
VHH is avidity. Avidity is used to describe the combined binding strength of mul-
tiple bond interactions, while aﬃ  nity is used to defi ne the strength of individual 
bonds. By the presence of several epitope copies on an analyte, a high apparent aﬃ  -
nity will be observed, due to avidity eﬀ ects. Peptide PAT49 represents a monomeric 
analyte, whereas FMDV and 12S particles display multiple epitope copies (60 and 
5, respectively; Table 1). The infl uence of avidity on the signal increase was investi-
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Table 2. Improvement factor of binding signal obtained by orientation of capture 
molecule M200. Signal obtained after injection of analyte at indicated concentra-
tion. Signal was measured as response unit (RU) 30 seconds after injection was 
stopped. Improvement factor was calculated by dividing the signal of uniformly 
oriented VHH M200 by the signal of randomly oriented VHH M200.
FMDV?(8200?kDa)?
Concentration?
analyte?(in?μg/mL)?
SPR?signal?of?randomly?
oriented??M200?(in?RU)?
SPR?signal?of?uniformly?
oriented??M200?(in?RU)?
improvement?
factor?
12? 1854? 3712? 2?
Peptide?PAT49?(3?kDa)?
1? 10? 138? 14?
R?phycoerythrin?PAT49?(240?kDa?w/o?peptide)?
50? 22? 1208? 55?
12S?particle?(265?282?kDa)?
40?? 446?? 464?? 1.0?
20?? 345?? 345?? 1.0?
5?? 310?? 406?? 1.3?
BSA?14xPAT49?(103?kDa)?
50? 28? 763?? 27?
25?? 31?? 695?? 22?
12?? 29?? 622?? 21?
6?? 23?? 598?? 26?
3?? 18?? 521?? 29?
BSA?2xPAT49?(72?kDa)?
50? 3? 508?? 170?
25?? 2? 454? 227?
12?? 2? 366? 183?
?
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gated by injecting various concentrations of BSA-14xPAT49 (ca. 14 peptides PAT49 
per binding unit) and 12S particles (5 GH-loops per binding unit) over all four fl ow 
channels. Control experiments using BSA-Cys showed no binding onto any of the 
channels (data not shown), while both 12S particles and BSA-14xPAT49 showed bin-
ding to VHH M200 (Fc1 and Fc3), but did not bind to reference VHH A23 (Fc2 and 
Fc4) (data not shown). For 12S particles only weak increases in signal (1 to 1.3-fold) 
could be observed for the uniformly oriented channel (Table 2). For BSA-14xPAT49 
containing 14 peptides, on the other hand, large increases in signal intensity (21 to 
29-fold) were consistently observed in the uniformly oriented channel (Table 2) over 
a range of analyte concentrations. Decrease of peptide number in BSA-2xPAT49 (2 
peptides PAT49 per binding unit) lead to a stronger increase in signal intensity for 
the uniformly oriented VHH (170 to 227-fold; Table 2).
5.2.4.2.3 Aﬃ  nity of Analyte
To study the diﬀ erences of analytes (natural analyte versus peptide PAT49), af-
fi nity of M200 was investigated by ELISA.23 Observed aﬃ  nity constants (KD) are 
shown in Table 1. The KD of M200 for the viral derived analytes (FMDV and 12S) was 
15-fold lower than the KD value for the peptide PAT49 analyte.
 
5.3 DISCUSSION
The experiments performed in the current work for the fi rst time highlight the 
importance of specifi c analyte properties on the eﬀ ect of uniform orientation of the 
capture molecule (Table 2; Fig. 3B and 4). Uniform orientation of the M200 VHH aﬀ ects 
the binding eﬃ  ciency of nearly all analytes, but the range of enhancement is rather 
large: from a hardly noticeable increase by a factor 1.3 to a large 227-fold increase.
The M200 VHH that were immobilized in randomly and uniformly oriented ways 
allowed us to investigate binding properties of a collection of analytes, which diﬀ er 
in properties such as molecular weight, number of epitopes and aﬃ  nity. 
Our initial hypothesis was that the size of the analyte is important for the eﬀ ect 
of uniform orientation. An experiment comparing peptide PAT49 to FMDV particles 
suggested this (Fig. 4A and B). Peptide PAT49 binding to randomly oriented M200 
resulted in a 14-times lower binding signal compared to uniformly oriented M200, 
whereas the eﬀ ect of orientation was modest for analyte FMDV. Peptide PAT49 (3 
kDa) is about 6 times smaller than M200 (18 kDa) and therefore diﬀ uses more eﬃ  ci-
ently through the dextran layer covering the CM5 SPR chip, binding to all accessible 
VHHs on the surface. This suggests that 14 times less VHHs are available for analyte 
binding in the random orientation. Larger analytes, however, can aﬀ ect binding by 
lateral packing leading to a lower amount of captured analyte. Tested FMDV, with 
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a mass of 8200 kDa and a diameter of 25 nm,24 represents such a big analyte. Orien-
tation of capture molecules showed only a modest signal increase for FMDV, which 
might be caused by molecular weight-related factors, such as steric hindrance, shiel-
ding neighboring capture molecules upon analyte binding, and a limitation in the 
capacity to penetrate the dextran layer. The eﬀ ect of size should be negligible when 
12S particles were compared with R-phycoerythrin-PAT49. Both have similar sizes 
(Table 1), and would benefi t in a similar way from uniform orientation. Surprisin-
gly, however, R-phycoerythrin-PAT49 showed an enormous, 55-fold signal increase 
upon uniform orientation of the M200 VHHs, while 12S particles did not show any 
such eﬀ ect (Fig. 4C and D, Table 2). Therefore other explanations for diﬀ erences in 
the eﬀ ect of uniform orientation were investigated.
A second explanation for diﬀ erences in the eﬀ ect of uniform orientation was 
possibly epitope avidity. Avidity, which refl ects the combined binding strength of 
multiple analyte-antibody interactions, could depend on many factors: e.g. capture 
molecule density, fl exibility of antibody, analyte, dextran layer and the availability 
of free antibodies. We tried to fi nd consistent eﬀ ects of the number of epitopes. In 
SPR, analyte bound to one capture molecule gives the same signal as an analyte 
bound via several capture molecules. However, binding to multiple capture mole-
cules leads to stabilization of the analyte-antibody complex on the chip and shifts 
the equilibrium constant.25 To examine the relation of analyte-avidity and signal in-
crease by uniform orientation, proteins varying in the number of exposed epitopes 
were compared, but no consistent relationship between epitope number and eﬀ ect 
of orientation could be observed. 
Comparing intact FMDV (60 GH-loop epitopes) and 12S particles (5 GH-loop 
epitopes), only a slight eﬀ ect could be observed, showing that more epitopes would 
lead to a somewhat stronger eﬀ ect of orientation (Table 2). On the other hand, the 
comparison of BSA-PAT49 carrying 14 or 2 peptide epitopes suggests an opposi-
te eﬀ ect: BSA-14xPAT49 carrying 14 epitopes showed ±25-fold higher binding by 
orientation, whereas BSA-2xPAT49 carrying only 2 epitopes showed a ±200-fold in-
crease in signal. The monomeric PAT49 peptide by itself, showed again a 14-fold im-
proved signal by orientation. Apparently there is not a straightforward relationship 
between the number of epitopes and the eﬀ ect of orientation. 
The experiments presented in this work indicate that the eﬀ ect of uniform ori-
entation is much higher on peptide PAT49 and its protein conjugates (BSA-PAT49 
and R-phycoerytrin-PAT49), compared to virus-derived analytes such as FMDV 
and 12S. In fact, the results in Figure 3 and 4 suggest that the binding of PAT49-
containing analytes is hampered on non-oriented M200 VHH. Possibly, the chemistry 
used for random immobilization could result in a bias towards wrongly-oriented 
capture molecules. For random orientation, covalent cross-linking between free, ac-
cessible primary amines of biotinylated VHH and the carboxyl group on the CM5 
surface was used. Primary amines are usually outward-facing in the protein due 
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to its positive charge under physiological conditions,26 and therefore are accessible 
for conjugation. VHHs can be immobilized via the ɛ-amines, present in lysine side 
chains, or via the α-amine, present at the N-terminus of the protein. Biotinylated 
M200 contains eight lysine side chains and A23 contains seven available lysine side 
chains (Fig. 2C), therefore multiple orientations during immobilization are possible 
via ɛ-amines. However, due to its lower pK value, the reactivity of the N-terminal 
amino group is about 300 times higher than that of amino groups of lysine side-
chains.7 The N-terminus of VHHs is located close to the analyte binding site. There-
fore, the use of the standard, non-oriented immobilization method could result in 
a situation where more VHHs are immobilized ‘up-side down` via the N-terminal 
α-amine in the non-orientated immobilization method than by the ɛ-amines present 
in lysine side chains. However, a predominant ‘up-side down` orientation of VHH 
would not explain why PAT49-containing analytes would bind more poorly, while 
this seems not to be the case for the more bulky FMDV and 12S analytes. Possibly, 
the confi guration of the binding site aﬀ ects binding behavior more strongly than 
avidity or size. The epitope amino acids as they occur in peptide PAT49 are probably 
not in their natural analyte environment. Therefore they may adopt a confi guration 
that diﬀ ers from the native (virus) confi guration, which may lower the aﬃ  nity of 
VHH M200. Indeed it was previously reported that the peptide conformation plays a 
crucial role in antibody-analyte interaction.27 The GH-loop forms a highly fl exible, 
disordered protrusion of structural protein VP1 on the virus surface, but synthe-
tic GH-loop peptides introduced into carrier molecules showed that stabilization of 
the loop is dependent on contacts of neighboring regions.28 Therefore the aﬃ  nity of 
M200 should diﬀ er between investigated analytes. Indeed, the aﬃ  nity for peptide 
PAT49 was lower than for the analytes FMDV and 12S, suggesting that aﬃ  nity of 
analytes has an eﬀ ect in the tested set-up. Also Peluso et al.14c suggested that aﬃ  nity 
might play a major role when low concentrations of analyte were used.
In all cases studied here, the uniform orientation of capture molecules leads to 
improvements of signal, both for the A23 and the M200 VHH. Although the extent 
to which orientation results in signal improvement diﬀ ered. The diﬀ erential eﬀ ect 
of uniform orientation on signal intensity between diﬀ erent capture molecules has 
been well documented. Many studies have been performed using staphylococcal 
protein A to orient antibodies, and have demonstrated clear eﬀ ects of orientation 
on immunoassay sensitivity (e.g. Tajima et al.)1b. Peluso et al. compared randomly 
biotinylated and site-specifi cally biotinylated capture molecules (immunoglobulins 
and Fab fragments), using three diﬀ erent antibodies, and observed 1.6 to 10-fold 
improvements, depending on the capture molecule.14c In their work, the orientation 
was mediated by either site-specifi c or random biotinylation. A study carried out 
on VHHs in a set-up very similar to ours, site-specifi c biotinylation showed a slightly 
decreased level of detection compared to VHHs that were randomly immobilized via 
the primary amines.8b Similar to our set-up, Saerens et al. used the C-terminus to 
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introduce the biotin moiety by BirA enzyme leading to unique probe biotinylation 
at the antipode of the analyte binding site. One of the explanations for the diﬀ erence 
between the two studies could be that the human prostate-specifi c analyte, which 
was used in their study, has properties that do not favor recognition by uniformly 
oriented VHH. Another explanation could be that the rigid human IgA-1 hinge deplo-
yed by Saerens et al. between the VHH and the AviTag interfered with correct orien-
tation, while the fl exible glycine-rich linker deployed in this study (Fig. 2C) would 
permit a correct orientation.
 
5.4 CONCLUSION
In the current work we show that analyte properties can have a large impact on 
biosensors signals when uniformly oriented and randomly oriented capture mole-
cules are used. Orientation eﬀ ects up to a factor 227 have been measured, and the 
observed range of orientation eﬀ ects (factor 1.3 to 227) was analyzed with respect to 
a series of analyte properties. While size and avidity eﬀ ects do not seem to give a 
systematic improvement factor, the strength of the interaction dominates the eﬀ ect 
of orientation of the antibody: weaker interactions benefi t much more from uniform 
orientation than stronger interactions. Clearly, this steers the further research that is 
needed into the eﬀ ect of capture molecule orientation on sensing of target and non-
target analytes. 
5.5 MATERIAL AND METHODS
5.5.1 Analytes of VHH
VHH A23 (Genbank accession no JN234011) detects the 16 kDa heat-shock protein 
of Mycobacterium tuberculosis, and was characterized before.15 Mycobacterium ly-
sates (M. tuberculosis 1, M. tuberculosis 27 and M. smegmatis, Royal Tropical Insti-
tute, Amsterdam, the Netherlands) were prepared as described before.15
VHH M200 is specifi c for the GH-loop of structural protein VP1 of foot-and-mouth 
disease virus (FDMV).17 FMDV analyte and 12S particles derived thereof by acidi-
fi cation were prepared as described before.29 Peptide PAT49 (acetyl-YGDGTVAN-
VRGDLQVLAQKAARALPC-amide), corresponding to amino acid residues 136-
160 of the GH-loop of the FMDV O1 Manisa strain was purchased from Peptide 2.0 
(Chantilly, US). Peptide PAT49 was coupled with the additional C-terminal cysteine 
residue to maleimide-activated bovine serum albumin (BSA) and R-phycoerythrin 
(Innova Biosciences Ltd., United Kingdom). Maleimide-activated protein was reac-
ted overnight at room temperature in phosphate-buﬀ ered saline (PBS) pH 7.2 with 
peptide PAT49 in a 1:20 and 1:5 molar ratio, resulting in BSA-PAT49 and R-phyco-
erythrin-PAT49. To subsequently block unreacted maleimide moieties, cysteine was 
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added in excess. BSA-PAT49 and R-phycoerythrin-PAT49 were purifi ed on Super-
dex 200 (GE Healthcare, Uppsala, Sweden) and concentrated using fi lter tubes (Mil-
lipore, the Netherlands). Protein concentrations were determined with the Pierce 
660 nm Protein assay using NanoDrop 1000 and albumin as reference protein for 
the standard curve.
5.5.2 Biotinylation of VHH 
VHHs are present in a vector for periplasmic VHH expression under control of the 
T7 promoter, based on the backbone of the pRSET-A vector (Invitrogen, the Nether-
lands). The C-terminus of the VHH was fused to an AviTag (GLNDIFEAQKIEWHE) 
(Avidity, LLC, Colorado) for in vivo biotinylation along with a His6 tag for puri-
fi cation purposes followed by a stop codon. Plasmid pBirAcm, an IPTG inducible 
plasmid containing the BirA gene engineered into pACYC184 (Avidity), was trans-
formed to E.coli BL21-AI and used for in vivo biotinylation. Expression was perfor-
med according to Cloutier et al.,30 purifi cation was performed as reported before.15
5.5.3 Western Blot Analysis 
Purifi ed biotinylated VHH (1.5 μg) was fi rst boiled and reduced in buﬀ er and 
electrophoresed on a 15% SDS-PAGE gel. For western blott ing, proteins were trans-
ferred from gel to a nitrocellulose membrane (Trans-Blot, Bio-Rad, Hercules, CA). 
These membranes were subsequently blocked overnight at room temperature in 2% 
milk in PBS pH 9.0 on a shaker, and then incubated with either anti-His6-Peroxidase 
(1:4000 in 2% [w/v] milk in PBS pH 9.0, Roche, Mannheim, Germany) or streptavi-
din-peroxidase (1:5000 in 2% [w/v] milk in PBS pH 9.0, Roche) for 1 h at room tempe-
rature on a shaker. Next, the membranes were washed once with 2% milk in PBS pH 
9.0, followed by two washing steps with PBS pH 9.0 containing 0.1% Tween 20 and 
two washing steps with PBS pH 9.0. Specifi c binding was detected with 3,3’,5,5’-te-
tramethylbenzidine (TMB) liquid substrate system for membranes (Sigma-Aldrich, 
the Netherlands). The molecular weight standard was Page Ruler Prestained Protein 
ladder (Thermo Scientifi c).
5.5.4 Surface Plasmon Resonance (SPR)
Carboxymethyl dextran sensor chips (CM5), HBS-EP buﬀ er (pH 7.4, consisting of 
10 mM 4-[2-hydroxyethyl]piperazine-1-ethanesulfonic acid, 150 mM sodium chlori-
de, 3 mM ethylenediaminetetraacetic acid, 0.005% v/v surfactant polysorbate 20), the 
amine coupling kit (containing 0.1 M N-hydroxysuccinimide [NHS], 0.4 M 1-ethyl-
3-[3-dimethylaminopropyl]carbodiimide hydrochloride [EDC] and 1 M ethanolami-
ne hydrochloride [pH 8.5]) were purchased from GE Healthcare (Uppsala, Sweden).
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Oriented immobilization: In a BIAcore 3000 streptavidin was immobilized onto a 
CM5 surface by the use of the amine coupling kit and the ´Aim-for–Immobilization` 
wizard as present in the BIAcore 3000 control software. To this aim the biosensor 
surface was activated by injecting (35 μL at a fl ow rate of 5 μL/min) a mixture of EDC 
and NHS (1:1; v/v) into fl ow channels (Fc3 and Fc4). Then streptavidin (50 μg/mL in 
coupling buﬀ er [10 mM sodium acetate, pH 4.0]) was injected and bound to the acti-
vated carboxymethylated dextran surface via its primary amine groups, aiming for 
an immobilization level of 4000 response units (RU). After coupling, the remaining 
active groups were blocked with ethanolamine hydrochloride (1 M, 35 μL at a fl ow 
rate of 5 μL/min). VHHs with a site-specifi cally att ached biotin label were subsequent-
ly captured onto a streptavidin surface in fl ow channels (Fc3 and Fc4, Fig. 1B) in an 
oriented manner. To non-covalently immobilize biotinylated VHHs on the streptavi-
din surface 10 μL biotinylated VHH M200 (50 μg/mL in HBS-EP buﬀ er) was injected 
at a fl ow of 5 μL/min over Fc3 resulting in 3183 ± 638 RU. The same procedure was 
repeated for biotinylated VHH A23 on Fc4 resulting in 3125 ± 423 RU.
Random orientation: Biotinylated VHHs were immobilized onto a CM5 surface 
by the use of the amine coupling kit and the ´Aim-for–Immobilization` wizard. The 
biosensor surface was activated by injecting (35 μL at a fl ow rate of 5 μL/min) a 
mixture of EDC and NHS (1:1, v/v) into fl ow channels (Fc1 and Fc2) (Fig. 1C). Then 
biotinylated VHH (50 μg/mL in coupling buﬀ er) was injected and bound to the acti-
vated carboxymethylated dextran surface via its primary amine groups, aiming for 
an immobilization level of 3500 response units (RU). After coupling, the remaining 
active groups were blocked with ethanolamine hydrochloride (1 M, 35 μL at a fl ow 
rate of 5 μL/min). Immobilization of biotinylated VHH M200 on Fc1 resulted in 3420 
± 317 RU, of biotinylated VHH A23 on Fc2 in 3344 ± 262 RU. 
The BIAcore 3000 SPR machine was operated at a constant temperature of 25 °C 
and a fl ow of 10 μL/min. 50 μL analyte preparations in HBS-EP buﬀ er, each of dif-
ferent analyte concentration, were injected over the four serially connected fl ow 
channels. Regeneration of the sensor surface was achieved with 5 μL of a 10 mM 
hydrogen chloride solution (HCl), which was passed through at a fl ow rate of 10 μL/
min after each run. Data points were measured 30 seconds after injection end at time 
point 400.5 sec. All sensorgrams were referenced by subtracting the signal from the 
reference fl ow channel and were evaluated using the BIAevaluation software. 
5.5.5 Aﬃ  nity Measurements
Aﬃ  nity of VHH M200 to peptide PAT49, FMDV and 12S was determined by ELI-
SA, using a competition assay as done before.30 Shortly, 100 μL of a 50 nM VHH M200 
solution was pre-incubated overnight with a dilution series of analyte at room tem-
perature in 2% milk PBS pH 9.0. Pre-incubated VHH M200 was then transferred to a 
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plate coated with a low density of analyte (FMDV: 1 μg/mL total protein correspon-
ding to 0.2 μg/mL FMDV, 12S particle: 1 μg/mL total protein corresponding to 0.2 
μg/mL 12S particle and peptide PAT49: 0.5 μg/mL) in 50 mM carbonate buﬀ er pH 
9.6. VHH M200 bound to the plate was detected using anti-His6-Peroxidase (1:4000 in 
2% (w/v) milk in PBS pH 9.0, Roche). Subsequently HRP activity was determined 
by adding 1-StepTM Ultra TMB-ELISA substrate (Pierce, Rockford, IL). The reaction 
was allowed to proceed in the dark for 30 min and then stopped with 1 M sulphuric 
acid and the OD was measured at 415 nm in a microtiter plate-reader (TECAN Spec-
traFluor Microplate Reader).
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CHAPTER 6
Oriented Llama Antibodies Strongly 
Increase Sensitivity of Biosensors
ABSTRACT
To reach high sensitivity in biosensors, uniform orientation of capture molecules 
on sensing surfaces is required. The objective of this study was the organization of 
capture molecules on surfaces in a way that the analyte binding site is exposed to the 
analyte solution. For this purpose, VHH proteins recognizing foot-and-mouth disease 
virus (FMDV) were used. Azides were introduced in the VHH to function as bioor-
thogonal reactive groups. The importance of oriented organization was addressed 
by comparing VHH containing multiple exposed azide groups to VHH carrying only 
a single azide group. A surface plasmon resonance (SPR) chip exposing cyclooctyne 
was reacted to azide functionalized VHH domains, using click chemistry. Compari-
son between random and uniform oriented capture molecules showed up to 800-
fold increase in biosensor sensitivity. This technique may increase the containment 
of infectious diseases such as FMDV as its strongly enhanced sensitivity may facili-
tate early diagnostics.
This chapter was submitt ed.
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6.1 INTRODUCTION
Biosensors combine analytical devices with biological capture components to 
sense the presence of analytes. Antibodies are proteins that are widely used in bio-
sensors, due to their high specifi city. In addition to full-sized antibodies (e.g. IgG), 
fragments of antibodies, such as Fabs (fragment, antigen binding) have been em-
ployed in biosensors.1 These fragments contain the analyte recognition site, but can 
be designed and produced as recombinant proteins for applications in biosensors.2 
The smallest natural antibody-based binding unit is the variable domain of llama 
heavy-chain antibodies (VHH), which has a diameter of a few nm.3 Such binding frag-
ments are att ractive for nanotechnology, since they can be easily tailored by protein 
engineering and included in biosensors.4 In the current chapter we show how such 
tailoring can be used to orient VHHs onto a sensor surface, which can lead to an im-
provement of the sensor sensitivity of several orders of magnitude (here: up to factor 
800).
Immobilization methods have an impact on the analytical performance in bio-
sensors, as they aﬀ ect the lifetime and orientation of the antibodies. Amine groups 
located at the surface of the antibody are often used to att ach the protein covalent-
ly to activated carboxyl groups on sensor materials.5 This method results in a ran-
dom orientation, which reduces the eﬃ  ciency of the sensor, as a large portion of the 
antibodies will not expose the analyte binding site to the analyte solution. Several 
techniques to position the antibodies in a uniform orientation on the surface have 
been explored, such as protein A or G for immunoglobulin or the biotin-streptavidin 
system.5a, 6 A common drawback of these methods is that they require an interme-
diate protein and rely on non-covalent protein-protein interactions. Inevitably this 
will negatively aﬀ ect the lifetime of the biosensor and increase the distance between 
capture component and sensor surface.5a To establish stable covalent links to prote-
ins in an aqueous environment, mild, biocompatible and selective click reactions, 
such as the 1,3-dipolar cycloaddition between an azide and an alkyne, have recently 
been developed.7 Such reactions can be catalyzed by copper(I), or may occur in the 
absence of a catalyst, when the ligand contains a highly strained cyclic alkyne (e.g. 
cyclooctyne) with a low activation energy (so-called CuAAC and SPAAC reactions, 
respectively).8 Azides may be incorporated into proteins as the non-natural amino-
acid azidohomoalanine (AHA), an analogue which replaces methionine.9 In this 
way, click chemistry has been deployed for the labelling of cells by dye conjugati-
on, or for establishing enzyme complexes.10 Here we explore both the CuAAC and 
SPAAC reactions to fi nally obtain a uniform orientation of VHH antibodies onto a 
surface plasmon resonance (SPR) biosensor surface (Fig. 1). This biosensor detects 
epitopes from foot-and-mouth disease virus (FMDV), and the virus itself. 
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Figure 1. Schematic illustration of the orientation of immobilized VHHs with tailor-made mo-
difi cations on a sensor chip. A: Azide-functionalized VHH receptors M200 and engineered VHH 
OmpA-M200 are smaller analogues of full llama heavy-chain IgG. B: Azide-functionalized 
VHH OmpA-M200 covalently coupled in a uniform orientation onto a cyclooctyne-functiona-
lized CM5 sensor. C: azide-functionalized VHH M200 covalently coupled in a random orienta-
tion via one of fi ve available azides onto a cyclooctyne-tailored CM5 sensor.
6.2 RESULTS AND DISCUSSION
To study oriented antibodies on alkyne-exposing surfaces, a VHH molecule with 
only a single accessible azide group was designed and compared to a VHH with fi ve 
accessible azides. VHH M200, which recognizes the virus FMDV,11 normally contains 
heavy?chain?IgG
OmpA?M200
dextran?layer
random?orientation?
uniform?orientation?
B
C
analyte
binding?
site
A
1,2,3?triazole
M200 azide group?(N3)
VHH
CH2
CH3
106
Chapter 6
fi ve methionine positions, and can thus be immobilized in fi ve orientations upon 
AHA introduction. M200 was mutated to remove those methionines, and to intro-
duce a single, C-terminal methionine group (OmpA-M200, Fig. 2). The C-terminus 
is one of the exposed parts of the VHH protein, and located opposite of the analyte 
binding site. Immobilization via this part of the protein would thus orient the VHH to 
expose its analyte binding region to the solvent (Fig. 1B). To study the infl uence of 
replacing the internal methionine residues on binding aﬃ  nity towards the analyte, 
VHHs were examined by enzyme linked immunosorbent assay (ELISA). The original 
VHH M200, containing fi ve methionine residues, showed similar ELISA responses 
as the engineered M200 (with altered methionines [M83, M88 and M153] and a me-
thionine introduced at the C-terminus, Fig. 2) (Fig. 3). This indicates that in this 
VHH, replacement of the internal methionine residues does not interfere with analyte 
binding. To obtain VHHs with only a single methionine, an OmpA singnal sequence 
Figure 2. Structure of VHHs. A: Protein sequence of VHH M200. The three complementarity 
determining regions CDR1, CDR2 and CDR3 are shaded; methionine residues are under-
lined, cursive and red. B: Protein sequence showing engineered VHH OmpA-M200 construct. 
C: Crystal structure of llama VHH domain raised against a carbazole hapten (PDB entry 1U0Q) 
showing N- and C-terminal position in VHH, CDR loops shown in blue (left). Red stars at me-
thionine positions were introduced representative for VHH M200 before (M200, middle) and 
after engineering (OmpA-M200, right).
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Figure 3. Binding of engineered VHH antibody fragments to analyte investigated by ELISA. 
Diﬀ erent concentrations of VHH M200-MET and engineered M200-MET (with altered methio-
nines [M83, M88 and M153] and a methionine introduced at the C-terminus) bind to surface 
coated analyte peptide PAT49 (for more detail see Text). Measurements were performed in 
duplicates, expressed as means ± SD.
was introduced at the N-terminus of the VHH protein sequence. This signal sequence 
will be cleaved oﬀ  during protein expression in bacteria, resulting in the loss of the 
N-terminal start methionine in the mature protein (OmpA-M200, Fig. 2). 
To introduce the azide functionality in the VHHs, proteins were expressed in a 
methionine auxotrophic E.coli strain supplied with AHA in the medium. The ef-
fi cient incorporation of AHA was confi rmed in purifi ed proteins by Electron-spray 
ionization time-of-fl ight (ESI-ToF) mass spectroscopy. MET diﬀ ers by 5 Da in mole-
cular mass to AHA (Fig. 4A). In Figure 4B, mass spectra of the M200-MET protein, 
the OmpA-M200-MET protein (both produced with MET) and the M200-AHA and 
OmpA-M200-AHA (both produced with AHA) are shown. The mass of M200-MET 
(18058.8 Da) corresponds to a full-length M200 protein, including an N-terminal 
MET (Fig. 4B).The mass of M200-AHA (18034.1 Da) is 24.7 Da lower, indicating re-
placements of all fi ve MET residues by AHA. For the OmpA-M200-MET protein, the 
observed mass (17732.0 Da) corresponds to a protein starting from the glutamine 
immediately after the OmpA cleavage site. The mass of OmpA-M200-AHA protein 
(17727.1 Da) is 4.9 Da lower than the mass of the OmpA-M200-MET protein, indi-
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Figure 4. Azidohomoalanine incorporation in VHH. A: Natural amino acid methionine (MET) 
shows similar structure than its non-natural analog azidohomoalanine (AHA) B: Electron-
spray ionization time-of-fl ight (ESI-TOF) mass spectra of M200 and OmpA-M200. Upon de-
convolution, peaks corresponding to the calculated masses (18058.1 Da for M200-MET, 18033.1 
Da for M200-AHA, 17732.5 Da for OmpA-M200-MET and 17727.5 Da for OmpA-M200-AHA) 
were detected.  
cating replacement of a single MET residue by AHA. Neither mutation, nor AHA 
incorporation had an eﬀ ect on the binding aﬃ  nity of the VHH towards the analyte as 
shown by ELISA experiments (Fig. 5).
To investigate the accessibility of incorporated azide groups in the AHA-functio-
nalized proteins, VHH proteins were reacted with alkyne-labelled polyethylene glycol 
(PEG). Three reactive PEG ligands were tested. The alkyne-PEG5000 was reacted to the 
protein using the CuAAC reaction. PEG2000 coupled to dibenzocyclooctyne (DIBO) 
and PEG5000 coupled to bicyclo[6.1.0]non-4-yn-9-ol (BCN) were reacted to the protein 
by a SPAAC reaction. Increases in molecular weight of the proteins by these click 
reactions to the PEG moieties were examined by observing mobility shifts of VHH 
on SDS-PAGE (Fig. 6). Protein M200-AHA, bearing fi ve AHA residues, showed an 
array of mobility shift bands after reaction to alkyne-PEG5000 via CuAAC (Fig. 6A). 
This indicates that multiple azide groups in M200-AHA are available for the click 
reaction. For protein OmpA-M200-AHA, all three click reactions showed mobility 
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shifts corresponding to the coupling of a single PEG unit (Fig. 6A, B, C). 
Based on this knowledge, an SPR biosensor surface was functionalized with BCN. 
Both azide-functionalized VHHs - M200-AHA and OmpA-M200-AHA - were immo-
bilized in separate SPR channels via the SPAAC reaction. M200-AHA will couple 
to the surface by one of the fi ve exposed azide groups, leaving no control over the 
orientation (Fig. 1C). In contrast, OmpA-M200-AHA contains only one azide group 
at the C-terminus and will att ach in a uniform direction on the surface (Fig. 1B). For 
comparison to conventional random immobilization methods, an SPR channel that 
was functionalized using NHS chemistry was included in the analysis. Two analytes 
were tested: FMDV viral particles (60 recognition sites), and peptide PAT49, which 
is the known epitope towards the antibody, with one recognition site. Concentration 
ranges of both analytes were analyzed to investigate the sensitivity of the sensor sur-
faces. To our surprise, the uniformly oriented OmpA-M200-AHA showed an 800-
fold higher sensitivity for peptide PAT49 than the randomly oriented M200-AHA: 
the threshold value of 10 RU was reached at 0.07 μg/mL for OmpA-M200-AHA, and 
at 55.4 μg/mL for M200-AHA (Fig. 7). This orientation eﬀ ect of almost three orders 
Figure 5. Binding of azidohomoalanine functionalized VHH antibody fragments to analyte in-
vestigated by ELISA. Diﬀ erent concentrations of VHH M200 and OmpAM200 bind to surface 
coated analyte peptide PAT49. Measurements were performed in duplicates, expressed as 
means ± SD.
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Figure 6. PEG-reacted VHHs size separated by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis. A: M200-AHA and OmpA-M200-AHA reacted with alkynl-PEG5000 via Cu-
AAC B: OmpA-M200-MET and OmpA-M200-AHA reacted with BCN-PEG5000 via SPAAC. 
In contrast to OmpA-M200-AHA, control reactions with OmpA-M200-MET, which was pro-
duced in the absence of AHA, did not show a mobility shift, indicating that the reaction was 
specifi c for the azide group. C: OmpA-M200-AHA reacted with DIBO-PEG2000 via SPAAC. 
Plus (+) indicates presence of PEG-compound, minus (-) absence. Indicated are the positions 
of relevant size markers in kDa. 
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of magnitude is, as far as we know, by far the largest orientation eﬀ ect observed up 
to now for any antibody-mediated biosensing event.  Orientation eﬀ ects typically 
range from 1 – 10.5b, 6a, 12 with only a handful reports that indicate signifi cantly larger 
ones.13 
For FMDV, the signals were much stronger, and the orientation eﬀ ect was less 
pronounced. Still ~10-fold higher sensitivity was observed in the oriented channel 
(Fig. 6). Previously we studied the eﬀ ect of analyte properties, such as the number of 
recognition sites, the molecular weight and the aﬃ  nity, on the biosensor response, 
using streptavidin-biotin and NHS chemistry.5a In that study it was already obser-
ved that the signal response of peptide PAT49 benefi ts (14-fold) from orientation, 
while detection of FMDV only marginally (2-fold) improved. These diﬀ erences ap-
peared to depend on the higher aﬃ  nity of FMDV for the M200 antibody: with a 
lower aﬃ  nity, the orientation eﬀ ects increased. It is not fully clear why the current 
orientation enhancement is even bigger, and more experimentation is required for a 
further development of the hypothesis, but the sheer magnitude of this eﬀ ect holds 
great promise for diagnostics.  
To investigate the stability of VHHs att ached to the surface via the various immo-
bilization strategies, repeated cycles of peptide PAT49 and FMDV injection and rege-
neration with 5 μL 10 mM HCl were performed. VHH immobilized by click chemistry 
show an average signal loss of 0.23% after each cycle, whereas VHHs immobilized by 
NHS chemistry show an average signal loss of 0.26% after each cycle (Appendix 2: 
Table S2). In other words: the azide-alkyne click reaction provides a covalent link 
that is at least as good as NHS-induced amide bond formation.
In summary, previously the eﬀ ect of orientation of antibodies has been studied 
using diﬀ erent immobilization strategies, which may complicate comparisons.5b, 6a 
The current study was performed using identical (SPAAC) chemistry for uniform 
and random immobilization, before comparing their sensing properties. Under the-
se circumstances, orienting antibodies on sensor surfaces by click chemistry leads 
to strongly improved sensitivity of biosensors, up to a factor 800. Such orientation 
eﬀ ects thus greatly enhance the potential of diagnostics, which is crucial for the early 
detection of diseases that is needed to contain spreading of aggressive viruses such 
as FMDV. Finally, further improvements may be anticipated by combining orienting 
proteins with tuning surfaces at the nanoscale, such as via polymer brushes or mo-
nolayers, as this will allow to create more intelligent materials.14 
6.3 MATERIALS AND METHODS
6.3.1 Variable domain of llama heavy-chain antibodies (VHH)
VHH M200 (GenBank accession no: AJ811563.1) is specifi c for peptide PAT49 (ace-
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Figure 7. Surface plasmon resonance analysis of M200-AHA and OmpA-M200-AHA capture 
molecules. A dilution series of peptide PAT49 (100 μg mL-1 - 0.006 μg mL-1) and FMDV (5.6 
μg mL-1 – 0.08 μg mL-1) was simultaneously analyzed on randomly oriented (M200-AHA 
click chemistry [circles] and M200-AHA NHS chemistry [triangles]) and uniformly oriented 
(OmpA-M200-AHA click chemistry [squares]) channels.
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tyl-YGDGTVANVRGDLQVLAQKAARALPC-amide), corresponding to amino acid 
residues 136-160 of the GH-loop of the foot-and-mouth disease virus (FDMV) of 
the O1 Mansia strain.11 Native VHH M200-encoding DNA is present in the PRI-VSV 
expression vector.5a A variant (OmpA-M200) of this plasmid was made which ex-
presses a protein with only a single methionine. Two internal methionine codons 
(coding for M83 and M88: Fig. 2) were altered to alanines by overlap extension PCR 
using oligonucleotides M200-M83A-M88A-F and M200-M83A-M88A-R (Appendix 
2, Table S1). Subsequently, the methionine residue (M153) in the C-terminal part of 
the protein, just before the His6 tag was altered to glycine using the same strategy 
and oligonucleotides M200-M153G-F and M200-M153G-R. A methionine was intro-
duced at the C-terminus by introducing six additional nucleotides (GGGATG) befo-
re the stop codon, encoding glycine and methionine, by amplifying the engineered 
M200 fragment using oligonucleotides M200-F and M200-R, and recloning the engi-
neered fragment in the PstI/NotI restriction sites of the PRI-VSV expression vector. 
Lastly, an OmpA signal sequence was introduce at the N-terminus of engineered 
M200 using oligonucleotides OmpA-F and OmpA-R. Oligonucleotides were hybri-
dized and ligated into PstI/NdeI digested PRI-VSV expression vector. Introduction 
of OmpA signal sequence results in loss of N-terminal start methionine in the matu-
re protein. The entire VHH fragment of the resulting plasmid PRI-VHH-OmpA-M200 
(Fig. 2) was analyzed by DNA sequencing using oligonucleotides M200-F and M200-
R. 
6.3.2 Expression and purifi cation of recombinant VHHs
Plasmids PRI-VHH-M200 and PRI-VHH-OmpA-M200 were introduced into E. coli 
B834 (DE3) pLysS bacteria (Novagen). Bacteria were used for protein expression as 
previous described.4b Azidohomoalanine (AHA) synthesis and expression of AHA 
containing VHHs (VHH-AHA) were performed as described before.15 To obtain recom-
binant protein, bacteria were lysed by sonication. In short, pellets were dissolved in 
1/10 volume lysis buﬀ er (50 mM NaH2PO4, 300 mM NaCl, adjusted to pH 6.0), comple-
mented with 1/100 volume protease inhibitor cocktail (Sigma, St Louis) and 1 mg/mL 
lysozyme. Lysozyme digestion was allowed for 30 min at 4°C before cells were so-
nicated with a Soniprep150 (MSE, London, United Kingdom) in 5 mL batches for 
10 cycles á 10 seconds with a break of 10 seconds. Cell lysate was then centrifuged 
for 30 min at 13.000 rpm and 4°C. Supernatant was used for VHH purifi cation using 
Ni-NTA Superfl ow resin (QIAGEN, Germany) as reported before.16 Eluates were 
concentrated to 200 μL using Amicon ultra-15 centrifugal fi lter units (cut-oﬀ  10K, 
Millipore, The Netherlands). Further purifi cation was performed by size exclusion 
chromatography using a Superdex 200 GL 10/300 column on an ÄKTA FPLCTM. 
VHHs were stored with a fi nal concentration of 15% glycerol at −20°C. Protein con-
centration was determined using Bradford test17 while successful expression and 
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purifi cation was verifi ed by 15% sodium dodecylsulphate polyacrylamide gel elec-
trophoresis (SDS-PAGE) stained with SYPRO ruby (BioRad, The Netherlands).  
6.3.3 Investigation of engineered VHH by enzyme linked immunosorbent assay (ELI-
SA)
Wells of ELISA plates (Maxisorb, NUNC, The Netherlands) were coated with 5 
μg/mL peptide PAT49 in 50 mM carbonate buﬀ er pH 9.6 and incubated at 4°C over-
night. Antigen-coated wells were emptied and washed three times with 200 μL 10 
mM phosphate-buﬀ ered saline pH 7.4 (PBS) with 0.05% Tween 20 (PBST) and then 
blocked with 200 μL PBS containing 3% nonfat powdered milk (w/v) and 0.05% 
Tween 20 (3% PBSMT) for 8 h at room temperature. Wells were emptied and washed 
three times with 200 μL PBST. 100 μL VHH at indicated concentration in PBS was ad-
ded and binding was allowed to occur at 4°C overnight. Excess VHHs were removed 
by washing three times with 200 μL PBST and 100 μL anti-His6-PO conjugate (Sigma 
Aldrich, Missouri, USA) was added at a 1:2000 dilution for 1 h in 3% PBSMT. Excess 
conjugate was washed oﬀ  one time with 200 μL PBST and two times with 200 μL 
demi water. Subsequently peroxidase activity was determined by adding 1-StepTM 
Ultra 3,3`,5,5`-tetramentylbenzidine (TMB) ELISA substrate (Pierce, Rockford, IL). 
The reaction was allowed to proceed in the dark for 30 min and then stopped with 
50 μL 1 M sulphuric acid. The absorbance was measured at 415 nm in a microtiter 
plate-reader (TECAN SpectraFluor Microplate Reader). All samples were measured 
in duplicates.
6.3.4 Click reaction with VHH
Bicyclo[6.1.0]non-4-yn-9-ol-polyethylene-glycol 5000 (BCN-PEG5000) conjugate 
was purchased from Synnaﬃ  x (Nijmegen, The Netherlands). DIBO-PEG2000 was sup-
plied by Marjoke Debets (Nijmegen University, The Netherlands). Alkyne-PEG5000 
was synthesized as described before.18 Bathophenanthroline sulfonated sodium salt 
was purchased from GFS Chemicals (Powell, US).
Click reactions were carried out overnight at ambient temperature. The Copper-
catalyzed azide–alkyne cycloaddition (CuAAC) was performed in Click solution (1 
vol. of 0.1 M CuBr with 2 vol. of 0.1 M ligand [bathophenanthroline sulfonated sodi-
um salt] in DMSO/t-BuOH 3:1). 20 μL phosphate buﬀ er containing 2 μL click soluti-
on and 2 μg VHH were reacted with 1 mM alkyne-PEG5000. Strain-promoted azide–al-
kyne cycloaddition (SPAAC) was performed in 20 μL phosphate buﬀ er containing 
2 μg VHH and 1 mM alkyne-reagent (BCN-PEG5000 or DIBO-PEG2000). Reactions were 
quenched by addition of 5 mM benzyl azide in DMSO. Quenching was allowed for 
3 h at ambient temperature before the eﬃ  ciency of the click reaction was verifi ed by 
SDS-PAGE protein chromatography.
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6.3.5 Surface plasmon resonance (SPR) 
The BIAacore 3000, carboxymethyl dextran sensor chips (CM5), HBS-EP buﬀ er 
(pH 7.4, consisting of 10 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonicacid, 
150 mM sodium chloride, 3 mM ethylenediaminetetraacetic acid, 0.005% v/v sur-
factant polysorbate 20), the amine coupling kit (containing 0.1 M N-hydroxysucci-
nimide [NHS], 0.4 M 1-ethyl-3-[3- dimethylaminopropyl]carbodiimide hydrochlori-
de [EDC] and 1 M ethanolamine hydrochloride [pH 8.5]) were purchased from GE 
Healthcare (Uppsala, Sweden). N-(1R,8S,9s)-bicyclo[6.1.0]non-4-yn-9-ylmethyloxy-
carbonyl 1,8-diamino-3,6-dioxaoctane (BCN-POE3-NH2) was purchased from Syn-
naﬃ  x (Nijmegen, The Netherlands). The experiment was replicated with two chips, 
which produced comparable results.
BCN functionalized surface: In a BIAcore 3000 alkyne-functionalized surfaces 
were prepared using standard EDC/NHS coupling chemistry. To this end the CM5 
biosensor surface was activated by injecting a mixture of EDC and NHS (1:1; v/v, 
35 μL at a fl ow rate of 5 μL/min) into fl ow channels (Fc1, Fc3 and Fc4). Then 50 μL 
BCN-POE3-NH2 (0.1 mg/mL in 10 mM maleic acid pH 6.0) was injected and bound 
to the activated carboxymethylated dextran surface via its primary amine groups. 
After coupling, the remaining active groups were blocked with ethanolamine hyd-
rochloride (35 μL at a fl ow rate of 5 μL/min). 
Reference channel (Fc1): All active free cyclooctynes were blocked with 35 μL 
2-azidoethanol (0.1 mg/mL in HBS-EP buﬀ er at a fl ow rate of 5 μL/min).
Random orientation by NHS chemistry (Fc2): The biosensor surface was activa-
ted by injecting (35 μL at a fl ow rate of 5 μL/min) a mixture of EDC and NHS (1:1, 
v/v) into fl ow channel Fc2. Then M200-AHA VHH (50 μg/mL diluted in coupling 
buﬀ er [10 mM sodium acetate, pH 4.0]) was injected and bound to the activated 
carboxymethylated dextran surface via its primary amine groups, aiming for a si-
milar immobilization level as Fc3. After coupling, the remaining active groups were 
blocked with ethanolamine hydrochloride (1 M, 35 μL at a fl ow rate of 5 μL/min). 
Immobilization of M200-AHA on Fc2 resulted in 4809 RU for chip1 and 3103 RU for 
chip 2.
Random orientation by click chemistry (Fc3): 50 μg/mL M200-AHA in 10 mM 
sodium acetate, pH 4.0 was immobilized (120 μL at a fl ow rate of 5 μL/min) on the 
BCN functionalized surface. After VHH coupling, the remaining active free cyclooc-
tynes were blocked with 35 μL 2-azidoethanol (0.1 mg/mL in HBS-EP buﬀ er at a 
fl ow rate of 5 μL/min). Immobilization of M200-AHA on Fc3 resulted in 6717 RU for 
chip1 and 4349 RU for chip 2.
Uniform orientation by click chemistry (Fc4): 50 μg/mL OmpA-M200-AHA in 
10 mM sodium acetate, pH 4.0 was immobilized (120 μL at a fl ow rate of 5 μL/min) 
on the BCN functionalized surface. After VHH coupling, the remaining active free 
cyclooctynes were blocked with 35 μL 2-azidoethanol (0.1 mg/mL in HBS-EP buﬀ er 
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at a fl ow rate of 5 μL/min). Immobilization of OmpA-M200-AHA on Fc4 resulted in 
4378 RU for chip 1 and 3419 RU for chip 2.
The BIAcore 3000 SPR machine was operated at a constant temperature of 25°C 
and a fl ow of 10 μL/min. 50 μL analyte preparations in HBS-EP buﬀ er, each of diﬀ e-
rent analyte concentration, were injected over the four serially connected fl ow chan-
nels. Regeneration of the sensor surface was achieved with 5 μL of a 10 mM hyd-
rogen chloride solution (HCl). Data points were measured 30 s after injection end. 
All sensorgrams were referenced by subtracting the signal from the reference fl ow 
channel (Fc1) and were evaluated using the BIAevaluation software. 
6.3.6 Electron-spray ionization time-of-fl ight (ESI-TOF) measurements
 
VHH constructs were analyzed by ESI-TOF on a JEOL AccuTOF. VHH (~ 1 mg/mL) 
in 100 mM ammonium acetate was injected through an Agilent system run on Mil-
liQ/0.1% formic acid. Deconvoluted spectra could be obtained using Mag Tran soft-
ware. Calculated masses included the loss of two protons due to disulphide bond 
formation.
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CHAPTER 7
General Discussion
ABSTRACT
This chapter gives an overview on the work done in this thesis and discusses 
some remaining questions and additional ideas.
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7.1 GENERAL DISCUSSION
The previous chapters explored the formation of tailor-made monolayers on cop-
per substrates, as well as several strategies to immobilize llama antibodies on sur-
faces. Combined, the achievements of both research topics described in this thesis 
are highly valuable for the further development of biosensors. Yet not all problems 
are solved and there is some room for improvement. This chapter refl ects on the 
work done, poses some remaining questions, and presents additional ideas and re-
commendations to place this work into a broader context.
In chapter 2, the generation of well-defi ned organic monolayers on oxide-free 
copper was described. Using a wet-chemical route, decanethiol self-assembled mo-
nolayers (SAMs) were created while the copper remained oxide-free. Using this 
route, extreme care has to be taken at any time to prevent the appearance of copper-
oxide during monolayer formation. The wet-chemical route explored by us is a pro-
mising technique for oxide-free monolayer fabrication on copper, yet there is some 
room for improvements in regard of handling. Hutt  and Liu used acetic acid as in 
situ etching agent during octadecanethiol monolayer formation to prevent copper-
oxide formation.1 Such an addition, for instance, could simplify the preparation of 
SAMs on copper. However, oxidation of copper substrates is fast, and even after 
formation of well-ordered monolayers oxidation remains an issue. In view of future 
applications a prolonged stability of oxide-free copper would be essential. Longer 
alkyl chains are known to self-assemble in a denser monolayer and provide a bett er 
protection barrier against oxygen and aqueous ions.2 Further research should there-
fore investigate longer molecule chains than octadecanethiol on copper substrates, 
as well as focus on the eﬀ ects of introduced functional groups, so as to make SAMs 
more stable against oxygen penetration. 
SAM formation is a fl exible route to generate thin and ordered bio-active mono-
molecular fi lms on a variety of substrates by organic molecules (both aliphatic and 
aromatic) containing free anchor groups such as thiols, disulphides, amines, silanes, 
or acids.3 Using such tailor-made surfaces detection elements like antibodies can be 
immobilized onto sensor surfaces. In chapter 2 it was shown that N-succinimidyl 
mercaptoundecanoate (NHS-MUA) monolayers allowed for the successful att ach-
ment of biomolecules via the amine group. Biotin-modifi ed copper surfaces were 
generated and successfully employed for streptavidin binding. It is expected that 
in a similar manner antibody immobilization can be achieved on NHS-terminated 
SAMs on copper in a one-step reaction via surface-accessible amine groups on the 
antibody. Nonspecifi c adsorption tailor-made surfaces due to a high surface energy 
is a further issue to be overcome. Nonspecifi c protein adsorption can be reduced by 
using functional end groups with specifi c properties.4 Also polymeric fi lms, such as 
dextran layers used on surface plasmon resonance (SPR) chips or the generic used 
polyethylene glycols (PEGs), and protein-repellent zwitt erionic polymer brushes 
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have been shown to reduce unspecifi c protein binding.5 Future research should 
therefore focus on the fi ne-tuning of the surfaces of interest in order to minimize 
nonspecifi c protein binding and maximize specifi c binding of the analyte to the sur-
face-immobilized detection element.
The development of a rapid, sensitive and specifi c method for analyte detection is 
of great importance in many sectors, such as food safety, disease control and health 
care. The ongoing miniaturization of sensor devices will stress the need of more 
eﬃ  cient detector elements in the future. This can be achieved by (1) altering the bio-
logical detection element, or by (2) improving the immobilization method thereof.
7.1.1 Biological Detection Elements in Biosensors
Chapter 3 outlined some of the commonly used detection elements in biosen-
sors. Antibodies have long been the most popular bio-recognition elements in bio-
sensors as they display high sensitivity and selectivity. By reducing the size of the 
antibody (in order to increase the immobilized quantity) and/or by increasing the 
binding eﬃ  ciency of the biological detection element, biosensor performance can 
be improved. Detection elements should ideally be small in size, specifi c, available 
for engineering and should have a high stability leading to a long shelf-life. The 
variable domain of llama antibodies (VHH) fulfi lls all of these requirements, and was 
thus explored as detection element in a SPR-based biosensor. In chapter 4 the suc-
cessful selection of tuberculosis specifi c VHHs was described in detail. A broad set of 
VHHs against the species-specifi c cytosolic 16 kDa heat-shock protein was obtained 
using two diﬀ erent phage display selection strategies. Surprisingly, all selected VHHs 
bound to the same protein of M. tuberculosis. This was unexpected, as the alpacas 
were immunized with a lysate of M. tuberculosis and therefore exposed to a large 
range of bacterial proteins. Each of these proteins is capable to trigger the immune 
response by stimulating a number of relevant cells. As a result, antibodies towards 
the ´foreign` proteins are generated, resulting in a batch of detection elements spe-
cifi c towards several bacterial proteins. In our study, however, selection resulted in 
a batch of diﬀ erent VHHs all specifi c for the 16 kDa heat-shock protein of M. tuber-
culosis. Recently it was shown that the selected VHHs bind to diﬀ erent recognition 
sites (epitopes) of the 16 kDa heat-shock protein, making them a useful tool for M. 
tuberculosis detection.6 It remains unclear for which reason all selected VHHs bind to 
only one bacterial protein of M. tuberculosis. It might be due to its rich presence in 
bacteria lysate, since it is a highly expressed protein, or due to its immunodominant 
behavior. A new immunization of alpacas would be necessary to unravel the pheno-
mena. Obviously it would be also interesting to have VHHs specifi c for other proteins 
of M. tuberculosis, for example for a secreted protein. Secreted antigens would be 
freely available in the sputum/blood and would not require the lysis of the bacteria 
to sense its presence. However, also here the generation of a new VHH library would 
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be necessary and one could argue that a secreted antigen may be too dilute for direct 
antigen detection in e.g. a sputum sample, making time consuming concentration 
steps necessary.   
Beside that, antibodies with a higher aﬃ  nity would be advantageous. The high-
est dissociation constant found for the tuberculosis specifi c VHHs was 4 × 10−10 M. 
However, other VHHs with a 10-fold higher aﬃ  nity have also been reported.7 In vivo 
or in vitro aﬃ  nity maturation based on mutation and selection can raise antibodies 
displaying a higher aﬃ  nity towards the antigen. First results indicated that in vitro 
aﬃ  nity-maturated tuberculosis specifi c VHHs showed bett er antigen binding behavi-
or.8 Selection can also be used to yield antibodies with other benefi cial properties, 
such as a longer shelf-life due to higher stability or an increased pH tolerance. Fu-
ture research should therefore explore possibilities to optimize properties of detec-
tion elements in order to increase the overall biosensor performance.
7.1.2 Immobilization Method of Detection Elements in Biosensors
As summarized in chapter 3, many methods have been explored in the past to 
orient antibodies on sensor surfaces in order to increase the antigen-binding capaci-
ty. In chapter 5 and 6, oriented immobilization of VHHs was put into practice using 
non-covalent and covalent strategies, respectively. The investigated methods disc-
losed that orientation of detection elements is benefi cial for antigen binding. 
In chapter 5, oriented non-covalent immobilization via the biotin-streptavidin 
system was compared to random covalent immobilization via the amine group. A 
broad set of antigens with diﬀ erent properties was studied with this sensor set-up. 
Results showed that such antigen properties infl uence the antigen-binding behavior 
and therefore also the outcome of the experiment. It remains unclear to which ex-
tent the introduced streptavidin layer infl uences the antigen binding behavior in the 
oriented non-covalent set-up (chapter 5). To clarify this issue, random biotinylated 
VHHs (via the amine groups) should be compared to site-specifi cally biotinylated 
VHHs (via Avi-tag at the C-terminus) on streptavidin-coated surfaces. 
In chapter 5, a set of antigens with diﬀ erent properties (molecular size, epito-
pe number and aﬃ  nity) was studied on the same pair of sensor chips (oriented vs 
non-oriented VHHs). Orientation of VHHs yielded in an insignifi cant low binding im-
provement for some antigens, but yielded in up to two orders of magnitude more 
sensitivity for other antigens. In our study, low aﬃ  nity antigens profi ted most from 
VHH orientation. Still it remains to be explored which features determine the relative 
aﬃ  nity of an antibody/analyte pair and which role is played by other factors (such 
as steric hindrance, epitope number and molecular size) in the whole sensor set-up. 
This outcome also suggests that it is complex to compare diﬀ erent immobilization 
strategies when another set of antibody/analyte was used. Since every antibody/
analyte pair diﬀ ers in its properties, the same immobilization method might lead to 
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diﬀ erent outcomes. Gaining more knowledge about this issue will greatly help to 
improve the design of biosensors. Investigating diﬀ erent antibody/analyte pairs on 
the same sensor using the same immobilization strategy should shed light on this 
issue. 
To yield covalently bound VHHs, a click immobilization method was explored 
in chapter 6. This work is essential for a bett er fundamental understanding of the 
antibody orientation since both VHHs were immobilized in a direct manner using 
the same chemistry without the interference of intermediate proteins. As observed 
before (chapter 5), resulted VHH orientation in a more sensitive antigen detection. 
The stunning observation that this orientation eﬀ ect could be as large as 800 was, 
in fact, way beyond our own hopes and expectations. This proved that for specifi c 
cases the (molecular biology) work required to obtain appropriately modifi ed anti-
bodies and the surface improvements to get an optimal surface architecture can be 
worth every minute of it! It should be pointed out that antigen binding was in the 
covalent immobilization set-up dependent on the antigen properties, even when the 
same immobilization chemistry was used for random and oriented VHH att achment 
(chapter 6). These pioneering observations are probably the most remarkable achie-
vements of this thesis. It was shown for the fi rst time that sensor sensitivity is not 
only infl uenced by the detection element orientation, but much stronger infl uenced 
by the analyte properties. 
The in chapter 6 chosen method to introduce azide in the protein requires time 
consuming protein engineering, but allowed the comparison of random and uni-
formly oriented VHHs. In future applications, azide groups can be incorporated at 
the VHH C-terminus in a more direct approach. The group of Schultz  showed that 
functionally unique unnatural amino acids such as p-azido-L-phenylalanine can be 
incorporated in proteins by expressing orthogonal tRNAs and aminoacyl-tRNA syn-
thetase.9 Introduction of the unnatural azide containing amino acid can be achieved 
in response to an amber nonsense codon. Another method was shown by the group 
of Ploegh.10 Anti-GFP VHH with azide or cyclooctyne moieties at the C-terminus was 
prepared using a sortase A-catalyzed ligation followed by click chemistry to prepare 
VHH dimers. Such azide functionalized VHHs could also be covalently immobilized 
onto cyclooctyne-functionalized surfaces using the strain-promoted alkyne-azide 
cycloaddition (SPAAC). Clearly, such approaches steer the further research that is 
needed into the eﬀ ect of capture molecule orientation on sensing of target and non-
target analytes.
It should be also noted that the VHH orientations investigated in chapter 5 and 6 
(oriented vs random immobilization) were studied in an indirect method by com-
paring the antigen-binding capacity using SPR as a model sensor. Where possible, 
future research should pay closer att ention to the real orientation of the VHHs. How-
ever, methods to visualize antibody orientation in a direct manner are still challen-
ging, as was reviewed in chapter 3. 
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Further expansion of the work could include studying VHH orientation on a two-
dimensional layer. The three-dimensional hydrogel matrix investigated in chapter 
4, 5 and 6 is fl exible and could infl uence orientation eﬀ ects. To have bett er control 
over orientation, oriented and random VHH immobilization should be studied on 
two-dimensional SAMs. Further on, the infl uence of the linker used to couple the 
VHH to the surface should be investigated. Linker properties (rigid, fl exible, short or 
long) will signifi cantly infl uence VHH orientation and knowledge in this fi eld would 
be valuable for future research in the biosensor sector. 
Another topic to investigate in the future concerns the newly produced OmpA-
VHH (chapter 6). In this constructs, the N-terminal start codon methionine was cut-oﬀ  
during postt ranslational processing at the OmpA signal sequence. This results in 
VHHs starting with glutamine as N-terminal amino acid (Fig. 1). In such materials, 
cyclization of the N-terminal amine and the subsequent loss of NH3 was observed 
as post-translational modifi cation in other monoclonal antibodies.11 This leads to a 
molecular weight loss of 17 Da, and was not observed as main product for our VHHs, 
but was to observe as side product (Fig. 4, chapter 6). Nevertheless, since this cyc-
lization reaction is spontaneous and highly dependent on temperature and buﬀ er 
composition, adjusting this condition could favor the formation of pyro-glutamine. 
This would ensure that the amine group at the N-terminus situated close to the 
antigen binding site is no longer available for NHS-chemistry immobilization, as 
was used for random immobilization in chapter 4 and 5. Since immobilization via 
the N-terminus amine group leads to a VHH immobilization not able to bind target 
analyte, using an N-terminally blocked VHHs could be interesting, as it may bias the 
distribution of random immobilized antibodies towards a more favored orientation 
and therefore maybe improve biosensor sensitivity. 
To summarize, many new insights have been obtained within the research pro-
ject showing that orienting antibodies on surfaces can yield an increase in the sensi-
Figure 1. Ribbon diagram of VHH and OmpA-VHH. The N-terminus of the protein situated 
close to the analyte binding site (shown in blue). VHH starts with methionine at the N-
terminus, OmpA-VHH with glutamine. Spontaneous formed pyro-glutamine displays no 
free amine group at the N-terminus for immobilization via NHS chemistry.
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tivity up to two orders of magnitude! Therefore, next to other routes, the biosensor 
sector should further follow this research path to improve sensitivity. Improving the 
detection element opens up several new possibilities, such as the development of 
smaller detection elements for the same limit of detection, or of detection elements 
that have a signifi cantly lower limit of detection. More sensitive biosensors will lead 
to an earlier detection of compounds present in small amounts, and will therefore be 
able to contribute to a further improvement of the overall quality of life. The achieve-
ments obtained here will thus hopefully help to optimize techniques to immobilize 
detection elements onto biosensing surfaces, and as such be highly relevant to im-
prove the performance of biosensors.
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Appendix 1
Figure S1. XPS spectra of copper substrate after etching step.
1.1 Monolayers of n-alkanethiols on copper
1.1.1 Freshly-etched copper substrate: 
Employing glycolic acid in EtOH (EKC 570, copper compatible post-etch residue 
remover from DuPont).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1000 800 600 400 200 0
20000
40000
60000
80000
100000
120000
140000
  
 
 
C
PS
Binding Energy (eV)
Wide Scan
Cu (100%)
  C
PS
  C
PS
970 960 950 940 930 920
5000
10000
15000
20000
25000
30000
35000
40000
45000
  
 
 
C
PS
Binding Energy (eV)
Cu
  C
PS
292 290 288 286 284 282
650
675
700
725
750
775
  
 
 
C
PS
Binding Energy (eV)
C
  C
PS
536 534 532 530 528
700
720
740
760
780
800
  
 
 
C
PS
Binding Energy (eV)
O
  C
PS
580 575 570 565 560 555 550
1000
2000
3000
4000
5000
6000
7000
  
 
 
C
PS
Binding Energy (eV)
CuLMM
  C
PS
129
Appendix 1
1.1.2 n-Decanethiol: 
Copper substrates were etched with EKC-570 solution in EtOH and the monolayers 
were prepared under argon atmosphere at 20 °C. Static water contact angle of resul-
ting monolayers: 109°.
Figure S2. XPS spectra of neat n-decanethiol monolayer on copper, 2 h.
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Appendix 1
Figure S3. XPS spectra of neat n-decanethiol monolayer on copper, 16 h.
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Appendix 1
Figure S4. XPS spectra of 500 mM (174 mg in 2.0 mL EtOH) 
n-decanethiol monolayer on copper, 2 h.
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Appendix 1
Figure S5. XPS spectra of 400 mM (140 mg in 2.0 mL EtOH) 
n-decanethiol monolayer on copper, 2 h.
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Figure S6. XPS spectra of 200 mM (70 mg in 2.0 mL EtOH) 
n-decanethiol monolayer on copper, 8 h.
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Appendix 1
Figure S7. XPS spectra of 50 mM (17 mg in 2.0 mL EtOH) 
n-decanethiol monolayer on copper, 2 h.
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Appendix 1
Figure S8. XPS spectra of 50 mM (17 mg in 2.0 mL EtOH) 
n-decanethiol monolayer on copper, 16 h.
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Appendix 1
Figure S9. XPS spectra of 10 mM (3.5 mg in 2.0 mL EtOH) 
n-decanethiol monolayer on copper, 16 h.
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1.1.3 n-Decanethiol - etching with HCl: 
Copper substrates were etched with HCl in EtOH (3.3 %) and the monolayers were 
prepared under argon atmosphere at 20 °C.
Figure S10. XPS spectra of neat n-decanethiol monolayer on copper, 
etching with HCl, 16 h.
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1.1.4 n-Octadecanethiol: 
Copper substrate was etched with EKC-570 solution in EtOH and the monolayer was 
prepared in toluene under argon atmosphere at 20 °C. Static water contact angle of 
resulting monolayer: 110°.
Figure S11. XPS spectra of 500 mM (287 mg in 2.0 mL toluene) 
n-octadecanethiol monolayer on copper, 16 h.
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1.2 Functional organic monolayers on copper: 
Copper substrates were etched with EKC-570 solution in EtOH and the monolayers 
were prepared in toluene under argon atmosphere at 20°C, for 16 h.
1.2.1 11-Mercaptoundecanoic acid (MUA): 
200 mM (87 mg, 0.40 mmol) MUA in 2.0 mL dry toluene. Static water contact angle 
of resulting monolayer: 50°.
Figure S12. XPS spectra of the acid-terminated copper monolayer.
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1.2.2 10-Mercaptodecanol (MD): 
200 mM (82 mg, 0.40 mmol) MD in 2.0 mL dry toluene. Static water contact angle of 
resulting monolayer: 40°.
Figure S13. XPS spectra of the alcohol-terminated copper monolayer.
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1.2.3 N-Succinimidyl mercaptoundecylenate (NHS-MUA): 
200 mM (126 mg, 0.40 mmol) NHS-MUA in 2.0 mL dry toluene. Static water contact 
angle of resulting monolayer: 55°.
Figure S14. XPS spectra of the NHS-ester-terminated copper monolayer.
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Figure S15. IRRA spectrum of the NHS-ester-terminated copper monolayer.
Table S1. Selected IR data for the NHS-ester-terminated copper monolayer.
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Frequency (cm-1) Assignment 
2919 ?a(CH2), antisymmetric stretch 
2851 ?s(CH2), symmetric stretch 
1817 ?(C=O), carbonyl stretch of the ester 
1788 ?s(C=O), symmetric stretch of the NHS 
1745 ?a(C=O), antisymmetric stretch of the NHS 
1375 ?s(C-N-C), symmetric C-N-C stretch of the NHS 
1214 Amide III, N-C=O vibration in the NHS 
1078 (N-C-O), N-C=O stretch of the NHS 
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1.3 Conjugation reactions: 
These reactions were carried out under argon atmosphere at 20 °C for 16 h.
1.3.1 β-D-Glucosamine: 
0.1 M (43 mg, 0.20 mmol) β-D-glucosamine, 0.1 mL NEt3 in 1.9 mL dry methanol. 
Static water contact angle of resulting monolayer: 76°.
Figure S16. XPS spectra obtained after reaction of NHS-ester-terminated 
copper monolayer with β-D-glucosamine.
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1.3.2 Glutathione: 
0.1 M (61 mg, 0.20 mmol) glutathione, 0.1 mL NEt3 in 1.9 mL dry methanol.
Static water contact angle of resulting monolayer: 24°.
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Figure S17. XPS spectra obtained after reaction of NHS-ester-terminated 
copper monolayer with glutathione.
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Figure S18. IRRA spectrum obtained after reaction of NHS-ester-terminated copper mono-
layer with glutathione.
Table S2. Selected IR data for the glutathione monolayer on copper.
 
Frequency (cm-1) Assignment 
2921 ?a(CH2), antisymmetric stretch 
2851 ?s(CH2), symmetric stretch 
1742 ?(C=O), free carboxylic acid stretch 
1659 Amide I, C=O (stretch) amide 
1552 Amide II, C-N (stretch); C-N-H (deformation) 
1410 ?s(CH2), scissoring 
1222 ?(C-OH), bending 
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1.3.3 5-(Biotinamido)pentylamine: 
0.01 M (6.6 mg, 0.02 mmol) 5-(biotinamido)-pentylamine, 0.1 mL NEt3 in 1.9 mL dry 
methanol. Static water contact angle of resulting monolayer: 57°.
Figure S19. XPS spectra obtained after reaction of NHS-ester-terminated 
copper monolayer with 5-(biotinamido)pentylamine.
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Figure S20. IRRA spectrum obtained after reaction of NHS-ester-terminated copper mono-
layer with 5-(biotinamido)pentylamine.
Table S3. Selected IR data for the biotin monolayer on copper.
Frequency (cm-1) Assignment 
3252 N-H stretch vibration 
2924 ?a(CH2), antisymmetric stretch 
2853 ?s(CH2), symmetric stretch 
1819 ?(C=O), carbonyl stretch of the ester 
1786 ?s(C=O), symmetric stretch of the NHS 
1747 ?a(C=O), antisymmetric stretch of the NHS 
1711 Amide I, C=O stretch vibration of cyclic urea 
1653 Amide I, C=O stretching vibration of the amide groups 
1539 Amide II, C-N (stretch), C-N-H (deformation) of the amide moiety 
1341 ?s(C-N-C), symmetric C-N-C stretch of the NHS 
1217 Amide III, N-C=O vibration in the NHS and biotin moiety 
1045 ?(N-C-O), N-C=O stretch of the NHS and biotin moiety 
148
Appendix 2
2.1  Oligonucleotides used for OmpA-M200 
Table S4. Oligonucleotides.
Changed amino acids in oligonucleotides shown in red and cursive. PstI/NdeI sticky ends are 
shown in cursive and underlined. 
 
Name Primer (5'? 3’) 
M200-F CACTATAGGGAGACCACAACGG 
M200-R CACCATCACCACGGTATGTAAG 
M200-M83A_M88A-F CGCCAAAAAGGCGGTGTATCTGCAAGCGAACAGCCTG 
M200-M83A_M88A-R CAGGCTGTTCGCTTGCAGATACACCGCCTTTTTGGCG 
M200-M153G-F CCGATATAGAAGGGAACCGCCTGGGC 
M200-M153G-R CCGATATAGAAGGGAACCGCCTGGGC 
OmpA-F  TATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGTTTCGCTACCGTGGCCCAGGCGCAGGTGCAGCTGCA
OmpA-R GCTGCACCTGCGCCTGGGCCACGGTAGCGAAACCAGCCAGTGCCACTGCAATCGCGATAGCTGTCTTTTTCA 
2.2  Average signal loss after peptide PAT49 binding 
 
?? ? NHS chemistry M200-AHA click chemistry OmpA-M200-AHA
Cycle 20 22.28 RU 12.19 RU 
Cycle 47 20.70 RU 11.42 RU 
   
loss RU after 27 cycles: 7.07% 6.32% 
loss per cycle: 0.26% 0.23% 
Table S5. Average signal loss after peptide PAT49 
binding followed by regeneration 
The average signal loss per cycle (measured in response diﬀ erence [RU]) was determined 
after repeated cycles of peptide PAT49 (50 μg mL-1) injection followed by regeneration with 5 
μL 10 mM HCl. Data points were measured 30 sec after injection end.  
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SUMMARY
In this thesis we set out to increase the knowledge of oriented detection elements 
on biosensor surfaces. In natural sensing systems, such as the eye, oriented proteins 
on surfaces are a common principle, which mediates highly sensitive detection sys-
tems. By following similar principles, namely the orientation of detection elements, 
biosensors can be up-graded to ´natural` standards with regard to sensitivity and 
potential for miniaturization. 
Chapter 1 is the introduction of this thesis, and describes several aspects that are 
important for the fi eld of biosensors. The research reported in this thesis is taking 
place at the interface of several scientifi c research disciplines: surface chemistry, pro-
tein engineering and coupling chemistry. Each of these aspects itself has the power 
to improve biosensor performance. Therefore, research and optimization in each 
area is of value for the biosensor community. 
Chapter 2 describes the formation of self-assembled monolayers (SAMs) on 
oxide-free copper. The preparation and characterization of well-ordered alkyl-thiol 
monolayers were described in detail. Monolayers of N-succinimidyl mercaptounde-
canoate (NHS-MUA) were prepared and served as a platform for further functiona-
lization with amine exposing biomolecules, such as β-d-glucosamine, the tripeptide 
glutathione, and biotin. Finally, the biotinylated copper surface was used to selec-
tively immobilize streptavidin.
Chapter 3 reviews the state-of-the-art of various antibody immobilization me-
thods. The presented methods diﬀ er in control over orientation (oriented vs random 
immobilization) as well as in the resulting stability of immobilization (covalent vs 
non-covalent att achment). The chapter also describes several methods that are cur-
rently used to elucidate antibody orientation in a more direct manner. 
We next selected llama antibody domains (VHHs) to obtain detection elements 
against tuberculosis (chapter 4). Two diﬀ erent selection strategies based on phage 
display were employed and resulted in a selection of VHHs. It was demonstrated that 
the selected VHHs were specifi c for tuberculosis causing mycobacteria and could be 
used as detection element in enzyme-linked immunosorbent assay (ELISA) as well 
as in a surface plasmon resonance (SPR)-based biosensor. 
In order to be able to orient llama antibody domains on surfaces, a strategy intro-
ducing biotin at the C-terminus of VHHs was used in chapter 5. Two diﬀ erent llama 
antibody domains were used, one VHH specifi c for tuberculosis and one for the foot-
and-mouth-disease virus (FMDV). By immobilization on a streptavidin coated-bio-
sensor surface, biotinylated VHHs were oriented. In this set-up, the analyte binding 
site of the VHH was exposed to the analyte solution. The infl uence on analyte binding 
of the oriented set-up was compared to a random set-up. Random immobilization 
was achieved using the amine groups in the VHH, via NHS-EDC coupling. By using 
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a batch of diﬀ erent analytes, all specifi c for VHH, the infl uence of analyte properties 
on binding was studied. It was shown that epitope number, molecular size and bin-
ding aﬃ  nity greatly infl uence the analyte binding. Importantly, it was shown that 
orientation of detection elements may strongly improve the intensity of the analyte 
binding signal, and that this eﬀ ect is much stronger for lower-aﬃ  nity analytes. 
In chapter 6 we investigated a novel strategy to immobilize VHHs specifi c for 
FMDV, and we deployed this strategy to couple VHH either in an oriented or in a 
random manner on the surface. An introduced azide group was used as functional 
handle for immobilization of the VHH. Azide groups were introduced in VHH with 
azidohomoalanine, a non-natural amino acid that replaces methionine in proteins 
expressed in methionine-depleted bacterial cultures. It was demonstrated that resi-
due-specifi c incorporation of azidohomoalanine enabled modifi cation of VHH (M200) 
at several positions of the fi ve introduced azide groups. Using molecular techniques, 
VHHs containing only a single azide were prepared (OmpA-M200). The two distinct 
azide-functionalized VHHs, M200 and OmpA-M200, containing fi ve or one azide 
group, respectively, were immobilized on cyclooctyne-functionalized surfaces. The 
oriented and non-oriented surfaces were investigated for detection sensitivity with 
SPR as model-biosensor. It was shown that oriented immobilization resulted in a 
much higher sensitivity of the biosensor.
In the general discussion, the most important achievements of this thesis are pre-
sented. Recommendations as well as additional thoughts on how to incorporate re-
sults of this research into the biosensor fi eld are discussed.
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Dit proefschrift is geschreven met als doel de kennis van georiënteerde detectie-
elementen op biosensoren te vergroten. In natuurlijke sensing systemen, zoals het 
oog, zijn zelfgeordende eiwitt en aan het oppervlak een algemeen begrip. Door het 
volgen van hetz elfde principe, de oriëntatie van eiwitt en zoals in dit proefschrift, 
kunnen synthetische biosensoren met recombinant eiwitt en opgewaardeerd naar 
´natuurlijke` normen inzake gevoeligheid en miniaturisatie.
Hoofdstuk 1 is de inleiding van dit proefschrift en beschrijft diverse aspecten 
die belangrijk zijn op het gebied van biosensoren. Het onderzoek beschreven in dit 
proefschrift valt onder verschillende wetenschappelijke onderzoeksdisciplines: op-
pervlakte chemie, eiwit engineering en koppelingschemie. Elk van deze aspecten is 
van belang voor een verbeterde werking van biosensoren. Daarom is onderzoek en 
optimalisatie in elk facet van waarde voor de biosensor-wereld. 
Hoofdstuk 2 beschrijft de vorming van zelf-geassembleerde monolagen (in En-
gels: self-assembled monolayers [SAM]) op oxide-vrij koper. Ook de bereiding en 
karakterisatie van welgeordende alkynthiol monolagen zijn beschreven. Monolagen 
van N-succinimidyl mercaptoundecanoaat (NHS-MUA) zijn gemaakt. Deze dienden 
als een platform voor verdere functionalisering met amine-biomoleculen zoals β-D-
glucosamine, het tripeptide glutathion en biotine. Ten slott e wordt het gebiotinyleer-
de koperoppervlak worden gebruikt om streptavidine selectief te immobiliseren.
In hoofdstuk 3 wordt de stand van zaken op het gebied van methodes voor  anti-
lichaam immobilisatie beschreven. De gepresenteerde methoden verschillen in con-
troleerbaarheid van oriëntatie (georiënteerde vs willekeurige immobilisatie) en in 
de resulterende stabiliteit van immobilisatie (covalent vs non-covalent gebonden). 
Ook worden verschillende actuele karakterisatiemethoden beschreven die worden 
toegepast om de oriëntatie van antilichamen op een directe manier te analyseren.
Vervolgens zijn lama antilichaam domeinen (VHHs) geïsoleerd om detectie-ele-
menten tegen tuberculose (hoofdstuk 4) te verkrijgen. Twee verschillende selectie-
strategieën gebaseerd op faagdisplay zijn toegepast en resulteerden in een selectie 
van een aantal verschillende VHHs. De gekozen VHHs zijn specifi ek voor tuberculose 
veroorzaakt mycobacteriën en kunnen worden gebruikt als detectie-element in en-
zyme-linked immunosorbent assay (ELISA) en in oppervlakte plasmon resonantie 
(Engels: surface plasmon resonance [SPR]) gebaseerde biosensoren.
Om lama antilichaam domeinen op oppervlakken te kunnen oriënteren is een 
biotine aan de C-terminus van VHHs gekoppeld (hoofdstuk 5). Er zijn twee verschil-
lende lama antilichaamdomeinen gebruikt, een VHH specifi ek voor tuberculose en 
een voor het mond- en klauwzeer (MKZ) virus. Door immobilisatie op streptavidine 
gecoate biosensoren, kunnen de  gebiotinyleerde VHHs georiënteerd worden gebon-
den. Op deze manier is de analyt bindingsplaats van het VHH vrij toegankelijk en kan 
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direct worden blootgesteld aan de analytoplossing. De invloed op de bindingseﬀ ec-
tiviteit van de analyt gerichte set-up werd vergeleken met een willekeurige opstel-
ling. Met een standaard (niet-georiënteerd) NHS-EDC koppeling werd willekeurige 
immobilisatie bereikt middels de aminegroepen in het VHH. Door het gebruik van 
een batch van verschillende analyten, specifi ek voor VHH, is de invloed van analyt 
binding met het detectie element orientatie onderzocht. Er is aangetoond dat o.a. 
epitoop aantal, molecuulgroott e en bindingsaﬃ  niteit de analyt binding sterk beïn-
vloeden. Aangetoond is dat oriëntatie van detectie-elementen de intensiteit van het 
analyt bindende signaal sterk verbetert en dat dit eﬀ ect veel sterker is voor analyten 
met een lagere aﬃ  niteit.
In hoofdstuk 6 werd een nieuwe strategie introduceerd om VHHs specifi ek voor 
de mond-en-klauwzeer virus (MKZ virus, Engels: FMDV van ´foot-and-mouth-di-
sease` virus) te immobiliseren. Deze strategie wordt ingezet om VHHs hetz ij in een 
georiënteerd, of op willekeurige wijze aan een oppervlak te koppelen. Voor immo-
bilisatie van de VHH M200, die MKZ virus herkend, werd een azidegroep geïntro-
duceerd als functionele handgreep. Deze azide groepen worden ingebouwd in VHH 
M200 via het aminozuur azidohomoalanine, een niet-natuurlijk aminozuur dat in 
plaats van methionine kan worden ingebouwd. Met behulp van moleculaire tech-
nieken is het mogelijk om VHHs met slechts een azide (OmpA-M200) te bereiden. De 
twee verschillende azide-gefunctionaliseerde VHHs, M200 en M200-OmpA, met vijf 
of slechts één azidegroep respectievelijk, worden geïmmobiliseerd op cyclooctyn-
gefunctionaliseerde oppervlakken. De georiënteerde en niet-georiënteerde opperv-
lakken worden onderzocht en vergeleken op gevoeligheid in een SPR biosensor. 
Er wordt aangetoond dat georiënteerde immobilisatie resulteert in een signifi cant 
hogere gevoeligheid van de biosensor.
In de algemene discussie worden de belangrijkste resultaten van dit proefschrift 
gepresenteerd. Tenslott e worden er aanbevelingen en alsmede aanvullende gedach-
ten gegeven over de wijze waarop de resultaten van dit onderzoek toegepast kun-
nen worden in de biosensor-wereld.
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ZUSAMMENFASSUNG
Diese Doktorarbeit gibt Einblicke in die Auswirkungen von orientierten Detek-
tionselementen auf Biosensoroberfl ächen. In natürlichen Messsystemen, wie dem 
Auge, sind orientierte Proteine an Oberfl ächen ein gängiges Prinzip und tragen maß-
geblich zur Sensitivität der empfi ndlichen Detektionssysteme bei. In dieser Dok-
torarbeit werden diverse Strategien zur Orientierung von Proteinen dargestellt, um 
leistungsfähigere Biosensoren zu entwickeln. Durch die orientierte Immobilisierung 
von Detektionselementen (hier: rekombinante Proteine) sollen Model-Biosensoren 
in Bezug auf Sensitivität und Potential zur Miniaturisierung verbessert werden.
Kapitel 1 dieser Doktorarbeit dient als Einführung und erläutert relevante For-
schungsbereiche auf dem Gebiet der Biosensoren. Aufgrund des Schwerpunktes der 
Doktorarbeit betreﬀ en die Forschungstätigkeiten verschiedene Disziplinen: Oberfl ä-
chenchemie, Protein-Engineering (von englisch: engineering; hier etwa Konstrukti-
on oder Manipulation) und Kopplungschemie. Jeder dieser Aspekte trägt dazu bei, 
die Leistung von Biosensoren zu verbessern. Die Forschung und Optimierung in 
diesen Bereichen ist daher wertvoll für den Biosensorensektor. 
In Kapitel 2 wird die Bildung von selbstorganisierten Monoschichten (von eng-
lisch: Self-assembled monolayers [SAMs]) auf oxid-freiem Kupfer beschrieben. Die 
Herstellung und Charakterisierung von wohlgeordneten Alkanethiol Monoschich-
ten werden im Detail dargestellt. Monoschichten von N-Succinimidyl mercaptoun-
decanoate (NHS-MUA) wurden hergestellt und dienten als Platt form für weitere 
Funktionalisierungen mit aminehaltigen Biomolekülen wie β-D-Glucosamine, dem 
Tripeptid Glutathion und Biotin. Ferner konnten biotinylierte Kupferoberfl ächen 
zur selektiven Immobilisierung von Streptavidin genutz t werden.
Das dritt e Kapitel beschäftigt sich mit diversen Antikörper-Immobilisierungs- 
Methoden, die aktuell in der Forschung Verwendung fi nden. Die vorgestellten Me-
thoden unterscheiden sich in ihrer Kontrolle über die Orientierung (orientierte vs 
zufällige Immobilisierung) sowie in der Stabilität der entstehenden Immobilisierung 
(kovalente vs nicht-kovalente Bindung). Zudem werden verschiedene Methoden be-
schrieben, um Antikörper-Orientierung in direkter Weise nachzuweisen.
Daran anschließend wird aufgezeigt, wie Antikörperdomänen (VHHs) von Lamas 
selektiert und als Detektionselemente gegen Tuberkulose verwendet wurden (Kapi-
tel 4). Zwei verschiedene Auswahl-Strategien, basierend auf Phagen-Display, wur-
den  angewendet und mündeten in einer Auswahl von VHHs. Die ausgewählten VHHs 
waren spezifi sch für Tuberkulose verursachende Mykobakterien und konnten als 
Detektionselement in einem antikörperbasierenden  Nachweisverfahren (Enzym-
Linked Immunosorbent Assay, ELISA) sowie in einem Model-Biosensor verwendet 
werden.
Um die Lama Antikörperdomänen auf Oberfl ächen zu orientieren, wurde - wie 
in Kapitel 5 dargestellt - eine Strategie verwendet, die ein Biotin Molekül an dem 
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C-Terminus der VHHs anhängt. Dazu wurden zwei verschiedenartige Lama Anti-
körperdomänen verwendet: ein VHH spezifi sch für Tuberkulose und ein VHH spe-
zifi sch für das Maul-und-Klauen-Seuche-Virus (MKSV, im Englischen: FMDV von 
´foot-and-mouth-disease` virus). Durch die Immobilisierung auf einer mit Strepta-
vidin beschichteten Biosensoroberfl äche konnten die biotinylierten VHHs eine orien-
tierte Anordnung auf der Oberfl äche einnehmen. In diesem Versuchsaufb au ist die 
Analyten-Bindestelle des VHHs der Analyten-Lösung zugewandt. Die orientierte An-
ordnung der Antikörperdomänen wurde mit einer zweiten, zufälligen Anordnung 
verglichen. Die Immobilisierung in einer zufälligen Anordnung wurde unter Ver-
wendung der Aminogruppen in den VHHs über NHS-EDC Kupplung erzielt. Durch 
die Verwendung einer Auswahl verschiedener Analyten, alle spezifi sch für die An-
tikörperdomäne, konnte der Einfl uss von Analyteigenschaften auf das Binden an 
die Antikörperdomäne untersucht werden. Es stellte sich heraus, dass Epitopnum-
mer, Molekülgröße und Bindungsaﬃ  nität großen Einfl uss auf das Bindeverhalten 
des Analyten haben. Durch die Orientierung von Detektionselementen konnte das 
Analyt-Bindesignal stark verbessert werden und es zeigte sich, dass der Eﬀ ekt für 
Analyten mit niedrigerer Aﬃ  nität viel dominanter ist.
In Kapitel 6 wurde eine neue Strategie untersucht, um die MKSV spezifi schen 
VHHs zu immobilisieren. Mit der verwendeten Methode wurden die VHH gezielt in 
einer orientierten oder in einer zufälligen Anordnung auf der Oberfl äche gekoppelt. 
Eine eingeführte Azidgruppe diente hierbei als funktioneller Griﬀ , an dem die VHH 
immobilisiert werden konnten. Die Azidgruppe wurde unter Verwendung der nicht 
in der Natur vorkommenden Aminosäure Azidohomoalanine in die Proteine einge-
baut. Es zeigte sich, dass einige der fünf spezifi sch eingebauten Azidgruppen in VHH 
M200 für eine chemische Reaktion mit einem Alkine zur Verfügung stehen. Durch 
die Verwendung molekularbiologischer Techniken konnten VHHs mit nur einem ein-
zigen Azid hergestellt werden (OmpA-M200). Die zwei verschiedenen Azid-funk-
tionalisierten VHHs, M200 und OmpA-M200, mit fünf oder nur einer Azidgruppe, 
wurden jeweils auf Cyclooctin-funktionalisierten Oberfl ächen immobilisiert. Die 
orientierten (OmpA-M200) oder zufällig (M200) immobilisierten VHHs wurden auf 
Nachweisempfi ndlichkeit mit Hilfe eines Model-Biosensors untersucht. Es stellte 
sich heraus, dass orientierte Immobilisierung zu einer viel höheren Sensitivität des 
Biosensors führt.
In der allgemeinen Diskussion werden die wichtigsten Erkenntnisse dieser Dok-
torarbeit zusammenfassend dargestellt. Empfehlungen, sowie weitere Gedanken 
darüber, wie die Ergebnisse dieser Forschung Anwendung im Biosensorsektor fi n-
den könnten, werden aufgezeigt.
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